<?xml version="1.0"  ?><!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd"><pmc-articleset><article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" article-type="review-article" xml:lang="en" dtd-version="1.4"><front><journal-meta><journal-id journal-id-type="nlm-ta">Front Cell Infect Microbiol</journal-id><journal-id journal-id-type="iso-abbrev">Front Cell Infect Microbiol</journal-id><journal-id journal-id-type="pmc-domain-id">1860</journal-id><journal-id journal-id-type="pmc-domain">fcimb</journal-id><journal-id journal-id-type="publisher-id">Front. Cell. Infect. Microbiol.</journal-id><journal-title-group><journal-title>Frontiers in Cellular and Infection Microbiology</journal-title></journal-title-group><issn pub-type="epub">2235-2988</issn><publisher><publisher-name>Frontiers Media SA</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="pmcid">PMC6904299</article-id><article-id pub-id-type="pmcid-ver">PMC6904299.1</article-id><article-id pub-id-type="pmcaid">6904299</article-id><article-id pub-id-type="pmcaiid">6904299</article-id><article-id pub-id-type="pmid">31867283</article-id><article-id pub-id-type="doi">10.3389/fcimb.2019.00401</article-id><article-version article-version-type="pmc-version">1</article-version><article-categories><subj-group subj-group-type="heading"><subject>Cellular and Infection Microbiology</subject><subj-group><subject>Review</subject></subj-group></subj-group></article-categories><title-group><article-title>Interleukin (IL)-21 in Inflammation and Immunity During Parasitic Diseases</article-title></title-group><contrib-group><contrib contrib-type="author"><name name-style="western"><surname>Solaymani-Mohammadi</surname><given-names initials="S">Shahram</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref><xref ref-type="corresp" rid="c001"><sup>*</sup></xref><uri xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="http://loop.frontiersin.org/people/786317/overview"/></contrib><contrib contrib-type="author"><name name-style="western"><surname>Eckmann</surname><given-names initials="L">Lars</given-names></name><xref ref-type="aff" rid="aff2"><sup>2</sup></xref><uri xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="http://loop.frontiersin.org/people/244750/overview"/></contrib><contrib contrib-type="author"><name name-style="western"><surname>Singer</surname><given-names initials="SM">Steven M.</given-names></name><xref ref-type="aff" rid="aff3"><sup>3</sup></xref></contrib></contrib-group><aff id="aff1"><sup>1</sup><institution>Center for Global Infectious Disease Research, Seattle Children's Research Institute</institution>, <addr-line>Seattle, WA</addr-line>, <country>United States</country></aff><aff id="aff2"><sup>2</sup><institution>Department of Medicine, University of California, San Diego</institution>, <addr-line>La Jolla, CA</addr-line>, <country>United States</country></aff><aff id="aff3"><sup>3</sup><institution>Department of Biology, Georgetown University</institution>, <addr-line>Washington, DC</addr-line>, <country>United States</country></aff><author-notes><fn fn-type="edited-by"><p>Edited by: Tiago W. P. Mineo, Federal University of Uberlandia, Brazil</p></fn><fn fn-type="edited-by"><p>Reviewed by: Maria Del Consuelo Gomez, National Polytechnic Institute, Mexico; Diego Luis Costa, National Institute of Allergy and Infectious Diseases (NIAID), United States</p></fn><corresp id="c001">*Correspondence: Shahram Solaymani-Mohammadi <email>shahram.solaymani-mohammadi@seattlechildrens.org</email></corresp><fn fn-type="other" id="fn001"><p>This article was submitted to Parasite and Host, a section of the journal Frontiers in Cellular and Infection Microbiology</p></fn></author-notes><pub-date pub-type="epub"><day>04</day><month>12</month><year>2019</year></pub-date><pub-date pub-type="collection"><year>2019</year></pub-date><volume>9</volume><issue-id pub-id-type="pmc-issue-id">328309</issue-id><elocation-id>401</elocation-id><history><date date-type="received"><day>20</day><month>8</month><year>2019</year></date><date date-type="accepted"><day>11</day><month>11</month><year>2019</year></date></history><pub-history><event event-type="pmc-release"><date><day>01</day><month>01</month><year>2019</year></date></event><event event-type="pmc-live"><date><day>20</day><month>12</month><year>2019</year></date></event><event event-type="pmc-last-change"><date iso-8601-date="2019-12-25 02:56:31.190"><day>25</day><month>12</month><year>2019</year></date></event></pub-history><permissions><copyright-statement>Copyright &#169; 2019 Solaymani-Mohammadi, Eckmann and Singer.</copyright-statement><copyright-year>2019</copyright-year><copyright-holder>Solaymani-Mohammadi, Eckmann and Singer</copyright-holder><license xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="http://creativecommons.org/licenses/by/4.0/"><ali:license_ref specific-use="textmining" content-type="ccbylicense">https://creativecommons.org/licenses/by/4.0/</ali:license_ref><license-p>This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.</license-p></license></permissions><self-uri xmlns:xlink="http://www.w3.org/1999/xlink" content-type="pmc-pdf" xlink:href="fcimb-09-00401.pdf"/><abstract><p>Parasitic diseases cause significant morbidity and mortality in the developing and underdeveloped countries. No efficacious vaccines are available against most parasitic diseases and there is a critical need for developing novel vaccine strategies for care. IL-21 is a pleiotropic cytokine whose functions in protection and immunopathology during parasitic diseases have been explored in limited ways. IL-21 and its cognate receptor, IL-21R, are highly expressed in parasitized organs of infected humans as well in murine models of the human parasitic diseases. Prior studies have indicated the ability of the IL-21/IL-21R signaling axis to regulate the effector functions (e.g., cytokine production) of T cell subsets by enhancing the expression of T-bet and STAT4 in human T cells, resulting in an augmented production of IFN-&#947;. Mice deficient for either IL-21 (<italic toggle="yes">Il21</italic><sup>&#8722;/&#8722;</sup>) or IL-21R (<italic toggle="yes">Il21r</italic><sup>&#8722;/&#8722;</sup>) showed significantly reduced inflammatory responses following parasitic infections as compared with their WT counterparts. Targeting the IL-21/IL-21R signaling axis may provide a novel approach for the development of new therapeutic agents for the prevention of parasite-induced immunopathology and tissue destruction.</p></abstract><kwd-group><kwd>interleukin (IL)-21</kwd><kwd>parasite</kwd><kwd>inflammation</kwd><kwd>immunity</kwd><kwd>cytokine</kwd><kwd>signaling</kwd></kwd-group><funding-group><award-group><funding-source id="cn001">National Institutes of Health<named-content content-type="fundref-id">10.13039/100000002</named-content></funding-source></award-group></funding-group><counts><fig-count count="1"/><table-count count="1"/><equation-count count="0"/><ref-count count="175"/><page-count count="14"/><word-count count="13951"/></counts><custom-meta-group><custom-meta><meta-name>pmc-status-qastatus</meta-name><meta-value>0</meta-value></custom-meta><custom-meta><meta-name>pmc-status-live</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-status-embargo</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-status-released</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-open-access</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-olf</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-manuscript</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-legally-suppressed</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-has-pdf</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-has-supplement</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-pdf-only</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-suppress-copyright</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-is-real-version</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-is-scanned-article</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-preprint</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-in-epmc</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-license-ref</meta-name><meta-value>CC BY</meta-value></custom-meta></custom-meta-group></article-meta></front><body><sec sec-type="intro" id="s1"><title>Introduction</title><p>Parasitic diseases pose a major public threat to the world's population, causing immense morbidity and mortality, especially in underdeveloped and developing countries (Mackey et al., <xref rid="B79" ref-type="bibr">2014</xref>; Torgerson et al., <xref rid="B150" ref-type="bibr">2014</xref>, <xref rid="B151" ref-type="bibr">2015</xref>). Parasites colonize and replicate in a wide range of human tissues and clinical symptoms can range from a completely asymptomatic profile to severe disease profiles that can be either transient or chronic (Solaymani-Mohammadi and Singer, <xref rid="B134" ref-type="bibr">2010</xref>). In immunocompetent individuals, most parasitic infections are generally considered self-limited, indicating the development and the maintenance of protective immune mechanisms against invading parasites (Okhuysen, <xref rid="B102" ref-type="bibr">2001</xref>; Meamar et al., <xref rid="B81" ref-type="bibr">2006</xref>; Saporito et al., <xref rid="B123" ref-type="bibr">2013</xref>; Lanocha-Arendarczyk et al., <xref rid="B69" ref-type="bibr">2018</xref>). However, multiple studies have suggested that host immune responses elicited during parasitic infections can mediate immunopathology and are responsible for many of the symptoms commonly observed during parasitic diseases (Phillips and Fox, <xref rid="B110" ref-type="bibr">1984</xref>; Pesce et al., <xref rid="B109" ref-type="bibr">2006</xref>; Babaei et al., <xref rid="B9" ref-type="bibr">2016</xref>; Ivanova et al., <xref rid="B59" ref-type="bibr">2019</xref>; Weaver et al., <xref rid="B162" ref-type="bibr">2019</xref>). These immunopathological changes may include parasite-induced morphological, functional, physiological, and structural alterations in parasitized tissues/cells, rendering infected individuals susceptible to organ dysfunction as well as the development of severe forms of clinical disease (Solaymani-Mohammadi and Singer, <xref rid="B135" ref-type="bibr">2013</xref>; Taniguchi et al., <xref rid="B148" ref-type="bibr">2015</xref>; Gorosito Serran et al., <xref rid="B48" ref-type="bibr">2017</xref>; Ma'ayeh et al., <xref rid="B78" ref-type="bibr">2018</xref>).</p><p>Increasing evidence suggests that immune responses meant to eliminate or restrict the invading tissue-residing parasites can drive organ fibrosis and the subsequent organ dysfunction (Pesce et al., <xref rid="B109" ref-type="bibr">2006</xref>; Nair et al., <xref rid="B94" ref-type="bibr">2011</xref>; Adams et al., <xref rid="B2" ref-type="bibr">2014</xref>; Sripa et al., <xref rid="B142" ref-type="bibr">2018</xref>; Ferreira et al., <xref rid="B40" ref-type="bibr">2019</xref>). For example, continuous and chronic infection episodes of the liver in humans infected with the blood fluke, <italic toggle="yes">Schistosoma mansoni</italic>, or cystic hydatidosis caused by the larval stage of <italic toggle="yes">Echinococcus granulosus</italic> can eventually lead to severe forms of liver fibrosis (Zhang C. et al., <xref rid="B170" ref-type="bibr">2016</xref>; Labsi et al., <xref rid="B68" ref-type="bibr">2018</xref>; Yong et al., <xref rid="B167" ref-type="bibr">2019</xref>). It has been suggested that T<sub>H1</sub> and T<sub>H2</sub> immune responses have opposing functions during human schistosomiasis; T<sub>H2</sub> polarization, mainly in response to <italic toggle="yes">Schistosoma</italic> egg antigens, promotes liver fibrosis during human schistosomiasis, whereas a T<sub>H1</sub>-biased immune response inhibits the development of liver fibrosis during schistosomiasis (Mentink-Kane and Wynn, <xref rid="B82" ref-type="bibr">2004</xref>; Wynn, <xref rid="B164" ref-type="bibr">2004</xref>; Wynn et al., <xref rid="B165" ref-type="bibr">2004</xref>). Increased levels of T<sub>H1</sub>-associated cytokines, such as TNF-&#945; and IFN-&#947;, are observed in the blood and tissues in different clinical presentations of malaria, suggesting pivotal roles played by these cytokines in protection against malaria in both rodent and human malaria (Hernandez-Valladares et al., <xref rid="B51" ref-type="bibr">2006</xref>; Poovassery et al., <xref rid="B113" ref-type="bibr">2009</xref>; Korner et al., <xref rid="B66" ref-type="bibr">2010</xref>; Fauconnier et al., <xref rid="B39" ref-type="bibr">2012</xref>). However, it is well-established that enhanced levels of TNF-&#945; are associated with a greater risk of the development of severe malaria in humans and mice deficient for this cytokine were resistant to the development of cerebral malaria (CM) following <italic toggle="yes">Plasmodium berghei</italic> infection (Rudin et al., <xref rid="B120" ref-type="bibr">1997</xref>; Perera et al., <xref rid="B107" ref-type="bibr">2013</xref>; Dunst et al., <xref rid="B36" ref-type="bibr">2017</xref>). Further analyses have indicated that proinflammatory cytokines, such as TNF-&#945;, can regulate the expression of chemokine/chemokine receptors and other adhesion molecules by endothelial cells of the brain and they can enhance the trafficking and the homing of inflammatory leukocytes to the brain, leading to an exacerbated disease profile (Pober and Sessa, <xref rid="B112" ref-type="bibr">2007</xref>; Miu et al., <xref rid="B88" ref-type="bibr">2008</xref>).</p><p>Due to a variety of factors, including elaborate mechanisms of antigenic variation and immune evasion used by many parasites, there have been no effective vaccines approved for humans against parasitic diseases. This lack of efficacious vaccines for most parasitic infections in humans coupled with the increasing emergence of drug-resistant parasite strains requires the continuous development of new therapeutic approaches. A comprehensive understanding of the host-parasite interactions as well as the cytokine crosstalk following parasitic infections, including identification of the mechanisms by which protective and deleterious immune responses are regulated, can help design novel strategies for fighting parasitic infections and reducing the associated morbidity and mortality.</p></sec><sec id="s2"><title>IL-21/IL-21R Signaling Pathway</title><p>IL-21 is a member of the common gamma chain (&#947;c) family of cytokines and is expressed by multiple immune cell types (Spolski and Leonard, <xref rid="B137" ref-type="bibr">2008</xref>), with activated CD4<sup>+</sup> T cells, including T follicular helper (T<sub>FH</sub>) cells and natural killer (NK) T cells, being the major sources of this cytokine (Spolski and Leonard, <xref rid="B138" ref-type="bibr">2010a</xref>; Crotty, <xref rid="B26" ref-type="bibr">2011</xref>; Linterman et al., <xref rid="B73" ref-type="bibr">2011</xref>). The induction of IL-21 in activated CD4<sup>+</sup> T cells is mediated by c-Maf <italic toggle="yes">in vitro</italic> (Hiramatsu et al., <xref rid="B52" ref-type="bibr">2010</xref>; Kroenke et al., <xref rid="B67" ref-type="bibr">2012</xref>) and <italic toggle="yes">in vivo</italic> (Bauquet et al., <xref rid="B13" ref-type="bibr">2009</xref>), whereas the expression of c-Maf in CD4<sup>+</sup> T cells is regulated by IL-6 (Hiramatsu et al., <xref rid="B52" ref-type="bibr">2010</xref>) or IL-27 (Pot et al., <xref rid="B114" ref-type="bibr">2009</xref>).</p><p>The biological functions of IL-21 are mediated by binding to its corresponding receptor, IL-21R. IL-21R is expressed by a wide range of immune cells, including T and B cells, NK cells, DCs and macrophages as well as non-immune cells, including epithelial cells and keratinocytes (Distler et al., <xref rid="B32" ref-type="bibr">2005</xref>; Caruso et al., <xref rid="B23" ref-type="bibr">2007</xref>; Crotty, <xref rid="B26" ref-type="bibr">2011</xref>). The ubiquitous expression of the IL-21R may explain the broad biological functions of IL-21 on the cells of hemopoietic and non-hemopoietic origins. The IL-21/IL-21R signaling activates the Janus kinase (JAK1/3)-signal transducer and activator of transcription (STAT) signaling pathway (Spolski and Leonard, <xref rid="B137" ref-type="bibr">2008</xref>). Accordingly, the phosphorylated STAT proteins are dimerized and translocated into the nucleus, where they bind to interferon (IFN)-&#947;-activated sequence (GAS) elements and initiate a gene transcription profile (i.e., <italic toggle="yes">Gzma, Gzmb, Il10, Eomes, Rorgt</italic>) (Spolski and Leonard, <xref rid="B140" ref-type="bibr">2014</xref>). IL-21 exerts its regulatory functions on the target cells predominantly via the activation of STAT3 but it also recruits STAT1 and STAT5 (Spolski and Leonard, <xref rid="B137" ref-type="bibr">2008</xref>; Wan et al., <xref rid="B158" ref-type="bibr">2013</xref>). The cascade of signaling events downstream of the IL-21-induced activation of STAT3 is well-characterized, however, what is still unclear is how the activation of STAT1 by IL-21 regulates the expression of the downstream IL-21 target genes (Wan et al., <xref rid="B158" ref-type="bibr">2013</xref>). Interestingly, the IL-21-induced activation of STAT1 leads to the augmented expression of <italic toggle="yes">Tbx21</italic> and <italic toggle="yes">Ifng</italic> genes (Wan et al., <xref rid="B157" ref-type="bibr">2015</xref>).</p><p>T<sub>FH</sub> cells are considered one of the major sources of the IL-21 production (Spolski and Leonard, <xref rid="B137" ref-type="bibr">2008</xref>, <xref rid="B138" ref-type="bibr">2010a</xref>,<xref rid="B139" ref-type="bibr">b</xref>). These cells are a specialized subset of CD4<sup>+</sup> T cells that can promote T cell-dependent humoral immune responses (Zotos et al., <xref rid="B175" ref-type="bibr">2010</xref>; Rankin et al., <xref rid="B115" ref-type="bibr">2011</xref>; Achour et al., <xref rid="B1" ref-type="bibr">2017</xref>). Multiple signaling pathways contribute to the differentiation and the development of T<sub>FH</sub> cells, among which IL-6 and the inducible T-cell costimulator (ICOS) ligand or ICOSL (CD275) have been shown to be important in the early differentiation of these cells in the mouse (Vinuesa et al., <xref rid="B153" ref-type="bibr">2016</xref>). T<sub>FH</sub> cells are identified by several surface markers, including CXCR5, ICOS, PD-1 and, in addition to IL-21, these cells canonically secret C-X-C motif chemokine 13 (CXCL13) and IL-4 (Crotty, <xref rid="B26" ref-type="bibr">2011</xref>; Liang et al., <xref rid="B71" ref-type="bibr">2011</xref>; Linterman et al., <xref rid="B73" ref-type="bibr">2011</xref>; Kroenke et al., <xref rid="B67" ref-type="bibr">2012</xref>). CXCL13 is expressed predominantly by non-T<sub>FH</sub> cell sources (i.e., stromal cells) in mice, whereas T<sub>FH</sub> cells are the major source of this molecule in humans (Pitzalis et al., <xref rid="B111" ref-type="bibr">2014</xref>; Crotty, <xref rid="B27" ref-type="bibr">2019</xref>). The transcription factor, B-cell lymphoma 6 (Bcl6) is required for the differentiation of T<sub>FH</sub> cells (Nurieva et al., <xref rid="B98" ref-type="bibr">2009</xref>; Hollister et al., <xref rid="B53" ref-type="bibr">2013</xref>), however, other transcription factors have been shown to regulate the differentiation of T<sub>FH</sub> cells via the induction of Bcl6 (Reviewed in Crotty, <xref rid="B27" ref-type="bibr">2019</xref>).</p><p>Germinal centers (GCs) are specialized locations in the secondary lymphoid tissues within which B cells proliferation, antibody somatic hypermutation and the affinity maturation (i.e., generation and selection of B cells with high affinity antibody secretion) occur (Zotos et al., <xref rid="B175" ref-type="bibr">2010</xref>; Mesin et al., <xref rid="B83" ref-type="bibr">2016</xref>). Severe impairment in B cells response to antigen of protein origin, a significant reduction in plasma cell formation in both the spleen and the bone marrow were observed in mice lacking IL-21 or its cognate receptor, IL-21R, <italic toggle="yes">Il21</italic><sup>&#8722;/&#8722;</sup>, and <italic toggle="yes">Il21r</italic><sup>&#8722;/&#8722;</sup>mice, respectively (Zotos et al., <xref rid="B175" ref-type="bibr">2010</xref>). It has been proposed that the IL-21/IL-21R signaling regulates the Bcl6 expression by B cells and the T<sub>FH</sub>-derived IL-21 promotes the transition of the peri-follicular pre-GC B cell to the intrafollicular phase (Linterman et al., <xref rid="B72" ref-type="bibr">2010</xref>; Gonzalez et al., <xref rid="B47" ref-type="bibr">2018</xref>). In addition to its role in the regulation of GC responses, earlier reports have identified IL-21/IL-21R signaling as a switch factor for the secretion of all IgG subclasses, especially IgG<sub>1</sub> and IgG<sub>3</sub>, as well as IgA by human splenic or peripheral na&#239;ve CD19<sup>+</sup> B cells (Pene et al., <xref rid="B106" ref-type="bibr">2004</xref>; Avery et al., <xref rid="B7" ref-type="bibr">2008a</xref>). The B cell-intrinsic signaling via IL-21/IL-21R axis and the downstream STAT3 signaling have been accounted for the generation and the development of long-lived antibody responses (Avery et al., <xref rid="B8" ref-type="bibr">2008b</xref>; Berglund et al., <xref rid="B15" ref-type="bibr">2013</xref>). Consistent with these findings, mice lacking the IL-21R (<italic toggle="yes">Il21r</italic><sup>&#8722;/&#8722;</sup>) failed to expand T cell-dependent, antigen-specific memory B cells and plasma cells (Rankin et al., <xref rid="B115" ref-type="bibr">2011</xref>). Altogether, these observations demonstrate diverse biological functions for the IL-21/IL-21R axis in B cell-mediated immunity, spanning from the generation and the development of GCs to B cell proliferation, the antibody affinity maturation and the generation and the expansion of memory B cells.</p><p>IL-21 can also regulate the effector function (e.g., cytokine production) of T cell subsets alone or in synergy with other cytokines (Strengell et al., <xref rid="B146" ref-type="bibr">2002</xref>). IL-21 exhibits synergy with IL-15 for the enhancement of the T-bet expression and with IL-12 for induction of STAT4-dependent DNA binding in NK cells and T cells and the subsequent augmentation of T<sub>H1</sub><bold>-</bold>polarized immune response, as evidenced by enhanced IFN-&#947; production (Strengell et al., <xref rid="B146" ref-type="bibr">2002</xref>). IL-21 also showed synergy with IFN-&#947; to induce the optimal expression of a certain set of signature interferon-stimulated genes (ISGs) in humans or mice (<xref ref-type="fig" rid="F1">Figure 1</xref>) (Wan et al., <xref rid="B157" ref-type="bibr">2015</xref>; Solaymani-Mohammadi and Berzofsky, <xref rid="B133" ref-type="bibr">2019</xref>). Interestingly, this effect on ISG expression was independent of STAT-3. These findings exemplify the breadth and the complexity of the IL-21/IL-21R signaling axis across species and in diverse biological settings (Strengell et al., <xref rid="B146" ref-type="bibr">2002</xref>).</p><fig id="F1" position="float" orientation="portrait"><label>Figure 1</label><caption><p>Synergy between the IL-21/IL-21R and the IFN-&#947;/IFN&#947;R pathways for the optimal expression of interferon-stimulated genes (ISGs).</p></caption><graphic xmlns:xlink="http://www.w3.org/1999/xlink" position="float" orientation="portrait" xlink:href="fcimb-09-00401-g0001.jpg"/></fig><p>Since its discovery there has been an increasing body of evidence suggesting a variety of roles played by the IL-21/IL-21R signaling axis in the regulation of immunity and inflammation in several infectious and non-infectious settings (Ozaki et al., <xref rid="B104" ref-type="bibr">2000</xref>; Sarra et al., <xref rid="B124" ref-type="bibr">2010</xref>; Cupi et al., <xref rid="B28" ref-type="bibr">2014</xref>; Wang et al., <xref rid="B161" ref-type="bibr">2016</xref>). In recent years, the IL-21/IL-21R signaling axis has been implicated in the regulation of immunity and the pathogenesis in several bacterial, viral, fungal, and parasitic infections (Moretto and Khan, <xref rid="B93" ref-type="bibr">2016</xref>; Solaymani-Mohammadi and Berzofsky, <xref rid="B133" ref-type="bibr">2019</xref>; Spolski et al., <xref rid="B141" ref-type="bibr">2019</xref>). The cytokine, or its cognate receptor, has been shown to be upregulated following infection with several protozoan and helminth parasites (Frohlich et al., <xref rid="B43" ref-type="bibr">2007</xref>; Moretto et al., <xref rid="B92" ref-type="bibr">2017</xref>). It has been suggested that the roles played by the IL-21/IL-21R signaling axis is context-dependent during microbial infections, including parasitic infections (Zhang Y. et al., <xref rid="B174" ref-type="bibr">2016</xref>).</p><p>While the IL-21/IL-21R pathway has been shown to be important in protection against several microbial pathogens, the IL-21/IL-21R signaling axis has been linked to excessive inflammation and associated pathogenesis observed during infectious and non-infectious inflammatory conditions (Stolfi et al., <xref rid="B144" ref-type="bibr">2011</xref>; Tortola et al., <xref rid="B152" ref-type="bibr">2019</xref>). Consistent with this notion, dysregulated IL-21 expression is associated with multiple inflammatory conditions, including Crohn's disease, celiac disease and arthritis (Stolfi et al., <xref rid="B144" ref-type="bibr">2011</xref>; Gensous et al., <xref rid="B44" ref-type="bibr">2018</xref>; Wang et al., <xref rid="B160" ref-type="bibr">2018</xref>). IL-21 is highly produced in human subjects with Crohn's disease and the blockade of the IL-21/IL-21R signaling axis in these patients resulted in reduced production of IFN-&#947; by mucosal lymphocytes (Monteleone et al., <xref rid="B91" ref-type="bibr">2005</xref>). As such, the lack of an intact IL-21/IL-21R signaling axis in mice (<italic toggle="yes">Il21r</italic><sup>&#8722;/&#8722;</sup>) resulted in attenuated inflammatory responses and reduced colitis in a murine model of human IBD (Wang et al., <xref rid="B161" ref-type="bibr">2016</xref>). The activation of STAT3 in target cells has been proposed as a mechanism by which the IL-21/IL-21R signaling promotes tissue inflammation (Stolfi et al., <xref rid="B144" ref-type="bibr">2011</xref>). These findings suggest that IL-21/IL-21R axis could be part of a positive feedback loop that amplifies an inflammatory response in the gut (Monteleone et al., <xref rid="B91" ref-type="bibr">2005</xref>; Fina et al., <xref rid="B42" ref-type="bibr">2008</xref>).</p><p>Despite the tissue distribution and the omnipresence of IL-21 target cells in tissues in which protozoan and helminth parasites reside, the role of the IL-21/IL-21R signaling pathway in protection against and/or the promotion of inflammation during parasitic infections is not fully understood. In recent years, however, it has been observed that IL-21 is induced in the periphery and mucosal tissues of humans and mice after infection with some parasites (Stumhofer et al., <xref rid="B147" ref-type="bibr">2013</xref>; Carpio et al., <xref rid="B22" ref-type="bibr">2015</xref>; Perez-Mazliah et al., <xref rid="B108" ref-type="bibr">2015</xref>; Cai et al., <xref rid="B20" ref-type="bibr">2016</xref>; Ryg-Cornejo et al., <xref rid="B122" ref-type="bibr">2016</xref>; Moretto et al., <xref rid="B92" ref-type="bibr">2017</xref>; Inoue et al., <xref rid="B57" ref-type="bibr">2018</xref>; Wikenheiser et al., <xref rid="B163" ref-type="bibr">2018</xref>) (<xref rid="T1" ref-type="table">Table 1</xref>). However, the exact mechanisms by which this signaling pathway regulates host immunity during parasitic infections are still unclear. Existing evidence suggests that the IL-21/IL-21R axis could play important roles in the development and the maintenance of anti-parasitic immunity and that targeting this signaling axis may provide an alternative approach for the development of new therapeutic agents for the prevention of parasite-induced immunopathology and tissue damage. Here, we review the roles of IL-21 and its receptor during protozoan and helminth infections in humans and in murine hosts.</p><table-wrap id="T1" position="float" orientation="portrait"><label>Table 1</label><caption><p>IL-21 in parasitic infections.</p></caption><table frame="hsides" rules="groups"><thead><tr><th valign="top" align="left" rowspan="1" colspan="1"><bold>Parasite Species</bold></th><th valign="top" align="left" rowspan="1" colspan="1"><bold>IL-21 Source/Cell type</bold></th><th valign="top" align="left" rowspan="1" colspan="1"><bold>References</bold></th></tr></thead><tbody><tr><td valign="top" align="left" colspan="3" rowspan="1"><bold>Protozoa</bold></td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1"><italic toggle="yes">P. falciparum</italic></td><td valign="top" align="left" rowspan="1" colspan="1">Plasma, serum; PBMCs<italic toggle="yes"><xref ref-type="table-fn" rid="TN1"><sup>a</sup></xref></italic> (CD4<sup>+</sup> T cells)</td><td valign="top" align="left" rowspan="1" colspan="1">Mewono et al., <xref rid="B85" ref-type="bibr">2008</xref>, <xref rid="B84" ref-type="bibr">2009</xref>; Moncunill et al., <xref rid="B90" ref-type="bibr">2017</xref>; Oyegue-Liabagui et al., <xref rid="B103" ref-type="bibr">2017</xref></td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1"><italic toggle="yes">P. vivax</italic></td><td valign="top" align="left" rowspan="1" colspan="1">T<sub>FH</sub> cells</td><td valign="top" align="left" rowspan="1" colspan="1">Figueiredo et al., <xref rid="B41" ref-type="bibr">2017</xref></td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1"><italic toggle="yes">P. chabaudi</italic></td><td valign="top" align="left" rowspan="1" colspan="1">T<sub>FH</sub> cells</td><td valign="top" align="left" rowspan="1" colspan="1">Carpio et al., <xref rid="B22" ref-type="bibr">2015</xref>; Perez-Mazliah et al., <xref rid="B108" ref-type="bibr">2015</xref></td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1"><italic toggle="yes">P. berghei</italic></td><td valign="top" align="left" rowspan="1" colspan="1"><italic toggle="yes">&#947;&#948;</italic> T cells; T<sub>FH</sub> cells</td><td valign="top" align="left" rowspan="1" colspan="1">Ryg-Cornejo et al., <xref rid="B122" ref-type="bibr">2016</xref>; Inoue et al., <xref rid="B57" ref-type="bibr">2018</xref></td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1"><italic toggle="yes">P. yoelii</italic></td><td valign="top" align="left" rowspan="1" colspan="1">T<sub>FH</sub><bold>-</bold>like CD4<sup>+</sup> T cells</td><td valign="top" align="left" rowspan="1" colspan="1">Wikenheiser et al., <xref rid="B163" ref-type="bibr">2018</xref></td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1"><italic toggle="yes">Babesia microti</italic></td><td valign="top" align="left" rowspan="1" colspan="1">Plasma; CD4<sup>+</sup>CD44<sup>+</sup> T cells</td><td valign="top" align="left" rowspan="1" colspan="1">Djokic et al., <xref rid="B33" ref-type="bibr">2018</xref>; Yi et al., <xref rid="B166" ref-type="bibr">2018</xref></td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1"><italic toggle="yes">Toxoplasma gondii</italic></td><td valign="top" align="left" rowspan="1" colspan="1">T<sub>FH</sub> cells, Splenic CD4<sup>+</sup> and CD8<sup>+</sup> T cells; BMNCs<italic toggle="yes"><xref ref-type="table-fn" rid="TN2"><sup>b</sup></xref></italic> (CD4<sup>+</sup> and CD8<sup>+</sup> T cells)</td><td valign="top" align="left" rowspan="1" colspan="1">Stumhofer et al., <xref rid="B147" ref-type="bibr">2013</xref>; Moretto et al., <xref rid="B92" ref-type="bibr">2017</xref></td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1"><italic toggle="yes">Trypanosoma cruzi</italic></td><td valign="top" align="left" rowspan="1" colspan="1">Serum; T<sub>H17</sub> cells</td><td valign="top" align="left" rowspan="1" colspan="1">Cai et al., <xref rid="B20" ref-type="bibr">2016</xref>; Natale et al., <xref rid="B96" ref-type="bibr">2018</xref></td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1"><italic toggle="yes">Leishmania</italic> spp.</td><td valign="top" align="left" rowspan="1" colspan="1">IL-21 mRNA from skin lesions and spleen; T<sub>FH</sub> cells, CD3<sup>+</sup> T cells; dLNs<xref ref-type="table-fn" rid="TN3"><sup>c</sup></xref></td><td valign="top" align="left" rowspan="1" colspan="1">Espitia et al., <xref rid="B37" ref-type="bibr">2010</xref>; Ansari et al., <xref rid="B3" ref-type="bibr">2011</xref>; Bollig et al., <xref rid="B16" ref-type="bibr">2012</xref>; Gibson-Corley et al., <xref rid="B45" ref-type="bibr">2012</xref>; Costa et al., <xref rid="B25" ref-type="bibr">2015</xref>; Kong et al., <xref rid="B65" ref-type="bibr">2017</xref>; Khatonier et al., <xref rid="B62" ref-type="bibr">2018</xref></td></tr><tr><td valign="top" align="left" colspan="3" rowspan="1"><bold>Helminths</bold></td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">Schistosomes</td><td valign="top" align="left" rowspan="1" colspan="1">Plasma; LPLs<italic toggle="yes"><xref ref-type="table-fn" rid="TN4"><sup>d</sup></xref></italic>; T cells and non-T cells; T<sub>FH</sub> cells; total splenocytes</td><td valign="top" align="left" rowspan="1" colspan="1">Milner et al., <xref rid="B87" ref-type="bibr">2010</xref>; Gringhuis et al., <xref rid="B49" ref-type="bibr">2014</xref>; Wang et al., <xref rid="B159" ref-type="bibr">2015</xref>; Torben et al., <xref rid="B149" ref-type="bibr">2017</xref></td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1"><italic toggle="yes">Fasciola hepatica</italic></td><td valign="top" align="left" rowspan="1" colspan="1">T<sub>FH</sub> cells</td><td valign="top" align="left" rowspan="1" colspan="1">Gringhuis et al., <xref rid="B49" ref-type="bibr">2014</xref></td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1"><italic toggle="yes">Echinococcus granulosus</italic></td><td valign="top" align="left" rowspan="1" colspan="1">Serum; PBMCs</td><td valign="top" align="left" rowspan="1" colspan="1">Zhang et al., <xref rid="B171" ref-type="bibr">2015</xref></td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1"><italic toggle="yes">Brugia malayi</italic></td><td valign="top" align="left" rowspan="1" colspan="1">PBMCs</td><td valign="top" align="left" rowspan="1" colspan="1">Babu et al., <xref rid="B10" ref-type="bibr">2009</xref>; Anuradha et al., <xref rid="B4" ref-type="bibr">2014</xref></td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1"><italic toggle="yes">Litomosoides sigmodontis</italic></td><td valign="top" align="left" rowspan="1" colspan="1">TCL<xref ref-type="table-fn" rid="TN5"><sup>e</sup></xref>; dLNs</td><td valign="top" align="left" rowspan="1" colspan="1">Ritter et al., <xref rid="B117" ref-type="bibr">2018</xref></td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1"><italic toggle="yes">Heligmosomoides polygyrus</italic></td><td valign="top" align="left" rowspan="1" colspan="1">Intestinal mucosa; T<sub>FH</sub> cells</td><td valign="top" align="left" rowspan="1" colspan="1">Naradikian et al., <xref rid="B95" ref-type="bibr">2016</xref>; Ariyaratne et al., <xref rid="B6" ref-type="bibr">2018</xref></td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1"><italic toggle="yes">Aspiculuris tetrapetra</italic></td><td valign="top" align="left" rowspan="1" colspan="1">Peyer's patches; spleen; mesenteric lymph nodes</td><td valign="top" align="left" rowspan="1" colspan="1">Gomez-Samblas et al., <xref rid="B46" ref-type="bibr">2018</xref></td></tr></tbody></table><table-wrap-foot><fn id="TN1"><label>a</label><p><italic toggle="yes">Peripheral blood mononuclear cells</italic>.</p></fn><fn id="TN2"><label>b</label><p><italic toggle="yes">Brain mononuclear cells</italic>.</p></fn><fn id="TN3"><label>c</label><p><italic toggle="yes">Draining lymph nodes</italic>.</p></fn><fn id="TN4"><label>d</label><p><italic toggle="yes">Lamina propria lymphocytes</italic>.</p></fn><fn id="TN5"><label>e</label><p><italic toggle="yes">Thoracic cavity lavage</italic>.</p></fn></table-wrap-foot></table-wrap></sec><sec id="s3"><title>Protozoan Parasites</title><sec><title>Blood-Dwelling Apicomplexa</title><sec><title><italic toggle="yes">Plasmodium</italic> spp.</title><p>IL-21 is induced during human infections with <italic toggle="yes">Plasmodium falciparum</italic> (Mewono et al., <xref rid="B85" ref-type="bibr">2008</xref>, <xref rid="B84" ref-type="bibr">2009</xref>) and <italic toggle="yes">Plasmodium vivax</italic> (Figueiredo et al., <xref rid="B41" ref-type="bibr">2017</xref>), as well as following vaccination against <italic toggle="yes">P. falciparum</italic> (Moncunill et al., <xref rid="B90" ref-type="bibr">2017</xref>). In one of the first reports on IL-21 induction in malaria, serum levels of IL-21, total parasite-specific IgG, and levels of IgG subclasses were measured in 73 Gabonese children positive for <italic toggle="yes">P. falciparum</italic> (Mewono et al., <xref rid="B85" ref-type="bibr">2008</xref>). Positive correlations were observed between IL-21 plasma levels and <italic toggle="yes">P. falciparum</italic>-specific anti-erythrocyte-binding antigen-175 (EBA-175)-peptide 4, and IgG<sub>1</sub> and IgG<sub>3</sub> subclasses. EBA-175 peptide 4, a 42-mer peptide (1062&#8211;1103), is a vaccine candidate with a molecular weight of 175-kD that binds to a sialic acid-containing ligand expressed on the surface of erythrocytes and has been shown to be critical in parasite invasion of erythrocytes (Camus and Hadley, <xref rid="B21" ref-type="bibr">1985</xref>). Recombinant antibodies generated against this protein inhibited the binding of merozoites to human RBCs <italic toggle="yes">in vitro</italic> (Sim, <xref rid="B131" ref-type="bibr">1990</xref>; Sim et al., <xref rid="B132" ref-type="bibr">1990</xref>). Interestingly, the study by Mewono et al. (<xref rid="B85" ref-type="bibr">2008</xref>) demonstrated that the plasma levels of IL-21 also positively correlated with the hemoglobin levels as well as the parasitemia, as a marker of the disease severity, in younger children with high parasite burdens. This study, however, did not investigate a potential correlation between the serum levels of IL-21 and the clinical phenotype.</p><p>In contrast to these findings, an independent clinical study performed to investigate the pro- and anti-inflammatory cytokine signature profiles in a distinct Gabonese population found no significantly elevated IL-21 levels in the sera of children infected with <italic toggle="yes">P. falciparum</italic> as compared with naive controls (Oyegue-Liabagui et al., <xref rid="B103" ref-type="bibr">2017</xref>). This study demonstrated a reverse correlation between the serum IL-21 and the severity of anemia. Uninfected controls were enrolled from children with a febrile syndrome or a history of fever 48 h prior to the admission. Elevated levels of IL-21 in uninfected controls could be due to non-<italic toggle="yes">P. falciparum</italic> induction of IL-21 production and may, in part, explain why no significant differences were observed between the levels of IL-21 in the sera of <italic toggle="yes">P. falciparum</italic>-infected human subjects as compared with uninfected controls. As such, the lack of significant elevation in plasma IL-21 between <italic toggle="yes">P. falciparum</italic>-infected as compared with uninfected control groups could be partially explained by the inclusion of uninfected controls concurrently infected with other parasitic or non-parasitic pathogens commonly found in areas where human <italic toggle="yes">P. falciparum</italic> infection is endemic (Dejon-Agobe et al., <xref rid="B31" ref-type="bibr">2018</xref>; M'Bondoukwe et al., <xref rid="B80" ref-type="bibr">2018</xref>). These two clinical studies did not measure levels of the <italic toggle="yes">P. falciparum</italic>-induced IL-21 production in human subjects with <italic toggle="yes">P. falciparum</italic> infections as well as in uninfected controls (Mewono et al., <xref rid="B85" ref-type="bibr">2008</xref>; Oyegue-Liabagui et al., <xref rid="B103" ref-type="bibr">2017</xref>). This lack of IL-21 production specificity may render some of the results of these two studies inconclusive.</p><p>A follow-up study by Mewono et al. (<xref rid="B84" ref-type="bibr">2009</xref>) demonstrated that IL-21 was induced following the stimulation of peripheral blood mononuclear cells (PBMCs) isolated from <italic toggle="yes">P. falciparum</italic>-experienced human subjects as compared with <italic toggle="yes">P. falciparum</italic>-na&#239;ve controls in response to two malaria vaccine candidates, the <italic toggle="yes">P. falciparum</italic> glutamate-rich protein (PfGLURP) or the <italic toggle="yes">P. falciparum</italic> merozoite surface protein 3 (PfMSP-3) (Mewono et al., <xref rid="B84" ref-type="bibr">2009</xref>). Interestingly, PBMCs isolated from the venous blood of both <italic toggle="yes">P. falciparum</italic>-experienced and <italic toggle="yes">P. falciparum</italic>-na&#239;ve controls used in a recall assay secreted IL-21 in response to either PfGLURP or PfMSP-3, with human subjects exposed to <italic toggle="yes">P. falciparum</italic> producing significantly higher levels of <italic toggle="yes">P. falciparum</italic> peptide-induced IL-21 (Mewono et al., <xref rid="B84" ref-type="bibr">2009</xref>).</p><p>PfGLURP or PfMSP-3 are expressed by all developmental stages of <italic toggle="yes">P. falciparum</italic> (pre-erythrocytic and erythrocytic stages) and on the surface of <italic toggle="yes">P. falciparum</italic> merozoites, respectively (Jordan et al., <xref rid="B60" ref-type="bibr">2009</xref>; Kaur et al., <xref rid="B61" ref-type="bibr">2017</xref>). These two <italic toggle="yes">P. falciparum</italic>-derived proteins are considered highly immunogenic and have been considered as vaccine candidates alone or in combination as fused proteins (e.g., GMZ2, a fusion of PfGLURP and PfMSP3) in clinical settings (Oeuvray et al., <xref rid="B101" ref-type="bibr">1994a</xref>,<xref rid="B100" ref-type="bibr">b</xref>; Roussilhon et al., <xref rid="B119" ref-type="bibr">2007</xref>; Belard et al., <xref rid="B14" ref-type="bibr">2011</xref>). The PfGLURP- or PfMSP-3-elicited IL-21 production by PBMCs derived from <italic toggle="yes">P. falciparum</italic>-experienced human subjects may suggest potential roles for this cytokine to mediate immunity to <italic toggle="yes">P. falciparum</italic> infections and may further provide a surrogate biomarker to measure the efficacy of malaria vaccines. These finding were further augmented by the observations that RTS, S/AS01E, a vaccine consisting of sequences of the <italic toggle="yes">P. falciparum</italic> circumsporozoite (CS) protein (RTS,S) and the hepatitis B surface antigen (HBsAg) induced the intracellular expression of IL-21 by antigen-specific CD4<sup>+</sup> T cells in pediatric subjects enrolled in a phase III clinical trial before and 1 month after initial vaccination (Moncunill et al., <xref rid="B90" ref-type="bibr">2017</xref>).</p><p>IL-21 expression during human malaria has been mostly studied in the context of malaria infections caused by <italic toggle="yes">P. falciparum</italic> (Moncunill et al., <xref rid="B90" ref-type="bibr">2017</xref>). However, further clinical studies demonstrated that uncomplicated <italic toggle="yes">P. vivax</italic> malaria infection in a Brazilian population induced significantly higher levels of serum IL-21 production and also promoted the expansion of T<sub>FH</sub> cells, defined as PD-1<sup>+</sup>ICOS<sup>+</sup>CXCR5<sup>+</sup>CD45RO<sup>+</sup>CD3<sup>+</sup>CD4<sup>+</sup> cells, in these patients (Figueiredo et al., <xref rid="B41" ref-type="bibr">2017</xref>). This study also showed the propensity of <italic toggle="yes">P. vivax</italic>-induced T<sub>FH</sub> cells to secret IL-21 and to induce immunoglobulin production (IgG<sub>1</sub> and IgG<sub>3</sub>) by B cells upon being co-cultured with na&#239;ve B cells (Figueiredo et al., <xref rid="B41" ref-type="bibr">2017</xref>).</p><p>IL-21 is expressed in several murine malaria models, including <italic toggle="yes">P. berghei</italic> (Ryg-Cornejo et al., <xref rid="B122" ref-type="bibr">2016</xref>; Inoue et al., <xref rid="B57" ref-type="bibr">2018</xref>), <italic toggle="yes">Plasmodium chabaudi</italic> (Perez-Mazliah et al., <xref rid="B108" ref-type="bibr">2015</xref>; Sebina et al., <xref rid="B127" ref-type="bibr">2017</xref>) and <italic toggle="yes">Plasmodium yoelii</italic> (Wikenheiser et al., <xref rid="B163" ref-type="bibr">2018</xref>). Genetic disruption of the IL-21/IL-21R singling axis compromised <italic toggle="yes">P. chabaudi</italic>-specific IgG responses and resulted in the impairment of memory B cell generation. The IL-21/IL-21R axis disruption also led to impaired resolution of parasitemia in the chronic phase of infection (Perez-Mazliah et al., <xref rid="B108" ref-type="bibr">2015</xref>). It also has been suggested that IL-21 promotes the humoral immune response against <italic toggle="yes">P. chabaudi chabaudi</italic>, as evidenced by the lack of the extrafollicular plasmablast development within the first week following the infection (Sebina et al., <xref rid="B127" ref-type="bibr">2017</xref>). Mice deficient in either IL-21 (<italic toggle="yes">Il21</italic><sup>&#8722;/&#8722;</sup>) or IL-21R (<italic toggle="yes">Il21r</italic><sup>&#8722;/&#8722;</sup>) were susceptible to rechallenge infections with homologous murine malaria parasites (Perez-Mazliah et al., <xref rid="B108" ref-type="bibr">2015</xref>). Studies using the mixed bone marrow chimeric mice also indicated that T-cell-derived (i.e., T<sub>FH</sub> cells) IL-21 interacted with the IL-21R expressed on B cells for the effective control of parasitemia during <italic toggle="yes">P. chabaudi</italic> infection, highlighting the requirement of T-cell/B cell crosstalk for the development and the maintenance of a robust and protective anti-malaria immune response in the mouse (Perez-Mazliah et al., <xref rid="B108" ref-type="bibr">2015</xref>).</p><p>Interestingly, IL-21 and IFN-&#947; were co-expressed by T<sub>FH</sub> cells generated during the erythrocytic phase of <italic toggle="yes">P. chabaudi</italic> infection in mice (Perez-Mazliah et al., <xref rid="B108" ref-type="bibr">2015</xref>). The IFN-&#947;-expressing T effector cells generated following <italic toggle="yes">P</italic>. <italic toggle="yes">chabaudi</italic> were predominantly positive for CXCR5, a marker for T<sub>FH</sub> cells, and acquired the ability to express IL-21 and IFN-&#947;, later in the course of infection and in the memory phase of the immune response (Carpio et al., <xref rid="B22" ref-type="bibr">2015</xref>). Generally, the regulation of the classical CXCR5<sup>hi</sup>PD-1<sup>hi</sup> GC T<sub>FH</sub> cell subset requires Bcl6, a master transcription factor critical for the differentiation of T<sub>FH</sub> cells. However, the regulation of the CXCR5<sup>+</sup>IL-21<sup>+</sup>IFN-&#947;<sup>+</sup> subset was independent of Bcl6 during infection of <italic toggle="yes">P</italic>. <italic toggle="yes">chabaudi</italic> in the mouse (Carpio et al., <xref rid="B22" ref-type="bibr">2015</xref>).</p><p>Murine <italic toggle="yes">P. berghei</italic> ANKA infection as well as immunization with irradiated <italic toggle="yes">P. berghei</italic> ANKA (iPbA) induced IL-21-expressing T<sub>FH</sub> cells (Ryg-Cornejo et al., <xref rid="B122" ref-type="bibr">2016</xref>). CXCR5<sup>int</sup>PD-1<sup>int</sup> T<sub>FH</sub> cells were the primary source of IL-21 expression early during the course of infection, whereas T<sub>FH</sub> cells with high expression of CXCR5 and PD-1 (CXCR5<sup>high</sup>PD-1<sup>high</sup>) also expressed IL-21 during the resolution phase of the infection (Ryg-Cornejo et al., <xref rid="B122" ref-type="bibr">2016</xref>). Interestingly, infection with <italic toggle="yes">P. berghei</italic>, but not vaccination with iPbA, could remodel the microstructure of the splenic GC and results in impaired T<sub>FH</sub> cells differentiation (Ryg-Cornejo et al., <xref rid="B122" ref-type="bibr">2016</xref>).</p><p>In addition to T<sub>FH</sub> cells, other immune cell types, including &#947;&#948; T-cells and a T<sub>FH</sub><bold>-</bold>like CD4<sup>+</sup> T cell population expressing the surface molecule, NK1.1, and T<sub>FH</sub> cell markers simultaneously, have also been shown to express IL-21, as well as IFN-&#947;, during the early phase of infection with <italic toggle="yes">P. berghei</italic> and <italic toggle="yes">P. yoelii</italic>, respectively (Inoue et al., <xref rid="B57" ref-type="bibr">2018</xref>; Wikenheiser et al., <xref rid="B163" ref-type="bibr">2018</xref>). The importance of the IL-21 expression by non-conventional T<sub>FH</sub> cells was reinforced by the observations that mice lacking &#947;&#948; T-cells were incompetent to control <italic toggle="yes">P. berghei</italic> infection and that the lack of ability to control infection correlated with the findings that &#947;&#948; T-cell-deficient mice had impaired levels of <italic toggle="yes">P. berghei</italic>-specific antibodies, decreased numbers of T<sub>FH</sub> cells and fewer GC B cell toward the later course of infection as compared with their C57BL/6 counterparts (Inoue et al., <xref rid="B57" ref-type="bibr">2018</xref>). Blockade of the IL-21R using the IL-21R-Fc led to a reduction in T<sub>FH</sub> cells and GC B cell numbers toward the later phase of infection, suggesting the importance of the IL-21 expressed by &#947;&#948; T-cell during the early phase of infection to promote the development of T<sub>FH</sub> cells as well as the GC B cells during the later course of infection (Inoue et al., <xref rid="B57" ref-type="bibr">2018</xref>). Altogether, these findings exemplify the requirement of the IL-21/IL-21R signaling axis for development of the GC reaction, the promotion of high-affinity parasite-specific antibody repertoire generation by B cells, and the regulation of the antibody class switching in these cells during experimental murine malaria infections (Perez-Mazliah et al., <xref rid="B108" ref-type="bibr">2015</xref>).</p></sec><sec><title><italic toggle="yes">Babesia</italic> sp.</title><p>The evidence supporting potential protective roles of the IL-21/IL-21R signaling axis during experimental murine babesiosis is limited (Djokic et al., <xref rid="B33" ref-type="bibr">2018</xref>; Yi et al., <xref rid="B166" ref-type="bibr">2018</xref>). No significant differences were observed in the plasma levels of IL-5, IL-17A, and IL-21 in <italic toggle="yes">Babesia microti</italic>-infected C3H/HeJ mice as compared with uninfected controls (Djokic et al., <xref rid="B33" ref-type="bibr">2018</xref>). A T<sub>H1</sub><bold>-</bold>mediated immunity, as opposed to a T<sub>H17</sub><bold>-</bold>biased immune response, was critical for the clearance of <italic toggle="yes">B. microti</italic> in susceptible C3H/HeJ mice (Djokic et al., <xref rid="B33" ref-type="bibr">2018</xref>). Conversely, <italic toggle="yes">B. microti</italic> was shown to elicit a strong immune response in C57BL/6 mice characterized by the induction of a GC reaction accompanied by the promotion of T<sub>FH</sub> cells generation and increased levels of the T cell effector cytokines, including IL-21 and IFN-&#947; (Yi et al., <xref rid="B166" ref-type="bibr">2018</xref>). This study also showed that T<sub>FH</sub> cells expanded upon <italic toggle="yes">B. microti</italic> infection. However, the specific expression of IL-21 by T<sub>FH</sub> cells, as one of the major expressors of IL-21, was not determined following <italic toggle="yes">B. microti</italic> infection in the mouse (Yi et al., <xref rid="B166" ref-type="bibr">2018</xref>). The differences in host strain susceptibility to <italic toggle="yes">B. microti</italic> infection, age discrepancies and the dose of inoculum could account for inconsistent findings observed between these two studies. Collectively, the lack of experimental evidence demonstrating a direct and protective role played by the IL-21/IL-21R signaling axis precludes a definite conclusion as to how this signaling axis regulates host immunity during experimental babesiosis and may warrant further future studies.</p></sec></sec><sec><title>Tissue-Dwelling Apicomplexa</title><sec><title>Toxoplasma gondii</title><p>It has been suggested that experimental toxoplasmosis elicits a strong T<sub>FH</sub> cell response and that IL-21 plays important roles in the regulation of T cell responses in an encephalitis susceptible mouse model of the disease (Moretto et al., <xref rid="B92" ref-type="bibr">2017</xref>). Nevertheless, the survival rate of <italic toggle="yes">Il21r</italic><sup>&#8722;/&#8722;</sup> mice infected with <italic toggle="yes">T. gondii</italic> was comparable with their wild-type counterparts, despite the significant impairment of IgG<sub>1</sub> in the serum of <italic toggle="yes">Il21r</italic><sup>&#8722;/&#8722;</sup> mice (Ozaki et al., <xref rid="B105" ref-type="bibr">2002</xref>).</p><p>To further dissect the roles of IL-21 in defining humoral immunity and its roles in the maintenance of a balance between protective and pathogenic immune response during acute <italic toggle="yes">T. gondii</italic> infection, it was demonstrated that a larger proportion of IL-21-expressing CD4<sup>+</sup> and CD8<sup>+</sup> T cells were found in the brain of wild-type mice chronically infected with <italic toggle="yes">T. gondii</italic> (Stumhofer et al., <xref rid="B147" ref-type="bibr">2013</xref>). As such, the requirement of IL-21 for the control of the <italic toggle="yes">T. gondii</italic> chronic infection was also confirmed by increased parasite burdens in the brains of chronically infected <italic toggle="yes">Il21</italic><sup>&#8722;/&#8722;</sup> mice as compared with their wild-type counterparts (Stumhofer et al., <xref rid="B147" ref-type="bibr">2013</xref>). Interestingly, <italic toggle="yes">Il21</italic><sup>&#8722;/&#8722;</sup> mice showed no immune-mediated pathology during the acute phase of infection and IgG production was impaired in these mice as compared with wild-type controls and the impairment in IgG production in <italic toggle="yes">Il21</italic><sup>&#8722;/&#8722;</sup> mice correlated with diminished numbers of GC B cells (Stumhofer et al., <xref rid="B147" ref-type="bibr">2013</xref>).</p><p>It has previously been shown that IL-21 acts synergistically with several cytokines, including IL-2 (Battaglia et al., <xref rid="B12" ref-type="bibr">2013</xref>), IL-15 (Kishida et al., <xref rid="B64" ref-type="bibr">2003</xref>; Strengell et al., <xref rid="B145" ref-type="bibr">2003</xref>; Zeng et al., <xref rid="B169" ref-type="bibr">2005</xref>; Li et al., <xref rid="B70" ref-type="bibr">2014</xref>), and IL-18 (Lusty et al., <xref rid="B77" ref-type="bibr">2017</xref>) to exert some of its biological functions. To explore the efficacy of a DNA vaccine (pVAX/TgMIC8) encoding the <italic toggle="yes">T. gondii</italic> microneme protein 8 (MIC8), mice were immunized in the absence or the presence of eukaryotic plasmids expressing murine IL-15 (pVAX/mIL-15), IL-21 (pVAX/mIL-21), or both (pVAX/mIL-21/mIL-15). Mice immunized with pVAX/TgMIC8 alone or combined with pVAX/mIL-15 and, to a lesser extent IL-21 (pVAX/mIL-21), mounted strong humoral T<sub>H1</sub> immune profiles (Li et al., <xref rid="B70" ref-type="bibr">2014</xref>). Interestingly, mice co-administered with a combination of pVAX/TgMIC8 and plasmids expressing both murine IL-15 and IL-21 (pVAX/mIL-21/mIL-15) elicited the strongest immune profiles as compared with controls, leading to a significant increase in survival and decreased numbers of tissue cysts in the brain (Li et al., <xref rid="B70" ref-type="bibr">2014</xref>). Similarly, vaccination with the <italic toggle="yes">T. gondii</italic> calcium-dependent protein kinase 1 (TgCDPK1) combined with plasmids expressing both murine IL-15 and IL-21 (pVAX/mIL-21/mIL-15) significantly increased survival time and led to reduced cyst numbers in the brain of mice receiving a combined pVAX-CDPK1/pVAX/mIL-21/mIL-15 vaccine regimen as compared with those mice receiving either pVAX-CDPK1 or pVAX/mIL-21/mIL-15 alone (Chen et al., <xref rid="B24" ref-type="bibr">2014</xref>). These findings may demonstrate a synergy between IL-21 and IL-15 for the optimal expression of parasite-specific humoral and cellular immune responses following vaccine administration. IL-21, in collaboration with IFN-&#947;, has also been found to be required for the optimal expression of several interferon-stimulated genes, including multiple MHC class molecules and chemokine/chemokine receptors (Solaymani-Mohammadi and Berzofsky, <xref rid="B133" ref-type="bibr">2019</xref>). Altogether, these observations further suggest that the inclusion of IL-21, in combination with other cytokines, as an adjuvant may lead to the optimal expression of molecules required for T cell-antigen-presenting cell (APC) interactions and may enhance the efficacy of the vaccines against <italic toggle="yes">T. gondii</italic> infection.</p></sec></sec><sec><title>Blood-Dwelling Kinetoplastids</title><sec><title>Trypanosoma cruzi</title><p>T<sub>H17</sub>-mediated immune responses have been mostly studied in the context of extracellular bacterial and fungal infections (Curtis and Way, <xref rid="B29" ref-type="bibr">2009</xref>; Zelante et al., <xref rid="B168" ref-type="bibr">2009</xref>; Sellge et al., <xref rid="B128" ref-type="bibr">2010</xref>; Das and Khader, <xref rid="B30" ref-type="bibr">2017</xref>). However, it has been demonstrated that <italic toggle="yes">T. cruzi</italic> infection elicits a strong proinflammatory cytokine profile characterized by increased expression of IFN-&#947;, TNF-&#945;, and IL-17 (Silva et al., <xref rid="B130" ref-type="bibr">1995</xref>; Michailowsky et al., <xref rid="B86" ref-type="bibr">2001</xref>; Miyazaki et al., <xref rid="B89" ref-type="bibr">2010</xref>). The T<sub>H17</sub> response is necessary for acute resistance to <italic toggle="yes">T. cruzi</italic> and the transcription factor T-bet regulates <italic toggle="yes">T. cruzi</italic>-specific T<sub>H17</sub> responses (Guo et al., <xref rid="B50" ref-type="bibr">2009</xref>). Consistent with the protective roles of T<sub>H17</sub> during <italic toggle="yes">T. cruzi</italic> infection, T<sub>H17</sub> cells provide help to CD8<sup>+</sup> T cells in an IL-21-dependent manner (Cai et al., <xref rid="B20" ref-type="bibr">2016</xref>). Interestingly, <italic toggle="yes">Rag</italic><sup>&#8722;/&#8722;</sup> mice reconstituted with <italic toggle="yes">Il21r</italic><sup>&#8722;/&#8722;</sup> CD8<sup>+</sup> T cells had consistently higher parasitemia levels as compared with those <italic toggle="yes">Rag</italic><sup>&#8722;/&#8722;</sup> mice receiving wild-type CD8<sup>+</sup> T cells and mice in the former group died before day 20 p.i. (Cai et al., <xref rid="B20" ref-type="bibr">2016</xref>). These findings suggested a protective role for IL-21 in the T<sub>H17&#8722;</sub>mediated resistance via providing help to CD8<sup>+</sup> T cells during experimental <italic toggle="yes">T. cruzi</italic> infection in murine hosts.</p><p>The serum levels of several cytokines, including IL-21, positively correlated with disease severity in patients with chronic Chagas disease caused by <italic toggle="yes">T. cruzi</italic> (Natale et al., <xref rid="B96" ref-type="bibr">2018</xref>). Consistently, lower levels of IL-21 production were observed in the sera of human subjects with less severe cardiac dysfunction as compared with those presented with an advanced cardiac dysfunction profile (Natale et al., <xref rid="B96" ref-type="bibr">2018</xref>). These observations may suggest a potential role for the IL-21/IL-21R axis in the promotion of pathology in chronically-infected human subjects. However, the mechanisms by which the IL-21/IL-21R signaling pathway may mediate the pathogenesis of acute and chronic <italic toggle="yes">T. cruzi</italic> infections still remain unclear and may warrant further investigations.</p></sec></sec><sec><title>Tissue-Dwelling Kinetoplastids</title><sec><title><italic toggle="yes">Leishmania</italic> spp.</title><p>IL-21 transcripts are detectable following cutaneous leishmaniasis caused by <italic toggle="yes">Leishmania panamensis, Leishmania major</italic>, and <italic toggle="yes">Leishmania braziliensis</italic> infections as well as in humans and mice infected with <italic toggle="yes">Leishmania donovani</italic>, the causative agent of visceral leishmaniasis (Espitia et al., <xref rid="B37" ref-type="bibr">2010</xref>; Bollig et al., <xref rid="B16" ref-type="bibr">2012</xref>; Costa et al., <xref rid="B25" ref-type="bibr">2015</xref>; Kong et al., <xref rid="B65" ref-type="bibr">2017</xref>; Khatonier et al., <xref rid="B62" ref-type="bibr">2018</xref>). IL-21 expression significantly and positively correlated with expression of IFN-&#947; and IL-27, but not FoxP3 or TGF-&#946;, in human subjects with <italic toggle="yes">L</italic>. <italic toggle="yes">braziliensis</italic> cutaneous lesions (Costa et al., <xref rid="B25" ref-type="bibr">2015</xref>). CD3<sup>+</sup> T cells were the major source of IL-21 expression during visceral leishmaniasis in humans (Ansari et al., <xref rid="B3" ref-type="bibr">2011</xref>). Further, recombinant human IL-21 could augment antigen-specific IL-10 production in a whole-blood assay (Ansari et al., <xref rid="B3" ref-type="bibr">2011</xref>). However, an earlier report failed to establish a connection between the lack of IL-21R signaling and impaired T<sub>H1</sub><bold>-</bold>biased immunity against <italic toggle="yes">L. major</italic> infection (Frohlich et al., <xref rid="B43" ref-type="bibr">2007</xref>). In this study, <italic toggle="yes">Il21r</italic><sup>&#8722;/&#8722;</sup> mice mounted a strong T<sub>H1</sub> immune response against <italic toggle="yes">L. major</italic> infection as evidenced by a higher percentage of antigen-specific IFN-&#947;<bold>-</bold>producing CD4<sup>+</sup> T cells and these mice had comparable footpad swellings as compared with C57BL/6 controls (Frohlich et al., <xref rid="B43" ref-type="bibr">2007</xref>). These findings suggest that the IL-21/IL-21R signaling axis was not required for host defense against <italic toggle="yes">L. major</italic> and that the absence of IL-21R signaling was not critical for the development of a T<sub>H1</sub><bold>-</bold>biased response against this intracellular protozoan parasite.</p><p>Host strain-specific susceptibility or resistant to infection is considered an important determinant of disease outcome in parasitic diseases (Araujo et al., <xref rid="B5" ref-type="bibr">1976</xref>; Ruebush and Hanson, <xref rid="B121" ref-type="bibr">1979</xref>; Ishii and Sano, <xref rid="B58" ref-type="bibr">1989</xref>; Duleu et al., <xref rid="B35" ref-type="bibr">2004</xref>). Varied susceptibility of C57BL/6 (resistant) and Balb/c (susceptible) strains to <italic toggle="yes">L. major</italic>, for example, represents a classical dichotomy as to how host's genetic background can contribute to disease outcome following leishmanial infections (Lohoff et al., <xref rid="B76" ref-type="bibr">1989</xref>; Scott, <xref rid="B126" ref-type="bibr">1991</xref>; Sommer et al., <xref rid="B136" ref-type="bibr">1998</xref>; Barbi et al., <xref rid="B11" ref-type="bibr">2008</xref>). Several mechanisms have been proposed as to why some mouse strains are more susceptible to a given parasite while others do not (von Stebut et al., <xref rid="B154" ref-type="bibr">1998</xref>; Rosas et al., <xref rid="B118" ref-type="bibr">2005</xref>; Nigg et al., <xref rid="B97" ref-type="bibr">2007</xref>). These may include discrepancies in the magnitude of a particular immune pathway and/or the differential expression of immune compartments and/or immune effector molecules between mouse strains (von Stebut et al., <xref rid="B155" ref-type="bibr">2000</xref>; Von Stebut et al., <xref rid="B156" ref-type="bibr">2003</xref>; Hurdayal et al., <xref rid="B55" ref-type="bibr">2013</xref>; Sassi et al., <xref rid="B125" ref-type="bibr">2015</xref>). Analysis of the GC B cell response in the draining lymph nodes (dLNs) of C3HeB/FeJ and C57BL/6 mice (which develop healing and non-healing lesions, respectively) in a <italic toggle="yes">L. major</italic>/<italic toggle="yes">Leishmania amazonensis</italic> model of co-infection revealed that the inability of C57BL/6 mice to resolve leishmanial lesions correlated with reduced numbers of GC B cells and memory B cells and fewer parasite-specific antibody-producing cells as compared with the C3HeB/FeJ strain (Gibson-Corley et al., <xref rid="B45" ref-type="bibr">2012</xref>). In this study, the differences in the local production of IL-21 or different expression levels of IL-21R did not explain the distinct clinical profiles observed between the two strains, since the two strains had comparable local production and expression of IL-21 and IL-21R, respectively (Gibson-Corley et al., <xref rid="B45" ref-type="bibr">2012</xref>). These findings may suggest that varied clinical profiles in the mouse strains developing healing (C3HeB/FeJ) vs. non-healing (C57BL/6) lesions can be mainly due to the mouse strain-dependent discrepancies in intrinsic T<sub>FH</sub> cell or B cell functional properties.</p><p>It is well-established that the IFN-regulatory factor (IRF) family of transcription factors are key players in T<sub>H</sub> differentiation; whereas IRF1 is crucial for T<sub>H1</sub> differentiation (Lohoff et al., <xref rid="B74" ref-type="bibr">1997</xref>; Lohoff and Mak, <xref rid="B75" ref-type="bibr">2005</xref>), IRF4 is required for T<sub>H2</sub> and T<sub>H17</sub> cell differentiation (Brustle et al., <xref rid="B19" ref-type="bibr">2007</xref>; Huber et al., <xref rid="B54" ref-type="bibr">2008</xref>). Mice deficient for IRF4 (<italic toggle="yes">Irf4</italic><sup>&#8722;/&#8722;</sup>) were characterized by their failure to form GCs in the draining popliteal lymph nodes in response to chronic <italic toggle="yes">L. major</italic> infection as well as their inability of dLN<bold>-</bold>derived T<sub>FH</sub> cells to optimally express and secrete IL-21 at both the mRNA and protein levels, respectively (Bollig et al., <xref rid="B16" ref-type="bibr">2012</xref>). These observations may suggest an important role played by IRF4 in T<sub>FH</sub> cells<bold>-</bold>derived IL-21 expression in response to a chronic, intracellular parasitic pathogen.</p></sec></sec></sec><sec id="s4"><title>Helminth Parasites</title><sec><title>Trematodes</title><sec><title>Schistosomes</title><p>Several studies have demonstrated that IL-21 is induced at both the mRNA and protein levels during natural infections with several species of schistosomes in humans and in murine models of schistosomiasis (Milner et al., <xref rid="B87" ref-type="bibr">2010</xref>; Bourke et al., <xref rid="B17" ref-type="bibr">2013</xref>; Zhang Y. et al., <xref rid="B174" ref-type="bibr">2016</xref>), as well as following vaccination with schistosome-derived peptides (Zhang et al., <xref rid="B172" ref-type="bibr">2013</xref>, <xref rid="B173" ref-type="bibr">2018</xref>; Bourke et al., <xref rid="B18" ref-type="bibr">2014</xref>; Fairfax et al., <xref rid="B38" ref-type="bibr">2015</xref>). Ileal lamina propria lymphocytes-(LPLs) and axillary lymph node-derived T cells and non-T cell subsets from uninfected rhesus macaques (<italic toggle="yes">Macaca mulatta</italic>) secreted high levels of IL-21 in a recall assay in response to <italic toggle="yes">S. mansoni</italic> (Sm) egg antigen (SmEA) and worm antigen (SmWA) preparations <italic toggle="yes">ex vivo</italic> (Torben et al., <xref rid="B149" ref-type="bibr">2017</xref>). Dendritic cell-specific adhesion molecule-3-grabbing non-integrin (DC-SIGN, CD209) controls the differentiation of T<sub>FH</sub> cells via IL-27 expression during infections with <italic toggle="yes">S. mansoni</italic> and the liver fluke, <italic toggle="yes">Fasciola hepatica</italic> (Gringhuis et al., <xref rid="B49" ref-type="bibr">2014</xref>). Interestingly, the transcription factor, IFN-stimulated gene factor 3 (ISGF3) induces the expression of the IL-27 subunit p28 by primed DCs, and IL-27 produced by DCs is required for the differentiation of T<sub>FH</sub> cells and the subsequent IL-21 expression by T<sub>FH</sub> cells during infections with trematodes, including <italic toggle="yes">S. mansoni</italic> and <italic toggle="yes">F. hepatica</italic> (Gringhuis et al., <xref rid="B49" ref-type="bibr">2014</xref>).</p><p>In contrast to potential roles played by the IL-21/IL-21R signaling axis in protective immunity during infection with trematodes, earlier studies demonstrated that the IL-21/IL-21R signaling pathway promotes the induction of tissue damage following <italic toggle="yes">Schistosoma</italic> spp. infections (Pesce et al., <xref rid="B109" ref-type="bibr">2006</xref>). While parasite burdens were comparable between wild-type mice and mice lacking a functional IL-21/IL-21R signaling axis (<italic toggle="yes">Il21r</italic><sup>&#8722;/&#8722;</sup>), the lack of a functional IL-21/IL-21R signaling pathway in <italic toggle="yes">Il21r</italic><sup>&#8722;/&#8722;</sup> mice infected with <italic toggle="yes">S. mansoni</italic> led to diminished T<sub>H2</sub>-dependent immunopathology in those mice, as evidenced by attenuated formation of granulomatous inflammation and liver fibrosis (Pesce et al., <xref rid="B109" ref-type="bibr">2006</xref>). Mechanistically, the impaired <italic toggle="yes">S. mansoni</italic>-induced granulomatous formation in <italic toggle="yes">Il21r</italic><sup>&#8722;/&#8722;</sup> mice correlated with a significant impairment in both the tissue expression and the function of T<sub>H2</sub> cytokines, including IL-4 and IL-13, required for the fibrotic tissue responses during <italic toggle="yes">S. mansoni</italic> infection (Pesce et al., <xref rid="B109" ref-type="bibr">2006</xref>). Furthermore, IL-21 treatment of the bone marrow<bold>-</bold>derived macrophages (BMDM) promotes the expression of cognate receptors for IL-4 and IL-13 (IL-4R&#945; and IL-13R&#945;1) in macrophages, indicating that the augmentation of alternate macrophage activation can occur in an IL-21/IL-21R axis<bold>-</bold>dependent manner (Pesce et al., <xref rid="B109" ref-type="bibr">2006</xref>).</p><p>It is known that the ICOS/ICOSL axis contributes to the T cell differentiation, T cell activation and its optimal functions (Hutloff et al., <xref rid="B56" ref-type="bibr">1999</xref>; Dong et al., <xref rid="B34" ref-type="bibr">2001</xref>). Mice deficient in either a functional ICOS or ICOSL (<italic toggle="yes">Icos</italic><sup>&#8722;/&#8722;</sup> and <italic toggle="yes">Icosl</italic><sup>&#8722;/&#8722;</sup> mice, respectively) had diminished levels of serum antibodies, defective antibody class switching and impaired GC formation and T<sub>H17</sub> cell development (Dong et al., <xref rid="B34" ref-type="bibr">2001</xref>; Nurieva et al., <xref rid="B99" ref-type="bibr">2003</xref>). Consistent with the requirement of the ICOS/ICOSL signaling pathway in the development and the function of T<sub>H17</sub> cells, <italic toggle="yes">Icosl</italic><sup>&#8722;/&#8722;</sup> mice infected with <italic toggle="yes">Schistosoma japonicum</italic> showed decreased expression of T<sub>H17</sub> cytokines, including IL-21 (Wang et al., <xref rid="B159" ref-type="bibr">2015</xref>). The impaired T<sub>H17</sub> cytokine expression in <italic toggle="yes">Icosl</italic><sup>&#8722;/&#8722;</sup> mice correlated with attenuated liver granulomatous inflammation around parasite eggs and the significant reduction in hepatic fibrosis in those mice as compared with wild-type controls (Wang et al., <xref rid="B159" ref-type="bibr">2015</xref>).</p><p>Interestingly, IL-21 does not directly promote the production of the <italic toggle="yes">Schistosoma</italic> egg-induced IL-17 production by antigen-specific CD4<sup>+</sup> T cells. Antibody neutralization of IL-21 in a DC-CD4<sup>+</sup> T cells co-culture setting, in which DCs are pulsed with egg antigens and co-cultured with na&#239;ve CD4<sup>+</sup> T cells, did not impair the antigen-specific IL-17 production by antigen-specific CD4<sup>+</sup> T cells (Shainheit et al., <xref rid="B129" ref-type="bibr">2008</xref>). This is consistent with studies demonstrating that the lack of the IL-21/IL-21R signaling axis does not impair the secretion of IL-17, as well as IFN-&#947;, following colonic inflammation (Wang et al., <xref rid="B161" ref-type="bibr">2016</xref>; Solaymani-Mohammadi and Berzofsky, <xref rid="B133" ref-type="bibr">2019</xref>). It is likely that the IL-21 promotion of tissue inflammation and immunopathology during schistosomiasis occurs via other signaling pathways independent of the IL-17/STAT3 signaling axis, most likely through STAT1 or STAT5 signaling.</p><p>The increased levels of IL-21 in human subjects with schistosomiasis as compared with healthy controls (Milner et al., <xref rid="B87" ref-type="bibr">2010</xref>) and the fact that mice deficient for the IL-21/IL-21R signaling pathway have significantly reduced parasite-induced tissue fibrosis suggest that this axis could play important roles in parasite-induced pathogenesis. Targeting this signaling axis may provide an alternative approach for the development of new therapeutic targets for the prevention of fibrotic reactions that develop during human infections with different species of <italic toggle="yes">Schistosoma</italic>.</p></sec></sec><sec><title>Cestodes</title><sec><title>Cystic Echinococcosis Caused by <italic toggle="yes">Echinococcus granulosus</italic></title><p>In a clinical study, the roles played by T<sub>FH</sub> cells and the cytokines they secrete, including IL-4 and IL-21, during different stages of human cystic echinococcosis (CE) were investigated in patients with active, transitional or inactive disease (Zhang et al., <xref rid="B171" ref-type="bibr">2015</xref>). The findings of this study demonstrated that the percentage of circulating T<sub>FH</sub> cells, defined as CCR7<sup>lo</sup>PD-1<sup>hi</sup>CXCR5<sup>+</sup>CD4<sup>+</sup>, increased in the PBMCs of patients with active and transitional disease as did the serum levels of IL-21 and IL-4 in those patients as compared with healthy controls (Zhang et al., <xref rid="B171" ref-type="bibr">2015</xref>). The expression of IL-21 and IL-4 by PMBCs isolated from patients with CE significantly increased in response to the hydatid fluid as compared with PMBCs from healthy volunteers (Zhang et al., <xref rid="B171" ref-type="bibr">2015</xref>). Interestingly, CE patients with inactive disease neither had increased percentages of circulating T<sub>FH</sub> cells nor did they show increased levels of IL-21 and IL-4 as compared with healthy controls. These observations suggest that T<sub>FH</sub> cells may be involved in host immunity or immunopathology associated with CE in humans via the expression of canonical cytokines expressed by these cells. However, the causality, the direction of any causality and the potential mechanisms underlying the differences in the T<sub>FH</sub> cells and cytokine profiles between human subjects with active, transitional or inactive CE still require further investigation.</p></sec></sec><sec><title>Nematodes</title><sec><title>Tissue- and Lumen-Dwelling Nematodes</title><p>Limited evidence suggests that T<sub>H17</sub> cytokines, including IL-17A, IL-17F, IL-21, and IL-23, are elevated in human subjects with lymphatic filariasis as well as in animal models of human filariasis and this cytokine signature is associated with helminth-induced immunopathology in chronic lymphatic filariasis (Babu et al., <xref rid="B10" ref-type="bibr">2009</xref>; Anuradha et al., <xref rid="B4" ref-type="bibr">2014</xref>; Ritter et al., <xref rid="B117" ref-type="bibr">2018</xref>).</p><p>The roles played by the IL-21/IL-21R signaling axis in the maintenance of intestinal immune homeostasis in the context of intestinal helminthiasis is not fully-understood. IL-21 was detectable following infection of mice with a natural murine intestinal nematode, <italic toggle="yes">Heligmosomoides polygyrus</italic> (Espitia et al., <xref rid="B37" ref-type="bibr">2010</xref>; Ariyaratne et al., <xref rid="B6" ref-type="bibr">2018</xref>). The expression of IL-21 in another murine model of intestinal nematodiasis, caused by the mouse pinworm, <italic toggle="yes">Aspiculuris tetraptera</italic>, was tissue-dependent and significantly higher levels of IL-21 transcripts were measured in the Peyer's patches (PP), and to a lesser extent in the spleens and in the mesenteric lymph nodes, of wild-type mice infected with <italic toggle="yes">A. tetraptera</italic> (Gomez-Samblas et al., <xref rid="B46" ref-type="bibr">2018</xref>). Mice deficient for a functional IL-21/IL-21R axis failed to elicit anti-helminth-specific IgG<sub>1</sub> responses and subsequently were unable to clear helminth infection as compared with their wild-type counterparts (King et al., <xref rid="B63" ref-type="bibr">2010</xref>). The IL-21/IL-21R axis was important for driving the differentiation of <italic toggle="yes">H. polygyrus</italic>-specific CD138<sup>+</sup> plasma cells following intestinal infection (King et al., <xref rid="B63" ref-type="bibr">2010</xref>). Despite the observations that <italic toggle="yes">Il21r</italic>&#945;<sup>&#8722;/&#8722;</sup> had impaired differentiation of CD138<sup>+</sup> plasma cells 2 weeks post-infection, this study did not find evidence demonstrating any roles for IL-21R signaling in GC formation, isotype class switching or T<sub>H2</sub> differentiation (King et al., <xref rid="B63" ref-type="bibr">2010</xref>). In contrast, it appears that the IL-21/IL-21R signaling axis also played critical roles in the development of T<sub>H2</sub> immune response following infection with the intestinal luminal nematodes, <italic toggle="yes">Nippostrongylus brasiliensis</italic> and <italic toggle="yes">H. polygyrus</italic> (Frohlich et al., <xref rid="B43" ref-type="bibr">2007</xref>). Mice deficient for the IL-21R (<italic toggle="yes">Il21r</italic><sup>&#8722;/&#8722;</sup>) showed reduced accumulation of immune subsets in the intestine, including lymphocytes, and reduced sizes and numbers of intestinal granuloma following helminth infections, suggesting a critical requirement of the IL-21/IL-21R axis for mounting T<sub>H2</sub> responses (Frohlich et al., <xref rid="B43" ref-type="bibr">2007</xref>). These findings may also suggest a role for this signaling pathway in the initiation and the promotion of inflammation and tissue immunopathology during intestinal inflammatory condition, as observed in other models of colonic infections (Solaymani-Mohammadi and Berzofsky, <xref rid="B133" ref-type="bibr">2019</xref>).</p><p>In another line of research, it was found that both IL-21 and IFN-&#947; can drive the expression of T-bet transcripts (<italic toggle="yes">Tbx21</italic>) and the intranuclear expression of T-bet protein in follicular B cells in the presence of TLR7 or TLR9 agonists <italic toggle="yes">in vitro</italic> (Naradikian et al., <xref rid="B95" ref-type="bibr">2016</xref>). This study also demonstrated that the IFN-&#947;-induced expression of T-bet was independent of either IL-4 or IL-21, since IFN-&#947; alone was sufficient for driving the expression of T-bet in follicular B cells (Naradikian et al., <xref rid="B95" ref-type="bibr">2016</xref>). In contrast, the stimulation of follicular B cells with IL-21 led to the expression of CD11c, whereas IFN-&#947; did not alter CD11c expression by those cells. Considering that the IL-21/IL-21R signaling axis signals mainly via STAT3, but also STAT-1 and STAT5, it is likely that the expression of CD11c is mediated by the IL-21-induced activation of STAT3 or STAT5, whereas the IL-21- or IFN-&#947;-induced expression of T-bet may occur mainly via the STAT1 pathway, a pathway via which both cytokines exert parts or all of their biological functions. Studies in a T<sub>H2</sub>-biased murine model of infection with <italic toggle="yes">H. polygyrus</italic> further confirmed that the two main cytokines secreted by T<sub>FH</sub> cells, IL-21 and IL-4, can cross-regulate the expression of T-bet and CD11c in the absence of an intact IFN-&#947;/IFN-&#947;R signaling axis (Naradikian et al., <xref rid="B95" ref-type="bibr">2016</xref>).</p></sec></sec></sec><sec sec-type="conclusions" id="s5"><title>Conclusion</title><p>To conclude, we and others already have shown that, in synergy with IFN-&#947;, the IL-21/IL-21R axis is required for the optimal expression of ISGs, including several chemokines and chemokine receptors, as well MHC class molecules required for protection against parasitic infections, in a STAT3-independent, most likely STAT1-dependent, manner in humans or in mice (Wan et al., <xref rid="B157" ref-type="bibr">2015</xref>; Solaymani-Mohammadi and Berzofsky, <xref rid="B133" ref-type="bibr">2019</xref>). Based on this, the use of recombinant human IL-21 in vaccine regimens in clinical trials (for example targeting <italic toggle="yes">P. falciparum</italic> infections) may provide novel and unique vaccine strategies to elicit an effective anti-malarial immune response and warranting a better protective outcome. Most studies investigating the roles played by the IL-21/IL-21R axis in parasitic infections, whether protective or detrimental, stemmed from reports in animal models. However, studies in animal models require careful interpretation and cannot be simply extrapolated to humans since animal immune responses, including murine hosts, are not always equivalent to those observed in humans. For instance, studies have utilized <italic toggle="yes">P. berghei</italic>, a rodent malaria parasite, to analyze the extent to which the IL-21/IL-21R axis contributes to host immunity during CM in the murine hosts as a surrogate for the human disease (Inoue et al., <xref rid="B57" ref-type="bibr">2018</xref>). Multiple studies, however, have highlighted significant differences as to how <italic toggle="yes">P. berghei</italic> induces CM in mice and that the murine infection with <italic toggle="yes">P. berghei</italic> does not recapitulate all aspects of the human disease (reviewed in Riley et al., <xref rid="B116" ref-type="bibr">2010</xref>; Stevenson et al., <xref rid="B143" ref-type="bibr">2010</xref>). Unveiling the IL-21/IL-21R crosstalk with other cytokine networks and their downstream genes will provide insight into the development of novel therapeutic targets for the parasite-induced immunopathology and the control of parasitic infections.</p></sec><sec id="s6"><title>Author Contributions</title><p>SS-M conceived the study, contributed hypotheses, and wrote the manuscript. LE and SS critically read the manuscript and provided feedback.</p><sec><title>Conflict of Interest</title><p>The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.</p></sec></sec></body><back><ack><p>We thank Dr. Stefan Kappe, Center for Global Infectious Disease Research, Seattle Children's Research Institute, Seattle, for his helpful comments and discussion.</p></ack><fn-group><fn fn-type="financial-disclosure"><p><bold>Funding.</bold> This work was supported by the NIH/NIAID grant R15AI109591 (SS) and the NIH/NIDDK grant DK120515 (LE).</p></fn></fn-group><ref-list><title>References</title><ref id="B1"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Achour</surname><given-names>A.</given-names></name><name name-style="western"><surname>Simon</surname><given-names>Q.</given-names></name><name name-style="western"><surname>Mohr</surname><given-names>A.</given-names></name><name name-style="western"><surname>Seite</surname><given-names>J. F.</given-names></name><name name-style="western"><surname>Youinou</surname><given-names>P.</given-names></name><name name-style="western"><surname>Bendaoud</surname><given-names>B.</given-names></name><etal/></person-group>. (<year>2017</year>). <article-title>Human regulatory B cells control the TFH cell response</article-title>. <source>J. Allergy Clin. Immunol.</source><volume>140</volume>, <fpage>215</fpage>&#8211;<lpage>222</lpage>. <pub-id pub-id-type="doi">10.1016/j.jaci.2016.09.042</pub-id><pub-id pub-id-type="pmid">27865860</pub-id></mixed-citation></ref><ref id="B2"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Adams</surname><given-names>P. N.</given-names></name><name name-style="western"><surname>Aldridge</surname><given-names>A.</given-names></name><name name-style="western"><surname>Vukman</surname><given-names>K. V.</given-names></name><name name-style="western"><surname>Donnelly</surname><given-names>S.</given-names></name><name name-style="western"><surname>O'Neill</surname><given-names>S. M.</given-names></name></person-group> (<year>2014</year>). <article-title>Fasciola hepatica tegumental antigens indirectly induce an M2 macrophage-like phenotype <italic toggle="yes">in vivo</italic></article-title>. <source>Prasite Immunol</source>. <volume>36</volume>, <fpage>531</fpage>&#8211;<lpage>539</lpage>. <pub-id pub-id-type="doi">10.1111/pim.12127</pub-id><pub-id pub-id-type="pmid">25039932</pub-id></mixed-citation></ref><ref id="B3"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Ansari</surname><given-names>N. A.</given-names></name><name name-style="western"><surname>Kumar</surname><given-names>R.</given-names></name><name name-style="western"><surname>Gautam</surname><given-names>S.</given-names></name><name name-style="western"><surname>Nylen</surname><given-names>S.</given-names></name><name name-style="western"><surname>Singh</surname><given-names>O. P.</given-names></name><name name-style="western"><surname>Sundar</surname><given-names>S.</given-names></name><etal/></person-group>. (<year>2011</year>). <article-title>IL-27 and IL-21 are associated with T cell IL-10 responses in human visceral leishmaniasis</article-title>. <source>J. Immunol.</source><volume>186</volume>, <fpage>3977</fpage>&#8211;<lpage>3985</lpage>. <pub-id pub-id-type="doi">10.4049/jimmunol.1003588</pub-id><pub-id pub-id-type="pmid">21357266</pub-id><pub-id pub-id-type="pmcid">PMC3076633</pub-id></mixed-citation></ref><ref id="B4"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Anuradha</surname><given-names>R.</given-names></name><name name-style="western"><surname>George</surname><given-names>P. J.</given-names></name><name name-style="western"><surname>Kumaran</surname><given-names>P.</given-names></name><name name-style="western"><surname>Nutman</surname><given-names>T. B.</given-names></name><name name-style="western"><surname>Babu</surname><given-names>S.</given-names></name></person-group> (<year>2014</year>). <article-title>Interleukin-10- and transforming growth factor beta-independent regulation of CD8(+) T cells expressing type 1 and type 2 cytokines in human lymphatic filariasis</article-title>. <source>Clin. Vaccine Immunol.</source><volume>21</volume>, <fpage>1620</fpage>&#8211;<lpage>1627</lpage>. <pub-id pub-id-type="doi">10.1128/CVI.00598-14</pub-id><pub-id pub-id-type="pmid">25253667</pub-id><pub-id pub-id-type="pmcid">PMC4248783</pub-id></mixed-citation></ref><ref id="B5"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Araujo</surname><given-names>F. G.</given-names></name><name name-style="western"><surname>Williams</surname><given-names>D. M.</given-names></name><name name-style="western"><surname>Grumet</surname><given-names>F. C.</given-names></name><name name-style="western"><surname>Remington</surname><given-names>J. S.</given-names></name></person-group> (<year>1976</year>). <article-title>Strain-dependent differences in murine susceptibility to toxoplasma</article-title>. <source>Infect. Immun.</source><volume>13</volume>, <fpage>1528</fpage>&#8211;<lpage>1530</lpage>. <pub-id pub-id-type="pmid">1270155</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1128/iai.13.5.1528-1530.1976</pub-id><pub-id pub-id-type="pmcid">PMC420794</pub-id></mixed-citation></ref><ref id="B6"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Ariyaratne</surname><given-names>A.</given-names></name><name name-style="western"><surname>Szabo</surname><given-names>E. K.</given-names></name><name name-style="western"><surname>Bowron</surname><given-names>J.</given-names></name><name name-style="western"><surname>Finney</surname><given-names>C. A. M.</given-names></name></person-group> (<year>2018</year>). <article-title>Increases in helminth-induced IL-21 protein levels disappear upon sample freezing</article-title>. <source>Cytokine</source><volume>108</volume>, <fpage>179</fpage>&#8211;<lpage>181</lpage>. <pub-id pub-id-type="doi">10.1016/j.cyto.2018.04.007</pub-id><pub-id pub-id-type="pmid">29684754</pub-id></mixed-citation></ref><ref id="B7"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Avery</surname><given-names>D. T.</given-names></name><name name-style="western"><surname>Bryant</surname><given-names>V. L.</given-names></name><name name-style="western"><surname>Ma</surname><given-names>C. S.</given-names></name><name name-style="western"><surname>de Waal Malefyt</surname><given-names>R.</given-names></name><name name-style="western"><surname>Tangye</surname><given-names>S. G.</given-names></name></person-group> (<year>2008a</year>). <article-title>IL-21-induced isotype switching to IgG and IgA by human naive B cells is differentially regulated by IL-4</article-title>. <source>J. Immunol.</source><volume>181</volume>, <fpage>1767</fpage>&#8211;<lpage>1779</lpage>. <pub-id pub-id-type="doi">10.4049/jimmunol.181.3.1767</pub-id><pub-id pub-id-type="pmid">18641314</pub-id></mixed-citation></ref><ref id="B8"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Avery</surname><given-names>D. T.</given-names></name><name name-style="western"><surname>Ma</surname><given-names>C. S.</given-names></name><name name-style="western"><surname>Bryant</surname><given-names>V. L.</given-names></name><name name-style="western"><surname>Santner-Nanan</surname><given-names>B.</given-names></name><name name-style="western"><surname>Nanan</surname><given-names>R.</given-names></name><name name-style="western"><surname>Wong</surname><given-names>M.</given-names></name><etal/></person-group>. (<year>2008b</year>). <article-title>STAT3 is required for IL-21-induced secretion of IgE from human naive B cells</article-title>. <source>Blood</source><volume>112</volume>, <fpage>1784</fpage>&#8211;<lpage>1793</lpage>. <pub-id pub-id-type="doi">10.1182/blood-2008-02-142745</pub-id><pub-id pub-id-type="pmid">18579794</pub-id></mixed-citation></ref><ref id="B9"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Babaei</surname><given-names>Z.</given-names></name><name name-style="western"><surname>Malihi</surname><given-names>N.</given-names></name><name name-style="western"><surname>Zia-Ali</surname><given-names>N.</given-names></name><name name-style="western"><surname>Sharifi</surname><given-names>I.</given-names></name><name name-style="western"><surname>Mohammadi</surname><given-names>M. A.</given-names></name><name name-style="western"><surname>Kagnoff</surname><given-names>M. F.</given-names></name><etal/></person-group>. (<year>2016</year>). <article-title>Adaptive immune response in symptomatic and asymptomatic enteric protozoal infection: evidence for a determining role of parasite genetic heterogeneity in host immunity to human giardiasis</article-title>. <source>Microbes. Infect.</source><volume>18</volume>, <fpage>687</fpage>&#8211;<lpage>695</lpage>. <pub-id pub-id-type="doi">10.1016/j.micinf.2016.06.009</pub-id><pub-id pub-id-type="pmid">27401766</pub-id><pub-id pub-id-type="pmcid">PMC5071134</pub-id></mixed-citation></ref><ref id="B10"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Babu</surname><given-names>S.</given-names></name><name name-style="western"><surname>Bhat</surname><given-names>S. Q.</given-names></name><name name-style="western"><surname>Pavan Kumar</surname><given-names>N.</given-names></name><name name-style="western"><surname>Lipira</surname><given-names>A. B.</given-names></name><name name-style="western"><surname>Kumar</surname><given-names>S.</given-names></name><name name-style="western"><surname>Karthik</surname><given-names>C.</given-names></name><etal/></person-group>. (<year>2009</year>). <article-title>Filarial lymphedema is characterized by antigen-specific Th1 and th17 proinflammatory responses and a lack of regulatory T cells</article-title>. <source>PLoS Negl. Trop. Dis.</source><volume>3</volume>:<fpage>e420</fpage>. <pub-id pub-id-type="doi">10.1371/journal.pntd.0000420</pub-id><pub-id pub-id-type="pmid">19381284</pub-id><pub-id pub-id-type="pmcid">PMC2666805</pub-id></mixed-citation></ref><ref id="B11"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Barbi</surname><given-names>J.</given-names></name><name name-style="western"><surname>Brombacher</surname><given-names>F.</given-names></name><name name-style="western"><surname>Satoskar</surname><given-names>A. R.</given-names></name></person-group> (<year>2008</year>). <article-title>T cells from Leishmania major-susceptible BALB/c mice have a defect in efficiently up-regulating CXCR3 upon activation</article-title>. <source>J. Immunol.</source><volume>181</volume>, <fpage>4613</fpage>&#8211;<lpage>4620</lpage>. <pub-id pub-id-type="doi">10.4049/jimmunol.181.7.4613</pub-id><pub-id pub-id-type="pmid">18802063</pub-id><pub-id pub-id-type="pmcid">PMC2562238</pub-id></mixed-citation></ref><ref id="B12"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Battaglia</surname><given-names>A.</given-names></name><name name-style="western"><surname>Buzzonetti</surname><given-names>A.</given-names></name><name name-style="western"><surname>Baranello</surname><given-names>C.</given-names></name><name name-style="western"><surname>Fanelli</surname><given-names>M.</given-names></name><name name-style="western"><surname>Fossati</surname><given-names>M.</given-names></name><name name-style="western"><surname>Catzola</surname><given-names>V.</given-names></name><etal/></person-group>. (<year>2013</year>). <article-title>Interleukin-21 (IL-21) synergizes with IL-2 to enhance T-cell receptor-induced human T-cell proliferation and counteracts IL-2/transforming growth factor-beta-induced regulatory T-cell development</article-title>. <source>Immunology</source><volume>139</volume>, <fpage>109</fpage>&#8211;<lpage>120</lpage>. <pub-id pub-id-type="doi">10.1111/imm.12061</pub-id><pub-id pub-id-type="pmid">23278180</pub-id><pub-id pub-id-type="pmcid">PMC3634543</pub-id></mixed-citation></ref><ref id="B13"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Bauquet</surname><given-names>A. T.</given-names></name><name name-style="western"><surname>Jin</surname><given-names>H.</given-names></name><name name-style="western"><surname>Paterson</surname><given-names>A. M.</given-names></name><name name-style="western"><surname>Mitsdoerffer</surname><given-names>M.</given-names></name><name name-style="western"><surname>Ho</surname><given-names>I. C.</given-names></name><name name-style="western"><surname>Sharpe</surname><given-names>A. H.</given-names></name><etal/></person-group>. (<year>2009</year>). <article-title>The costimulatory molecule ICOS regulates the expression of c-Maf and IL-21 in the development of follicular T helper cells and TH-17 cells</article-title>. <source>Nat. Immunol.</source><volume>10</volume>, <fpage>167</fpage>&#8211;<lpage>175</lpage>. <pub-id pub-id-type="doi">10.1038/ni.1690</pub-id><pub-id pub-id-type="pmid">19098919</pub-id><pub-id pub-id-type="pmcid">PMC2742982</pub-id></mixed-citation></ref><ref id="B14"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Belard</surname><given-names>S.</given-names></name><name name-style="western"><surname>Issifou</surname><given-names>S.</given-names></name><name name-style="western"><surname>Hounkpatin</surname><given-names>A. B.</given-names></name><name name-style="western"><surname>Schaumburg</surname><given-names>F.</given-names></name><name name-style="western"><surname>Ngoa</surname><given-names>U. A.</given-names></name><name name-style="western"><surname>Esen</surname><given-names>M.</given-names></name><etal/></person-group>. (<year>2011</year>). <article-title>A randomized controlled phase Ib trial of the malaria vaccine candidate GMZ2 in African children</article-title>. <source>PLoS ONE</source><volume>6</volume>:<fpage>e22525</fpage>. <pub-id pub-id-type="doi">10.1371/journal.pone.0022525</pub-id><pub-id pub-id-type="pmid">21829466</pub-id><pub-id pub-id-type="pmcid">PMC3145647</pub-id></mixed-citation></ref><ref id="B15"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Berglund</surname><given-names>L. J.</given-names></name><name name-style="western"><surname>Avery</surname><given-names>D. T.</given-names></name><name name-style="western"><surname>Ma</surname><given-names>C. S.</given-names></name><name name-style="western"><surname>Moens</surname><given-names>L.</given-names></name><name name-style="western"><surname>Deenick</surname><given-names>E. K.</given-names></name><name name-style="western"><surname>Bustamante</surname><given-names>J.</given-names></name><etal/></person-group>. (<year>2013</year>). <article-title>IL-21 signalling via STAT3 primes human naive B cells to respond to IL-2 to enhance their differentiation into plasmablasts</article-title>. <source>Blood</source><volume>122</volume>, <fpage>3940</fpage>&#8211;<lpage>3950</lpage>. <pub-id pub-id-type="doi">10.1182/blood-2013-06-506865</pub-id><pub-id pub-id-type="pmid">24159173</pub-id><pub-id pub-id-type="pmcid">PMC3854113</pub-id></mixed-citation></ref><ref id="B16"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Bollig</surname><given-names>N.</given-names></name><name name-style="western"><surname>Brustle</surname><given-names>A.</given-names></name><name name-style="western"><surname>Kellner</surname><given-names>K.</given-names></name><name name-style="western"><surname>Ackermann</surname><given-names>W.</given-names></name><name name-style="western"><surname>Abass</surname><given-names>E.</given-names></name><name name-style="western"><surname>Raifer</surname><given-names>H.</given-names></name><etal/></person-group>. (<year>2012</year>). <article-title>Transcription factor IRF4 determines germinal center formation through follicular T-helper cell differentiation</article-title>. <source>Proc. Natl. Acad. Sci. U.S.A.</source><volume>109</volume>, <fpage>8664</fpage>&#8211;<lpage>8669</lpage>. <pub-id pub-id-type="doi">10.1073/pnas.1205834109</pub-id><pub-id pub-id-type="pmid">22552227</pub-id><pub-id pub-id-type="pmcid">PMC3365194</pub-id></mixed-citation></ref><ref id="B17"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Bourke</surname><given-names>C. D.</given-names></name><name name-style="western"><surname>Nausch</surname><given-names>N.</given-names></name><name name-style="western"><surname>Rujeni</surname><given-names>N.</given-names></name><name name-style="western"><surname>Appleby</surname><given-names>L. J.</given-names></name><name name-style="western"><surname>Mitchell</surname><given-names>K. M.</given-names></name><name name-style="western"><surname>Midzi</surname><given-names>N.</given-names></name><etal/></person-group>. (<year>2013</year>). <article-title>Integrated analysis of innate, Th1, Th2, Th17, and regulatory cytokines identifies changes in immune polarisation following treatment of human schistosomiasis</article-title>. <source>J. Infect. Dis.</source><volume>208</volume>, <fpage>159</fpage>&#8211;<lpage>169</lpage>. <pub-id pub-id-type="doi">10.1093/infdis/jis524</pub-id><pub-id pub-id-type="pmid">23045617</pub-id><pub-id pub-id-type="pmcid">PMC3666130</pub-id></mixed-citation></ref><ref id="B18"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Bourke</surname><given-names>C. D.</given-names></name><name name-style="western"><surname>Nausch</surname><given-names>N.</given-names></name><name name-style="western"><surname>Rujeni</surname><given-names>N.</given-names></name><name name-style="western"><surname>Appleby</surname><given-names>L. J.</given-names></name><name name-style="western"><surname>Trottein</surname><given-names>F.</given-names></name><name name-style="western"><surname>Midzi</surname><given-names>N.</given-names></name><etal/></person-group>. (<year>2014</year>). <article-title>Cytokine responses to the anti-schistosome vaccine candidate antigen glutathione-S-transferase vary with host age and are boosted by praziquantel treatment</article-title>. <source>PLoS Negl. Trop. Dis.</source><volume>8</volume>:<fpage>e2846</fpage>. <pub-id pub-id-type="doi">10.1371/journal.pntd.0002846</pub-id><pub-id pub-id-type="pmid">24810615</pub-id><pub-id pub-id-type="pmcid">PMC4014416</pub-id></mixed-citation></ref><ref id="B19"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Brustle</surname><given-names>A.</given-names></name><name name-style="western"><surname>Heink</surname><given-names>S.</given-names></name><name name-style="western"><surname>Huber</surname><given-names>M.</given-names></name><name name-style="western"><surname>Rosenplanter</surname><given-names>C.</given-names></name><name name-style="western"><surname>Stadelmann</surname><given-names>C.</given-names></name><name name-style="western"><surname>Yu</surname><given-names>P.</given-names></name><etal/></person-group>. (<year>2007</year>). <article-title>The development of inflammatory T(H)-17 cells requires interferon-regulatory factor 4</article-title>. <source>Nat. Immunol.</source><volume>8</volume>, <fpage>958</fpage>&#8211;<lpage>966</lpage>. <pub-id pub-id-type="doi">10.1038/ni1500</pub-id><pub-id pub-id-type="pmid">17676043</pub-id></mixed-citation></ref><ref id="B20"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Cai</surname><given-names>C. W.</given-names></name><name name-style="western"><surname>Blase</surname><given-names>J. R.</given-names></name><name name-style="western"><surname>Zhang</surname><given-names>X.</given-names></name><name name-style="western"><surname>Eickhoff</surname><given-names>C. S.</given-names></name><name name-style="western"><surname>Hoft</surname><given-names>D. F.</given-names></name></person-group> (<year>2016</year>). <article-title>Th17 Cells Are More Protective Than Th1 Cells Against the Intracellular Parasite <italic toggle="yes">Trypanosoma cruzi</italic></article-title>. <source>PLoS Pathog.</source><volume>12</volume>:<fpage>e1005902</fpage>. <pub-id pub-id-type="doi">10.1371/journal.ppat.1005902</pub-id><pub-id pub-id-type="pmid">27695083</pub-id><pub-id pub-id-type="pmcid">PMC5047564</pub-id></mixed-citation></ref><ref id="B21"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Camus</surname><given-names>D.</given-names></name><name name-style="western"><surname>Hadley</surname><given-names>T. J.</given-names></name></person-group> (<year>1985</year>). <article-title>A <italic toggle="yes">Plasmodium falciparum</italic> antigen that binds to host erythrocytes and merozoites</article-title>. <source>Science</source><volume>230</volume>, <fpage>553</fpage>&#8211;<lpage>556</lpage>. <pub-id pub-id-type="doi">10.1126/science.3901257</pub-id><pub-id pub-id-type="pmid">3901257</pub-id></mixed-citation></ref><ref id="B22"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Carpio</surname><given-names>V. H.</given-names></name><name name-style="western"><surname>Opata</surname><given-names>M. M.</given-names></name><name name-style="western"><surname>Montanez</surname><given-names>M. E.</given-names></name><name name-style="western"><surname>Banerjee</surname><given-names>P. P.</given-names></name><name name-style="western"><surname>Dent</surname><given-names>A. L.</given-names></name><name name-style="western"><surname>Stephens</surname><given-names>R.</given-names></name></person-group> (<year>2015</year>). <article-title>IFN-gamma and IL-21 double producing T cells are Bcl6-independent and survive into the memory phase in <italic toggle="yes">Plasmodium chabaudi</italic> infection</article-title>. <source>PLoS ONE</source><volume>10</volume>:<fpage>e0144654</fpage>. <pub-id pub-id-type="doi">10.1371/journal.pone.0144654</pub-id><pub-id pub-id-type="pmid">26646149</pub-id><pub-id pub-id-type="pmcid">PMC4672895</pub-id></mixed-citation></ref><ref id="B23"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Caruso</surname><given-names>R.</given-names></name><name name-style="western"><surname>Fina</surname><given-names>D.</given-names></name><name name-style="western"><surname>Peluso</surname><given-names>I.</given-names></name><name name-style="western"><surname>Fantini</surname><given-names>M. C.</given-names></name><name name-style="western"><surname>Tosti</surname><given-names>C.</given-names></name><name name-style="western"><surname>Del Vecchio Blanco</surname><given-names>G.</given-names></name><etal/></person-group>. (<year>2007</year>). <article-title>IL-21 is highly produced in <italic toggle="yes">Helicobacter pylori</italic>-infected gastric mucosa and promotes gelatinases synthesis</article-title>. <source>J. Immunol.</source><volume>178</volume>, <fpage>5957</fpage>&#8211;<lpage>5965</lpage>. <pub-id pub-id-type="doi">10.4049/jimmunol.178.9.5957</pub-id><pub-id pub-id-type="pmid">17442980</pub-id></mixed-citation></ref><ref id="B24"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Chen</surname><given-names>J.</given-names></name><name name-style="western"><surname>Li</surname><given-names>Z. Y.</given-names></name><name name-style="western"><surname>Huang</surname><given-names>S. Y.</given-names></name><name name-style="western"><surname>Petersen</surname><given-names>E.</given-names></name><name name-style="western"><surname>Song</surname><given-names>H. Q.</given-names></name><name name-style="western"><surname>Zhou</surname><given-names>D. H.</given-names></name><etal/></person-group>. (<year>2014</year>). <article-title>Protective efficacy of <italic toggle="yes">Toxoplasma gondii</italic> calcium-dependent protein kinase 1 (TgCDPK1) adjuvated with recombinant IL-15 and IL-21 against experimental toxoplasmosis in mice</article-title>. <source>BMC Infect. Dis.</source><volume>14</volume>:<fpage>487</fpage>. <pub-id pub-id-type="doi">10.1186/1471-2334-14-487</pub-id><pub-id pub-id-type="pmid">25192845</pub-id><pub-id pub-id-type="pmcid">PMC4165937</pub-id></mixed-citation></ref><ref id="B25"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Costa</surname><given-names>D. L.</given-names></name><name name-style="western"><surname>Cardoso</surname><given-names>T. M.</given-names></name><name name-style="western"><surname>Queiroz</surname><given-names>A.</given-names></name><name name-style="western"><surname>Milanezi</surname><given-names>C. M.</given-names></name><name name-style="western"><surname>Bacellar</surname><given-names>O.</given-names></name><name name-style="western"><surname>Carvalho</surname><given-names>E. M.</given-names></name><etal/></person-group>. (<year>2015</year>). <article-title>Tr-1-like CD4+CD25-CD127-/lowFOXP3- cells are the main source of interleukin 10 in patients with cutaneous leishmaniasis due to <italic toggle="yes">Leishmania braziliensis</italic></article-title>. <source>J. Infect. Dis.</source><volume>211</volume>, <fpage>708</fpage>&#8211;<lpage>718</lpage>. <pub-id pub-id-type="doi">10.1093/infdis/jiu406</pub-id><pub-id pub-id-type="pmid">25139022</pub-id><pub-id pub-id-type="pmcid">PMC4402371</pub-id></mixed-citation></ref><ref id="B26"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Crotty</surname><given-names>S.</given-names></name></person-group> (<year>2011</year>). <article-title>Follicular helper CD4 T cells (TFH)</article-title>. <source>Annu. Rev. Immunol.</source><volume>29</volume>, <fpage>621</fpage>&#8211;<lpage>663</lpage>. <pub-id pub-id-type="doi">10.1146/annurev-immunol-031210-101400</pub-id><pub-id pub-id-type="pmid">21314428</pub-id></mixed-citation></ref><ref id="B27"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Crotty</surname><given-names>S.</given-names></name></person-group> (<year>2019</year>). <article-title>T follicular helper cell biology: a decade of discovery and diseases</article-title>. <source>Immunity</source><volume>50</volume>, <fpage>1132</fpage>&#8211;<lpage>1148</lpage>. <pub-id pub-id-type="doi">10.1016/j.immuni.2019.04.011</pub-id><pub-id pub-id-type="pmid">31117010</pub-id><pub-id pub-id-type="pmcid">PMC6532429</pub-id></mixed-citation></ref><ref id="B28"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Cupi</surname><given-names>M. L.</given-names></name><name name-style="western"><surname>Sarra</surname><given-names>M.</given-names></name><name name-style="western"><surname>Marafini</surname><given-names>I.</given-names></name><name name-style="western"><surname>Monteleone</surname><given-names>I.</given-names></name><name name-style="western"><surname>Franze</surname><given-names>E.</given-names></name><name name-style="western"><surname>Ortenzi</surname><given-names>A.</given-names></name><etal/></person-group>. (<year>2014</year>). <article-title>Plasma cells in the mucosa of patients with inflammatory bowel disease produce granzyme B and possess cytotoxic activities</article-title>. <source>J. Immunol.</source><volume>192</volume>, <fpage>6083</fpage>&#8211;<lpage>6091</lpage>. <pub-id pub-id-type="doi">10.4049/jimmunol.1302238</pub-id><pub-id pub-id-type="pmid">24835396</pub-id></mixed-citation></ref><ref id="B29"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Curtis</surname><given-names>M. M.</given-names></name><name name-style="western"><surname>Way</surname><given-names>S. S.</given-names></name></person-group> (<year>2009</year>). <article-title>Interleukin-17 in host defence against bacterial, mycobacterial and fungal pathogens</article-title>. <source>Immunology</source><volume>126</volume>, <fpage>177</fpage>&#8211;<lpage>185</lpage>. <pub-id pub-id-type="doi">10.1111/j.1365-2567.2008.03017.x</pub-id><pub-id pub-id-type="pmid">19125888</pub-id><pub-id pub-id-type="pmcid">PMC2632692</pub-id></mixed-citation></ref><ref id="B30"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Das</surname><given-names>S.</given-names></name><name name-style="western"><surname>Khader</surname><given-names>S.</given-names></name></person-group> (<year>2017</year>). <article-title>Yin and yang of interleukin-17 in host immunity to infection</article-title>. <source>F1000Res</source><volume>6</volume>:<fpage>741</fpage>. <pub-id pub-id-type="doi">10.12688/f1000research.10862.1</pub-id><pub-id pub-id-type="pmid">28713557</pub-id><pub-id pub-id-type="pmcid">PMC5490359</pub-id></mixed-citation></ref><ref id="B31"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Dejon-Agobe</surname><given-names>J. C.</given-names></name><name name-style="western"><surname>Zinsou</surname><given-names>J. F.</given-names></name><name name-style="western"><surname>Honkpehedji</surname><given-names>Y. J.</given-names></name><name name-style="western"><surname>Ateba-Ngoa</surname><given-names>U.</given-names></name><name name-style="western"><surname>Edoa</surname><given-names>J. R.</given-names></name><name name-style="western"><surname>Adegbite</surname><given-names>B. R.</given-names></name><etal/></person-group>. (<year>2018</year>). <article-title><italic toggle="yes">Schistosoma haematobium</italic> effects on <italic toggle="yes">Plasmodium falciparum</italic> infection modified by soil-transmitted helminths in school-age children living in rural areas of Gabon</article-title>. <source>PLoS Negl. Trop. Dis.</source><volume>12</volume>:<fpage>e0006663</fpage>. <pub-id pub-id-type="doi">10.1371/journal.pntd.0006663</pub-id><pub-id pub-id-type="pmid">30080853</pub-id><pub-id pub-id-type="pmcid">PMC6095623</pub-id></mixed-citation></ref><ref id="B32"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Distler</surname><given-names>J. H.</given-names></name><name name-style="western"><surname>Jungel</surname><given-names>A.</given-names></name><name name-style="western"><surname>Kowal-Bielecka</surname><given-names>O.</given-names></name><name name-style="western"><surname>Michel</surname><given-names>B. A.</given-names></name><name name-style="western"><surname>Gay</surname><given-names>R. E.</given-names></name><name name-style="western"><surname>Sprott</surname><given-names>H.</given-names></name><etal/></person-group>. (<year>2005</year>). <article-title>Expression of interleukin-21 receptor in epidermis from patients with systemic sclerosis</article-title>. <source>Arthritis Rheum.</source><volume>52</volume>, <fpage>856</fpage>&#8211;<lpage>864</lpage>. <pub-id pub-id-type="doi">10.1002/art.20883</pub-id><pub-id pub-id-type="pmid">15751077</pub-id></mixed-citation></ref><ref id="B33"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Djokic</surname><given-names>V.</given-names></name><name name-style="western"><surname>Akoolo</surname><given-names>L.</given-names></name><name name-style="western"><surname>Parveen</surname><given-names>N.</given-names></name></person-group> (<year>2018</year>). <article-title>Babesia microti Infection changes host spleen architecture and is cleared by a Th1 immune response</article-title>. <source>Front. Microbiol.</source><volume>9</volume>:<fpage>85</fpage>. <pub-id pub-id-type="doi">10.3389/fmicb.2018.00085</pub-id><pub-id pub-id-type="pmid">29445365</pub-id><pub-id pub-id-type="pmcid">PMC5797759</pub-id></mixed-citation></ref><ref id="B34"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Dong</surname><given-names>C.</given-names></name><name name-style="western"><surname>Juedes</surname><given-names>A. E.</given-names></name><name name-style="western"><surname>Temann</surname><given-names>U. A.</given-names></name><name name-style="western"><surname>Shresta</surname><given-names>S.</given-names></name><name name-style="western"><surname>Allison</surname><given-names>J. P.</given-names></name><name name-style="western"><surname>Ruddle</surname><given-names>N. H.</given-names></name><etal/></person-group>. (<year>2001</year>). <article-title>ICOS co-stimulatory receptor is essential for T-cell activation and function</article-title>. <source>Nature</source><volume>409</volume>, <fpage>97</fpage>&#8211;<lpage>101</lpage>. <pub-id pub-id-type="doi">10.1038/35051100</pub-id><pub-id pub-id-type="pmid">11343121</pub-id></mixed-citation></ref><ref id="B35"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Duleu</surname><given-names>S.</given-names></name><name name-style="western"><surname>Vincendeau</surname><given-names>P.</given-names></name><name name-style="western"><surname>Courtois</surname><given-names>P.</given-names></name><name name-style="western"><surname>Semballa</surname><given-names>S.</given-names></name><name name-style="western"><surname>Lagroye</surname><given-names>I.</given-names></name><name name-style="western"><surname>Daulouede</surname><given-names>S.</given-names></name><etal/></person-group>. (<year>2004</year>). <article-title>Mouse strain susceptibility to trypanosome infection: an arginase-dependent effect</article-title>. <source>J. Immunol.</source><volume>172</volume>, <fpage>6298</fpage>&#8211;<lpage>6303</lpage>. <pub-id pub-id-type="doi">10.4049/jimmunol.172.10.6298</pub-id><pub-id pub-id-type="pmid">15128819</pub-id></mixed-citation></ref><ref id="B36"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Dunst</surname><given-names>J.</given-names></name><name name-style="western"><surname>Kamena</surname><given-names>F.</given-names></name><name name-style="western"><surname>Matuschewski</surname><given-names>K.</given-names></name></person-group> (<year>2017</year>). <article-title>Cytokines and chemokines in cerebral malaria pathogenesis</article-title>. <source>Front. Cell. Infect. Microbiol.</source><volume>7</volume>:<fpage>324</fpage>. <pub-id pub-id-type="doi">10.3389/fcimb.2017.00324</pub-id><pub-id pub-id-type="pmid">28775960</pub-id><pub-id pub-id-type="pmcid">PMC5517394</pub-id></mixed-citation></ref><ref id="B37"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Espitia</surname><given-names>C. M.</given-names></name><name name-style="western"><surname>Zhao</surname><given-names>W.</given-names></name><name name-style="western"><surname>Saldarriaga</surname><given-names>O.</given-names></name><name name-style="western"><surname>Osorio</surname><given-names>Y.</given-names></name><name name-style="western"><surname>Harrison</surname><given-names>L. M.</given-names></name><name name-style="western"><surname>Cappello</surname><given-names>M.</given-names></name><etal/></person-group>. (<year>2010</year>). <article-title>Duplex real-time reverse transcriptase PCR to determine cytokine mRNA expression in a hamster model of New World cutaneous leishmaniasis</article-title>. <source>BMC Immunol.</source><volume>11</volume>:<fpage>31</fpage>. <pub-id pub-id-type="doi">10.1186/1471-2172-11-31</pub-id><pub-id pub-id-type="pmid">20569429</pub-id><pub-id pub-id-type="pmcid">PMC2909172</pub-id></mixed-citation></ref><ref id="B38"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Fairfax</surname><given-names>K. C.</given-names></name><name name-style="western"><surname>Everts</surname><given-names>B.</given-names></name><name name-style="western"><surname>Amiel</surname><given-names>E.</given-names></name><name name-style="western"><surname>Smith</surname><given-names>A. M.</given-names></name><name name-style="western"><surname>Schramm</surname><given-names>G.</given-names></name><name name-style="western"><surname>Haas</surname><given-names>H.</given-names></name><etal/></person-group> (<year>2015</year>). <article-title>IL-4-secreting secondary T follicular helper (Tfh) cells arise from memory T cells, not persisting Tfh cells, through a B cell-dependent mechanism</article-title>. <source>J. Immunol.</source><volume>194</volume>, <fpage>2999</fpage>&#8211;<lpage>3010</lpage>. <pub-id pub-id-type="doi">10.4049/jimmunol.1401225</pub-id><pub-id pub-id-type="pmid">25712216</pub-id><pub-id pub-id-type="pmcid">PMC4495582</pub-id></mixed-citation></ref><ref id="B39"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Fauconnier</surname><given-names>M.</given-names></name><name name-style="western"><surname>Palomo</surname><given-names>J.</given-names></name><name name-style="western"><surname>Bourigault</surname><given-names>M. L.</given-names></name><name name-style="western"><surname>Meme</surname><given-names>S.</given-names></name><name name-style="western"><surname>Szeremeta</surname><given-names>F.</given-names></name><name name-style="western"><surname>Beloeil</surname><given-names>J. C.</given-names></name><etal/></person-group>. (<year>2012</year>). <article-title>IL-12Rbeta2 is essential for the development of experimental cerebral malaria</article-title>. <source>J. Immunol.</source><volume>188</volume>, <fpage>1905</fpage>&#8211;<lpage>1914</lpage>. <pub-id pub-id-type="doi">10.4049/jimmunol.1101978</pub-id><pub-id pub-id-type="pmid">22238458</pub-id></mixed-citation></ref><ref id="B40"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Ferreira</surname><given-names>R. R.</given-names></name><name name-style="western"><surname>Abreu</surname><given-names>R. D. S.</given-names></name><name name-style="western"><surname>Vilar-Pereira</surname><given-names>G.</given-names></name><name name-style="western"><surname>Degrave</surname><given-names>W.</given-names></name><name name-style="western"><surname>Meuser-Batista</surname><given-names>M.</given-names></name><name name-style="western"><surname>Ferreira</surname><given-names>N. V. C.</given-names></name><etal/></person-group>. (<year>2019</year>). <article-title>TGF-beta inhibitor therapy decreases fibrosis and stimulates cardiac improvement in a pre-clinical study of chronic Chagas' heart disease</article-title>. <source>PLoS Negl. Trop. Dis.</source><volume>13</volume>:<fpage>e0007602</fpage>. <pub-id pub-id-type="doi">10.1371/journal.pntd.0007602</pub-id><pub-id pub-id-type="pmid">31365537</pub-id><pub-id pub-id-type="pmcid">PMC6690554</pub-id></mixed-citation></ref><ref id="B41"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Figueiredo</surname><given-names>M. M.</given-names></name><name name-style="western"><surname>Costa</surname><given-names>P. A. C.</given-names></name><name name-style="western"><surname>Diniz</surname><given-names>S. Q.</given-names></name><name name-style="western"><surname>Henriques</surname><given-names>P. M.</given-names></name><name name-style="western"><surname>Kano</surname><given-names>F. S.</given-names></name><name name-style="western"><surname>Tada</surname><given-names>M. S.</given-names></name><etal/></person-group>. (<year>2017</year>). <article-title>T follicular helper cells regulate the activation of B lymphocytes and antibody production during <italic toggle="yes">Plasmodium vivax</italic> infection</article-title>. <source>PLoS Pathog.</source><volume>13</volume>:<fpage>e1006484</fpage>. <pub-id pub-id-type="doi">10.1371/journal.ppat.1006484</pub-id><pub-id pub-id-type="pmid">28700710</pub-id><pub-id pub-id-type="pmcid">PMC5519210</pub-id></mixed-citation></ref><ref id="B42"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Fina</surname><given-names>D.</given-names></name><name name-style="western"><surname>Sarra</surname><given-names>M.</given-names></name><name name-style="western"><surname>Caruso</surname><given-names>R.</given-names></name><name name-style="western"><surname>Del Vecchio Blanco</surname><given-names>G.</given-names></name><name name-style="western"><surname>Pallone</surname><given-names>F.</given-names></name><name name-style="western"><surname>MacDonald</surname><given-names>T. T.</given-names></name><etal/></person-group>. (<year>2008</year>). <article-title>Interleukin 21 contributes to the mucosal T helper cell type 1 response in coeliac disease</article-title>. <source>Gut</source><volume>57</volume>, <fpage>887</fpage>&#8211;<lpage>892</lpage>. <pub-id pub-id-type="doi">10.1136/gut.2007.129882</pub-id><pub-id pub-id-type="pmid">17965065</pub-id></mixed-citation></ref><ref id="B43"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Frohlich</surname><given-names>A.</given-names></name><name name-style="western"><surname>Marsland</surname><given-names>B. J.</given-names></name><name name-style="western"><surname>Sonderegger</surname><given-names>I.</given-names></name><name name-style="western"><surname>Kurrer</surname><given-names>M.</given-names></name><name name-style="western"><surname>Hodge</surname><given-names>M. R.</given-names></name><name name-style="western"><surname>Harris</surname><given-names>N. L.</given-names></name><etal/></person-group>. (<year>2007</year>). <article-title>IL-21 receptor signaling is integral to the development of Th2 effector responses <italic toggle="yes">in vivo</italic></article-title>. <source>Blood</source><volume>109</volume>, <fpage>2023</fpage>&#8211;<lpage>2031</lpage>. <pub-id pub-id-type="doi">10.1182/blood-2006-05-021600</pub-id><pub-id pub-id-type="pmid">17077330</pub-id></mixed-citation></ref><ref id="B44"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Gensous</surname><given-names>N.</given-names></name><name name-style="western"><surname>Charrier</surname><given-names>M.</given-names></name><name name-style="western"><surname>Duluc</surname><given-names>D.</given-names></name><name name-style="western"><surname>Contin-Bordes</surname><given-names>C.</given-names></name><name name-style="western"><surname>Truchetet</surname><given-names>M. E.</given-names></name><name name-style="western"><surname>Lazaro</surname><given-names>E.</given-names></name><etal/></person-group>. (<year>2018</year>). <article-title>T follicular helper cells in autoimmune disorders</article-title>. <source>Front. Immunol.</source><volume>9</volume>:<fpage>1637</fpage>. <pub-id pub-id-type="doi">10.3389/fimmu.2018.01637</pub-id><pub-id pub-id-type="pmid">30065726</pub-id><pub-id pub-id-type="pmcid">PMC6056609</pub-id></mixed-citation></ref><ref id="B45"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Gibson-Corley</surname><given-names>K. N.</given-names></name><name name-style="western"><surname>Boggiatto</surname><given-names>P. M.</given-names></name><name name-style="western"><surname>Bockenstedt</surname><given-names>M. M.</given-names></name><name name-style="western"><surname>Petersen</surname><given-names>C. A.</given-names></name><name name-style="western"><surname>Waldschmidt</surname><given-names>T. J.</given-names></name><name name-style="western"><surname>Jones</surname><given-names>D. E.</given-names></name></person-group> (<year>2012</year>). <article-title>Promotion of a functional B cell germinal center response after <italic toggle="yes">Leishmania</italic> species co-infection is associated with lesion resolution</article-title>. <source>Am. J. Pathol.</source><volume>180</volume>, <fpage>2009</fpage>&#8211;<lpage>2017</lpage>. <pub-id pub-id-type="doi">10.1016/j.ajpath.2012.01.012</pub-id><pub-id pub-id-type="pmid">22429963</pub-id><pub-id pub-id-type="pmcid">PMC3349825</pub-id></mixed-citation></ref><ref id="B46"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Gomez-Samblas</surname><given-names>M.</given-names></name><name name-style="western"><surname>Bernal</surname><given-names>D.</given-names></name><name name-style="western"><surname>Bolado-Ortiz</surname><given-names>A.</given-names></name><name name-style="western"><surname>Vilchez</surname><given-names>S.</given-names></name><name name-style="western"><surname>Bolas-Fernandez</surname><given-names>F.</given-names></name><name name-style="western"><surname>Espino</surname><given-names>A. M.</given-names></name><etal/></person-group>. (<year>2018</year>). <article-title>Intraperitoneal administration of the anti-IL-23 antibody prevents the establishment of intestinal nematodes in mice</article-title>. <source>Sci. Rep.</source><volume>8</volume>:<fpage>7787</fpage>. <pub-id pub-id-type="doi">10.1038/s41598-018-26194-x</pub-id><pub-id pub-id-type="pmid">29773890</pub-id><pub-id pub-id-type="pmcid">PMC5958071</pub-id></mixed-citation></ref><ref id="B47"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Gonzalez</surname><given-names>D. G.</given-names></name><name name-style="western"><surname>Cote</surname><given-names>C. M.</given-names></name><name name-style="western"><surname>Patel</surname><given-names>J. R.</given-names></name><name name-style="western"><surname>Smith</surname><given-names>C. B.</given-names></name><name name-style="western"><surname>Zhang</surname><given-names>Y.</given-names></name><name name-style="western"><surname>Nickerson</surname><given-names>K. M.</given-names></name><etal/></person-group>. (<year>2018</year>). <article-title>Nonredundant roles of IL-21 and IL-4 in the phased initiation of germinal center B cells and subsequent self-renewal transitions</article-title>. <source>J. Immunol.</source><volume>201</volume>, <fpage>3569</fpage>&#8211;<lpage>3579</lpage>. <pub-id pub-id-type="doi">10.4049/jimmunol.1500497</pub-id><pub-id pub-id-type="pmid">30446568</pub-id><pub-id pub-id-type="pmcid">PMC6289626</pub-id></mixed-citation></ref><ref id="B48"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Gorosito Serran</surname><given-names>M.</given-names></name><name name-style="western"><surname>Tosello Boari</surname><given-names>J.</given-names></name><name name-style="western"><surname>Fiocca Vernengo</surname><given-names>F.</given-names></name><name name-style="western"><surname>Beccaria</surname><given-names>C. G.</given-names></name><name name-style="western"><surname>Ramello</surname><given-names>M. C.</given-names></name><name name-style="western"><surname>Bermejo</surname><given-names>D. A.</given-names></name><etal/></person-group>. (<year>2017</year>). <article-title>Unconventional pro-inflammatory CD4(+) T cell response in B cell-deficient mice infected with <italic toggle="yes">Trypanosoma cruzi</italic></article-title>. <source>Front. Immunol.</source><volume>8</volume>:<fpage>1548</fpage>. <pub-id pub-id-type="doi">10.3389/fimmu.2017.01548</pub-id><pub-id pub-id-type="pmid">29209313</pub-id><pub-id pub-id-type="pmcid">PMC5702327</pub-id></mixed-citation></ref><ref id="B49"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Gringhuis</surname><given-names>S. I.</given-names></name><name name-style="western"><surname>Kaptein</surname><given-names>T. M.</given-names></name><name name-style="western"><surname>Wevers</surname><given-names>B. A.</given-names></name><name name-style="western"><surname>van der Vlist</surname><given-names>M.</given-names></name><name name-style="western"><surname>Klaver</surname><given-names>E. J.</given-names></name><name name-style="western"><surname>van Die</surname><given-names>I.</given-names></name><etal/></person-group>. (<year>2014</year>). <article-title>Fucose-based PAMPs prime dendritic cells for follicular T helper cell polarization via DC-SIGN-dependent IL-27 production</article-title>. <source>Nat. Commun.</source><volume>5</volume>:<fpage>5074</fpage>. <pub-id pub-id-type="doi">10.1038/ncomms6074</pub-id><pub-id pub-id-type="pmid">25278262</pub-id></mixed-citation></ref><ref id="B50"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Guo</surname><given-names>S.</given-names></name><name name-style="western"><surname>Cobb</surname><given-names>D.</given-names></name><name name-style="western"><surname>Smeltz</surname><given-names>R. B.</given-names></name></person-group> (<year>2009</year>). <article-title>T-bet inhibits the <italic toggle="yes">in vivo</italic> differentiation of parasite-specific CD4+ Th17 cells in a T cell-intrinsic manner</article-title>. <source>J. Immunol.</source><volume>182</volume>, <fpage>6179</fpage>&#8211;<lpage>6186</lpage>. <pub-id pub-id-type="doi">10.4049/jimmunol.0803821</pub-id><pub-id pub-id-type="pmid">19414771</pub-id></mixed-citation></ref><ref id="B51"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Hernandez-Valladares</surname><given-names>M.</given-names></name><name name-style="western"><surname>Naessens</surname><given-names>J.</given-names></name><name name-style="western"><surname>Musoke</surname><given-names>A. J.</given-names></name><name name-style="western"><surname>Sekikawa</surname><given-names>K.</given-names></name><name name-style="western"><surname>Rihet</surname><given-names>P.</given-names></name><name name-style="western"><surname>Ole-Moiyoi</surname><given-names>O. K.</given-names></name><etal/></person-group>. (<year>2006</year>). <article-title>Pathology of Tnf-deficient mice infected with <italic toggle="yes">Plasmodium chabaudi</italic> adami 408XZ</article-title>. <source>Exp. Parasitol.</source><volume>114</volume>, <fpage>271</fpage>&#8211;<lpage>278</lpage>. <pub-id pub-id-type="doi">10.1016/j.exppara.2006.04.003</pub-id><pub-id pub-id-type="pmid">16716303</pub-id></mixed-citation></ref><ref id="B52"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Hiramatsu</surname><given-names>Y.</given-names></name><name name-style="western"><surname>Suto</surname><given-names>A.</given-names></name><name name-style="western"><surname>Kashiwakuma</surname><given-names>D.</given-names></name><name name-style="western"><surname>Kanari</surname><given-names>H.</given-names></name><name name-style="western"><surname>Kagami</surname><given-names>S.</given-names></name><name name-style="western"><surname>Ikeda</surname><given-names>K.</given-names></name><etal/></person-group>. (<year>2010</year>). <article-title>c-Maf activates the promoter and enhancer of the IL-21 gene, and TGF-beta inhibits c-Maf-induced IL-21 production in CD4+ T cells</article-title>. <source>J. Leukoc. Biol.</source><volume>87</volume>, <fpage>703</fpage>&#8211;<lpage>712</lpage>. <pub-id pub-id-type="doi">10.1189/jlb.0909639</pub-id><pub-id pub-id-type="pmid">20042469</pub-id></mixed-citation></ref><ref id="B53"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Hollister</surname><given-names>K.</given-names></name><name name-style="western"><surname>Kusam</surname><given-names>S.</given-names></name><name name-style="western"><surname>Wu</surname><given-names>H.</given-names></name><name name-style="western"><surname>Clegg</surname><given-names>N.</given-names></name><name name-style="western"><surname>Mondal</surname><given-names>A.</given-names></name><name name-style="western"><surname>Sawant</surname><given-names>D. V.</given-names></name><etal/></person-group>. (<year>2013</year>). <article-title>Insights into the role of Bcl6 in follicular Th cells using a new conditional mutant mouse model</article-title>. <source>J. Immunol.</source><volume>191</volume>, <fpage>3705</fpage>&#8211;<lpage>3711</lpage>. <pub-id pub-id-type="doi">10.4049/jimmunol.1300378</pub-id><pub-id pub-id-type="pmid">23980208</pub-id><pub-id pub-id-type="pmcid">PMC3783642</pub-id></mixed-citation></ref><ref id="B54"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Huber</surname><given-names>M.</given-names></name><name name-style="western"><surname>Brustle</surname><given-names>A.</given-names></name><name name-style="western"><surname>Reinhard</surname><given-names>K.</given-names></name><name name-style="western"><surname>Guralnik</surname><given-names>A.</given-names></name><name name-style="western"><surname>Walter</surname><given-names>G.</given-names></name><name name-style="western"><surname>Mahiny</surname><given-names>A.</given-names></name><etal/></person-group>. (<year>2008</year>). <article-title>IRF4 is essential for IL-21-mediated induction, amplification, and stabilization of the Th17 phenotype</article-title>. <source>Proc. Natl. Acad. Sci.U.S.A.</source><volume>105</volume>, <fpage>20846</fpage>&#8211;<lpage>20851</lpage>. <pub-id pub-id-type="doi">10.1073/pnas.0809077106</pub-id><pub-id pub-id-type="pmid">19088203</pub-id><pub-id pub-id-type="pmcid">PMC2634912</pub-id></mixed-citation></ref><ref id="B55"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Hurdayal</surname><given-names>R.</given-names></name><name name-style="western"><surname>Nieuwenhuizen</surname><given-names>N. E.</given-names></name><name name-style="western"><surname>Revaz-Breton</surname><given-names>M.</given-names></name><name name-style="western"><surname>Smith</surname><given-names>L.</given-names></name><name name-style="western"><surname>Hoving</surname><given-names>J. C.</given-names></name><name name-style="western"><surname>Parihar</surname><given-names>S. P.</given-names></name><etal/></person-group>. (<year>2013</year>). <article-title>Deletion of IL-4 receptor alpha on dendritic cells renders BALB/c mice hypersusceptible to <italic toggle="yes">Leishmania</italic> major infection</article-title>. <source>PLoS Pathog.</source><volume>9</volume>:<fpage>e1003699</fpage>. <pub-id pub-id-type="doi">10.1371/journal.ppat.1003699</pub-id><pub-id pub-id-type="pmid">24204259</pub-id><pub-id pub-id-type="pmcid">PMC3812013</pub-id></mixed-citation></ref><ref id="B56"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Hutloff</surname><given-names>A.</given-names></name><name name-style="western"><surname>Dittrich</surname><given-names>A. M.</given-names></name><name name-style="western"><surname>Beier</surname><given-names>K. C.</given-names></name><name name-style="western"><surname>Eljaschewitsch</surname><given-names>B.</given-names></name><name name-style="western"><surname>Kraft</surname><given-names>R.</given-names></name><name name-style="western"><surname>Anagnostopoulos</surname><given-names>I.</given-names></name><etal/></person-group>. (<year>1999</year>). <article-title>ICOS is an inducible T-cell co-stimulator structurally and functionally related to CD28</article-title>. <source>Nature</source><volume>397</volume>, <fpage>263</fpage>&#8211;<lpage>266</lpage>. <pub-id pub-id-type="doi">10.1038/16717</pub-id><pub-id pub-id-type="pmid">9930702</pub-id></mixed-citation></ref><ref id="B57"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Inoue</surname><given-names>S. I.</given-names></name><name name-style="western"><surname>Niikura</surname><given-names>M.</given-names></name><name name-style="western"><surname>Asahi</surname><given-names>H.</given-names></name><name name-style="western"><surname>Kawakami</surname><given-names>Y.</given-names></name><name name-style="western"><surname>Kobayashi</surname><given-names>F.</given-names></name></person-group> (<year>2018</year>). <article-title>gammadelta T cells modulate humoral immunity against <italic toggle="yes">Plasmodium berghei</italic> infection</article-title>. <source>Immunology</source><volume>155</volume>, <fpage>519</fpage>&#8211;<lpage>532</lpage>. <pub-id pub-id-type="doi">10.1111/imm.12997</pub-id><pub-id pub-id-type="pmid">30144035</pub-id><pub-id pub-id-type="pmcid">PMC6231001</pub-id></mixed-citation></ref><ref id="B58"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Ishii</surname><given-names>A. I.</given-names></name><name name-style="western"><surname>Sano</surname><given-names>M.</given-names></name></person-group> (<year>1989</year>). <article-title>Strain-dependent differences in susceptibility of mice to experimental <italic toggle="yes">Angiostrongylus costaricensis</italic> infection</article-title>. <source>J. Helminthol.</source><volume>63</volume>, <fpage>302</fpage>&#8211;<lpage>306</lpage>. <pub-id pub-id-type="doi">10.1017/S0022149X00009196</pub-id><pub-id pub-id-type="pmid">2532233</pub-id></mixed-citation></ref><ref id="B59"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Ivanova</surname><given-names>D. L.</given-names></name><name name-style="western"><surname>Denton</surname><given-names>S. L.</given-names></name><name name-style="western"><surname>Fettel</surname><given-names>K. D.</given-names></name><name name-style="western"><surname>Sondgeroth</surname><given-names>K. S.</given-names></name><name name-style="western"><surname>Munoz Gutierrez</surname><given-names>J.</given-names></name><name name-style="western"><surname>Bangoura</surname><given-names>B.</given-names></name><etal/></person-group>. (<year>2019</year>). <article-title>Innate lymphoid cells in protection, pathology, and adaptive immunity during apicomplexan infection</article-title>. <source>Front. Immunol.</source><volume>10</volume>:<fpage>196</fpage>. <pub-id pub-id-type="doi">10.3389/fimmu.2019.00196</pub-id><pub-id pub-id-type="pmid">30873151</pub-id><pub-id pub-id-type="pmcid">PMC6403415</pub-id></mixed-citation></ref><ref id="B60"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Jordan</surname><given-names>S. J.</given-names></name><name name-style="western"><surname>Branch</surname><given-names>O. H.</given-names></name><name name-style="western"><surname>Castro</surname><given-names>J. C.</given-names></name><name name-style="western"><surname>Oster</surname><given-names>R. A.</given-names></name><name name-style="western"><surname>Rayner</surname><given-names>J. C.</given-names></name></person-group> (<year>2009</year>). <article-title>Genetic diversity of the malaria vaccine candidate <italic toggle="yes">Plasmodium falciparum</italic> merozoite surface protein-3 in a hypoendemic transmission environment</article-title>. <source>Am. J. Trop. Med. Hyg.</source><volume>80</volume>, <fpage>479</fpage>&#8211;<lpage>486</lpage>. <pub-id pub-id-type="doi">10.4269/ajtmh.2009.80.479</pub-id><pub-id pub-id-type="pmid">19270302</pub-id><pub-id pub-id-type="pmcid">PMC2723947</pub-id></mixed-citation></ref><ref id="B61"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Kaur</surname><given-names>H.</given-names></name><name name-style="western"><surname>Sehgal</surname><given-names>R.</given-names></name><name name-style="western"><surname>Goyal</surname><given-names>K.</given-names></name><name name-style="western"><surname>Makkar</surname><given-names>N.</given-names></name><name name-style="western"><surname>Yadav</surname><given-names>R.</given-names></name><name name-style="western"><surname>Bharti</surname><given-names>P. K.</given-names></name><etal/></person-group>. (<year>2017</year>). <article-title>Genetic diversity of <italic toggle="yes">Plasmodium falciparum</italic> merozoite surface protein-1 (block 2), glutamate-rich protein and sexual stage antigen Pfs25 from Chandigarh, North India</article-title>. <source>Trop. Med. Int. Health.</source><volume>22</volume>, <fpage>1590</fpage>&#8211;<lpage>1598</lpage>. <pub-id pub-id-type="doi">10.1111/tmi.12990</pub-id><pub-id pub-id-type="pmid">29029367</pub-id></mixed-citation></ref><ref id="B62"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Khatonier</surname><given-names>R.</given-names></name><name name-style="western"><surname>Khan</surname><given-names>A. M.</given-names></name><name name-style="western"><surname>Sarmah</surname><given-names>P.</given-names></name><name name-style="western"><surname>Ahmed</surname><given-names>G. U.</given-names></name></person-group> (<year>2018</year>). <article-title>Role of IL-21 in host pathogenesis in experimental visceral leishmaniasis</article-title>. <source>J. Parasit. Dis.</source><volume>42</volume>, <fpage>500</fpage>&#8211;<lpage>504</lpage>. <pub-id pub-id-type="doi">10.1007/s12639-018-1025-8</pub-id><pub-id pub-id-type="pmid">30538346</pub-id><pub-id pub-id-type="pmcid">PMC6261154</pub-id></mixed-citation></ref><ref id="B63"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>King</surname><given-names>I. L.</given-names></name><name name-style="western"><surname>Mohrs</surname><given-names>K.</given-names></name><name name-style="western"><surname>Mohrs</surname><given-names>M.</given-names></name></person-group> (<year>2010</year>). <article-title>A nonredundant role for IL-21 receptor signaling in plasma cell differentiation and protective type 2 immunity against gastrointestinal helminth infection</article-title>. <source>J. Immunol.</source><volume>185</volume>, <fpage>6138</fpage>&#8211;<lpage>6145</lpage>. <pub-id pub-id-type="doi">10.4049/jimmunol.1001703</pub-id><pub-id pub-id-type="pmid">20926797</pub-id><pub-id pub-id-type="pmcid">PMC3065293</pub-id></mixed-citation></ref><ref id="B64"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Kishida</surname><given-names>T.</given-names></name><name name-style="western"><surname>Asada</surname><given-names>H.</given-names></name><name name-style="western"><surname>Itokawa</surname><given-names>Y.</given-names></name><name name-style="western"><surname>Cui</surname><given-names>F. D.</given-names></name><name name-style="western"><surname>Shin-Ya</surname><given-names>M.</given-names></name><name name-style="western"><surname>Gojo</surname><given-names>S.</given-names></name><etal/></person-group>. (<year>2003</year>). <article-title>Interleukin (IL)-21 and IL-15 genetic transfer synergistically augments therapeutic antitumor immunity and promotes regression of metastatic lymphoma</article-title>. <source>Mol. Ther.</source><volume>8</volume>, <fpage>552</fpage>&#8211;<lpage>558</lpage>. <pub-id pub-id-type="doi">10.1016/S1525-0016(03)00222-3</pub-id><pub-id pub-id-type="pmid">14529827</pub-id></mixed-citation></ref><ref id="B65"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Kong</surname><given-names>F.</given-names></name><name name-style="western"><surname>Saldarriaga</surname><given-names>O. A.</given-names></name><name name-style="western"><surname>Spratt</surname><given-names>H.</given-names></name><name name-style="western"><surname>Osorio</surname><given-names>E. Y.</given-names></name><name name-style="western"><surname>Travi</surname><given-names>B. L.</given-names></name><name name-style="western"><surname>Luxon</surname><given-names>B. A.</given-names></name><etal/></person-group>. (<year>2017</year>). <article-title>Transcriptional profiling in experimental visceral leishmaniasis reveals a broad splenic inflammatory environment that conditions macrophages toward a disease-promoting phenotype</article-title>. <source>PLoS Pathog.</source><volume>13</volume>:<fpage>e1006165</fpage>. <pub-id pub-id-type="doi">10.1371/journal.ppat.1006165</pub-id><pub-id pub-id-type="pmid">28141856</pub-id><pub-id pub-id-type="pmcid">PMC5283737</pub-id></mixed-citation></ref><ref id="B66"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Korner</surname><given-names>H.</given-names></name><name name-style="western"><surname>McMorran</surname><given-names>B.</given-names></name><name name-style="western"><surname>Schluter</surname><given-names>D.</given-names></name><name name-style="western"><surname>Fromm</surname><given-names>P.</given-names></name></person-group> (<year>2010</year>). <article-title>The role of TNF in parasitic diseases: still more questions than answers</article-title>. <source>Int. J. Parasitol.</source><volume>40</volume>, <fpage>879</fpage>&#8211;<lpage>888</lpage>. <pub-id pub-id-type="doi">10.1016/j.ijpara.2010.03.011</pub-id><pub-id pub-id-type="pmid">20399786</pub-id></mixed-citation></ref><ref id="B67"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Kroenke</surname><given-names>M. A.</given-names></name><name name-style="western"><surname>Eto</surname><given-names>D.</given-names></name><name name-style="western"><surname>Locci</surname><given-names>M.</given-names></name><name name-style="western"><surname>Cho</surname><given-names>M.</given-names></name><name name-style="western"><surname>Davidson</surname><given-names>T.</given-names></name><name name-style="western"><surname>Haddad</surname><given-names>E. K.</given-names></name><etal/></person-group>. (<year>2012</year>). <article-title>Bcl6 and Maf cooperate to instruct human follicular helper CD4 T cell differentiation</article-title>. <source>J. Immunol.</source><volume>188</volume>, <fpage>3734</fpage>&#8211;<lpage>3744</lpage>. <pub-id pub-id-type="doi">10.4049/jimmunol.1103246</pub-id><pub-id pub-id-type="pmid">22427637</pub-id><pub-id pub-id-type="pmcid">PMC3324673</pub-id></mixed-citation></ref><ref id="B68"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Labsi</surname><given-names>M.</given-names></name><name name-style="western"><surname>Soufli</surname><given-names>I.</given-names></name><name name-style="western"><surname>Khelifi</surname><given-names>L.</given-names></name><name name-style="western"><surname>Amir</surname><given-names>Z. C.</given-names></name><name name-style="western"><surname>Touil-Boukoffa</surname><given-names>C.</given-names></name></person-group> (<year>2018</year>). <article-title><italic toggle="yes">In vivo</italic> treatment with IL-17A attenuates hydatid cyst growth and liver fibrogenesis in an experimental model of echinococcosis</article-title>. <source>Acta Trop.</source><volume>181</volume>, <fpage>6</fpage>&#8211;<lpage>10</lpage>. <pub-id pub-id-type="doi">10.1016/j.actatropica.2018.01.014</pub-id><pub-id pub-id-type="pmid">29407850</pub-id></mixed-citation></ref><ref id="B69"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Lanocha-Arendarczyk</surname><given-names>N.</given-names></name><name name-style="western"><surname>Kolasa-Wolosiuk</surname><given-names>A.</given-names></name><name name-style="western"><surname>Wojciechowska-Koszko</surname><given-names>I.</given-names></name><name name-style="western"><surname>Kot</surname><given-names>K.</given-names></name><name name-style="western"><surname>Roszkowska</surname><given-names>P.</given-names></name><name name-style="western"><surname>Krasnodebska-Szponder</surname><given-names>B.</given-names></name><etal/></person-group>. (<year>2018</year>). <article-title>Changes in the immune system in experimental acanthamoebiasis in immunocompetent and immunosuppressed hosts</article-title>. <source>Parasit. Vectors</source><volume>11</volume>:<fpage>517</fpage>. <pub-id pub-id-type="doi">10.1186/s13071-018-3108-x</pub-id><pub-id pub-id-type="pmid">30236160</pub-id><pub-id pub-id-type="pmcid">PMC6149055</pub-id></mixed-citation></ref><ref id="B70"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Li</surname><given-names>Z. Y.</given-names></name><name name-style="western"><surname>Chen</surname><given-names>J.</given-names></name><name name-style="western"><surname>Petersen</surname><given-names>E.</given-names></name><name name-style="western"><surname>Zhou</surname><given-names>D. H.</given-names></name><name name-style="western"><surname>Huang</surname><given-names>S. Y.</given-names></name><name name-style="western"><surname>Song</surname><given-names>H. Q.</given-names></name><etal/></person-group>. (<year>2014</year>). <article-title>Synergy of mIL-21 and mIL-15 in enhancing DNA vaccine efficacy against acute and chronic <italic toggle="yes">Toxoplasma gondii</italic> infection in mice</article-title>. <source>Vaccine</source><volume>32</volume>, <fpage>3058</fpage>&#8211;<lpage>3065</lpage>. <pub-id pub-id-type="doi">10.1016/j.vaccine.2014.03.042</pub-id><pub-id pub-id-type="pmid">24690150</pub-id></mixed-citation></ref><ref id="B71"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Liang</surname><given-names>H. E.</given-names></name><name name-style="western"><surname>Reinhardt</surname><given-names>R. L.</given-names></name><name name-style="western"><surname>Bando</surname><given-names>J. K.</given-names></name><name name-style="western"><surname>Sullivan</surname><given-names>B. M.</given-names></name><name name-style="western"><surname>Ho</surname><given-names>I. C.</given-names></name><name name-style="western"><surname>Locksley</surname><given-names>R. M.</given-names></name></person-group> (<year>2011</year>). <article-title>Divergent expression patterns of IL-4 and IL-13 define unique functions in allergic immunity</article-title>. <source>Nat. Immunol.</source><volume>13</volume>, <fpage>58</fpage>&#8211;<lpage>66</lpage>. <pub-id pub-id-type="doi">10.1038/ni.2182</pub-id><pub-id pub-id-type="pmid">22138715</pub-id><pub-id pub-id-type="pmcid">PMC3242938</pub-id></mixed-citation></ref><ref id="B72"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Linterman</surname><given-names>M. A.</given-names></name><name name-style="western"><surname>Beaton</surname><given-names>L.</given-names></name><name name-style="western"><surname>Yu</surname><given-names>D.</given-names></name><name name-style="western"><surname>Ramiscal</surname><given-names>R. R.</given-names></name><name name-style="western"><surname>Srivastava</surname><given-names>M.</given-names></name><name name-style="western"><surname>Hogan</surname><given-names>J. J.</given-names></name><etal/></person-group>. (<year>2010</year>). <article-title>IL-21 acts directly on B cells to regulate Bcl-6 expression and germinal center responses</article-title>. <source>J. Exp. Med.</source><volume>207</volume>, <fpage>353</fpage>&#8211;<lpage>363</lpage>. <pub-id pub-id-type="doi">10.1084/jem.20091738</pub-id><pub-id pub-id-type="pmid">20142429</pub-id><pub-id pub-id-type="pmcid">PMC2822609</pub-id></mixed-citation></ref><ref id="B73"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Linterman</surname><given-names>M. A.</given-names></name><name name-style="western"><surname>Pierson</surname><given-names>W.</given-names></name><name name-style="western"><surname>Lee</surname><given-names>S. K.</given-names></name><name name-style="western"><surname>Kallies</surname><given-names>A.</given-names></name><name name-style="western"><surname>Kawamoto</surname><given-names>S.</given-names></name><name name-style="western"><surname>Rayner</surname><given-names>T. F.</given-names></name><etal/></person-group>. (<year>2011</year>). <article-title>Foxp3+ follicular regulatory T cells control the germinal center response</article-title>. <source>Nat. Med.</source><volume>17</volume>, <fpage>975</fpage>&#8211;<lpage>982</lpage>. <pub-id pub-id-type="doi">10.1038/nm.2425</pub-id><pub-id pub-id-type="pmid">21785433</pub-id><pub-id pub-id-type="pmcid">PMC3182542</pub-id></mixed-citation></ref><ref id="B74"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Lohoff</surname><given-names>M.</given-names></name><name name-style="western"><surname>Ferrick</surname><given-names>D.</given-names></name><name name-style="western"><surname>Mittrucker</surname><given-names>H. W.</given-names></name><name name-style="western"><surname>Duncan</surname><given-names>G. S.</given-names></name><name name-style="western"><surname>Bischof</surname><given-names>S.</given-names></name><name name-style="western"><surname>Rollinghoff</surname><given-names>M.</given-names></name><etal/></person-group>. (<year>1997</year>). <article-title>Interferon regulatory factor-1 is required for a T helper 1 immune response <italic toggle="yes">in vivo</italic></article-title>. <source>Immunity</source><volume>6</volume>, <fpage>681</fpage>&#8211;<lpage>689</lpage>. <pub-id pub-id-type="doi">10.1016/S1074-7613(00)80444-6</pub-id><pub-id pub-id-type="pmid">9208841</pub-id></mixed-citation></ref><ref id="B75"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Lohoff</surname><given-names>M.</given-names></name><name name-style="western"><surname>Mak</surname><given-names>T. W.</given-names></name></person-group> (<year>2005</year>). <article-title>Roles of interferon-regulatory factors in T-helper-cell differentiation</article-title>. <source>Nat. Rev. Immunol.</source><volume>5</volume>, <fpage>125</fpage>&#8211;<lpage>135</lpage>. <pub-id pub-id-type="doi">10.1038/nri1552</pub-id><pub-id pub-id-type="pmid">15688040</pub-id></mixed-citation></ref><ref id="B76"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Lohoff</surname><given-names>M.</given-names></name><name name-style="western"><surname>Sommer</surname><given-names>F.</given-names></name><name name-style="western"><surname>Solbach</surname><given-names>W.</given-names></name><name name-style="western"><surname>Rollinghoff</surname><given-names>M.</given-names></name></person-group> (<year>1989</year>). <article-title>Coexistence of antigen-specific TH1 and TH2 cells in genetically susceptible BALB/c mice infected with Leishmania major</article-title>. <source>Immunobiology</source><volume>179</volume>, <fpage>412</fpage>&#8211;<lpage>21</lpage>. <pub-id pub-id-type="doi">10.1016/S0171-2985(89)80045-2</pub-id><pub-id pub-id-type="pmid">2575598</pub-id></mixed-citation></ref><ref id="B77"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Lusty</surname><given-names>E.</given-names></name><name name-style="western"><surname>Poznanski</surname><given-names>S. M.</given-names></name><name name-style="western"><surname>Kwofie</surname><given-names>K.</given-names></name><name name-style="western"><surname>Mandur</surname><given-names>T. S.</given-names></name><name name-style="western"><surname>Lee</surname><given-names>D. A.</given-names></name><name name-style="western"><surname>Richards</surname><given-names>C. D.</given-names></name><etal/></person-group> (<year>2017</year>). <article-title>IL-18/IL-15/IL-12 synergy induces elevated and prolonged IFN-gamma production by ex vivo expanded NK cells which is not due to enhanced STAT4 activation</article-title>. <source>Mol. Immunol.</source><volume>88</volume>, <fpage>138</fpage>&#8211;<lpage>147</lpage>. <pub-id pub-id-type="doi">10.1016/j.molimm.2017.06.025</pub-id><pub-id pub-id-type="pmid">28644973</pub-id></mixed-citation></ref><ref id="B78"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Ma'ayeh</surname><given-names>S. Y.</given-names></name><name name-style="western"><surname>Knorr</surname><given-names>L.</given-names></name><name name-style="western"><surname>Skold</surname><given-names>K.</given-names></name><name name-style="western"><surname>Garnham</surname><given-names>A.</given-names></name><name name-style="western"><surname>Ansell</surname><given-names>B. R. E.</given-names></name><name name-style="western"><surname>Jex</surname><given-names>A. R.</given-names></name><etal/></person-group> (<year>2018</year>). <article-title>Responses of the differentiated intestinal epithelial cell line Caco-2 to Infection with the <italic toggle="yes">Giardia intestinalis</italic> GS isolate</article-title>. <source>Front. Cell. Infect. Microbiol.</source><volume>8</volume>:<fpage>244</fpage><pub-id pub-id-type="doi">10.3389/fcimb.2018.00297</pub-id><pub-id pub-id-type="pmid">30062089</pub-id><pub-id pub-id-type="pmcid">PMC6055019</pub-id></mixed-citation></ref><ref id="B79"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Mackey</surname><given-names>T. K.</given-names></name><name name-style="western"><surname>Liang</surname><given-names>B. A.</given-names></name><name name-style="western"><surname>Cuomo</surname><given-names>R.</given-names></name><name name-style="western"><surname>Hafen</surname><given-names>R.</given-names></name><name name-style="western"><surname>Brouwer</surname><given-names>K. C.</given-names></name><name name-style="western"><surname>Lee</surname><given-names>D. E.</given-names></name></person-group> (<year>2014</year>). <article-title>Emerging and reemerging neglected tropical diseases: a review of key characteristics, risk factors, and the policy and innovation environment</article-title>. <source>Clin. Microbiol. Rev.</source><volume>27</volume>, <fpage>949</fpage>&#8211;<lpage>979</lpage>. <pub-id pub-id-type="doi">10.1128/CMR.00045-14</pub-id><pub-id pub-id-type="pmid">25278579</pub-id><pub-id pub-id-type="pmcid">PMC4187634</pub-id></mixed-citation></ref><ref id="B80"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>M'Bondoukwe</surname><given-names>N. P.</given-names></name><name name-style="western"><surname>Kendjo</surname><given-names>E.</given-names></name><name name-style="western"><surname>Mawili-Mboumba</surname><given-names>D. P.</given-names></name><name name-style="western"><surname>Koumba Lengongo</surname><given-names>J. V.</given-names></name><name name-style="western"><surname>Offouga Mbouoronde</surname><given-names>C.</given-names></name><name name-style="western"><surname>Nkoghe</surname><given-names>D.</given-names></name><etal/></person-group> (<year>2018</year>). <article-title>Prevalence of and risk factors for malaria, filariasis, and intestinal parasites as single infections or co-infections in different settlements of Gabon, Central Africa</article-title>. <source>Infect. Dis. Poverty</source><volume>7</volume>:<fpage>6</fpage><pub-id pub-id-type="doi">10.1186/s40249-017-0381-4</pub-id><pub-id pub-id-type="pmid">29378644</pub-id><pub-id pub-id-type="pmcid">PMC5789590</pub-id></mixed-citation></ref><ref id="B81"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Meamar</surname><given-names>A. R.</given-names></name><name name-style="western"><surname>Rezaian</surname><given-names>M.</given-names></name><name name-style="western"><surname>Rezaie</surname><given-names>S.</given-names></name><name name-style="western"><surname>Mohraz</surname><given-names>M.</given-names></name><name name-style="western"><surname>Kia</surname><given-names>E. B.</given-names></name><name name-style="western"><surname>Houpt</surname><given-names>E. R.</given-names></name><etal/></person-group>. (<year>2006</year>). <article-title><italic toggle="yes">Cryptosporidium parvum</italic> bovine genotype oocysts in the respiratory samples of an AIDS patient: efficacy of treatment with a combination of azithromycin and paromomycin</article-title>. <source>Parasitol. Res.</source><volume>98</volume>, <fpage>593</fpage>&#8211;<lpage>595</lpage>. <pub-id pub-id-type="doi">10.1007/s00436-005-0097-4</pub-id><pub-id pub-id-type="pmid">16416289</pub-id></mixed-citation></ref><ref id="B82"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Mentink-Kane</surname><given-names>M. M.</given-names></name><name name-style="western"><surname>Wynn</surname><given-names>T. A.</given-names></name></person-group> (<year>2004</year>). <article-title>Opposing roles for IL-13 and IL-13 receptor alpha 2 in health and disease</article-title>. <source>Immunol. Rev.</source><volume>202</volume>, <fpage>191</fpage>&#8211;<lpage>202</lpage>. <pub-id pub-id-type="doi">10.1111/j.0105-2896.2004.00210.x</pub-id><pub-id pub-id-type="pmid">15546394</pub-id></mixed-citation></ref><ref id="B83"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Mesin</surname><given-names>L.</given-names></name><name name-style="western"><surname>Ersching</surname><given-names>J.</given-names></name><name name-style="western"><surname>Victora</surname><given-names>G. D.</given-names></name></person-group> (<year>2016</year>). <article-title>Germinal center B cell dynamics</article-title>. <source>Immunity</source><volume>45</volume>, <fpage>471</fpage>&#8211;<lpage>482</lpage>. <pub-id pub-id-type="doi">10.1016/j.immuni.2016.09.001</pub-id><pub-id pub-id-type="pmid">27653600</pub-id><pub-id pub-id-type="pmcid">PMC5123673</pub-id></mixed-citation></ref><ref id="B84"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Mewono</surname><given-names>L.</given-names></name><name name-style="western"><surname>Agnandji</surname><given-names>S. T.</given-names></name><name name-style="western"><surname>Matondo Maya</surname><given-names>D. W.</given-names></name><name name-style="western"><surname>Mouima</surname><given-names>A. M.</given-names></name><name name-style="western"><surname>Iroungou</surname><given-names>B. A.</given-names></name><name name-style="western"><surname>Issifou</surname><given-names>S.</given-names></name><etal/></person-group>. (<year>2009</year>). <article-title>Malaria antigen-mediated enhancement of interleukin-21 responses of peripheral blood mononuclear cells in African adults</article-title>. <source>Exp. Parasitol.</source><volume>122</volume>, <fpage>37</fpage>&#8211;<lpage>40</lpage>. <pub-id pub-id-type="doi">10.1016/j.exppara.2009.01.007</pub-id><pub-id pub-id-type="pmid">19545527</pub-id></mixed-citation></ref><ref id="B85"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Mewono</surname><given-names>L.</given-names></name><name name-style="western"><surname>Matondo Maya</surname><given-names>D. W.</given-names></name><name name-style="western"><surname>Matsiegui</surname><given-names>P. B.</given-names></name><name name-style="western"><surname>Agnandji</surname><given-names>S. T.</given-names></name><name name-style="western"><surname>Kendjo</surname><given-names>E.</given-names></name><name name-style="western"><surname>Barondi</surname><given-names>F.</given-names></name><etal/></person-group>. (<year>2008</year>). <article-title>Interleukin-21 is associated with IgG1 and IgG3 antibodies to erythrocyte-binding antigen-175 peptide 4 of <italic toggle="yes">Plasmodium falciparum</italic> in Gabonese children with acute falciparum malaria</article-title>. <source>Eur. Cytokine Netw.</source><volume>19</volume>, <fpage>30</fpage>&#8211;<lpage>36</lpage>. <pub-id pub-id-type="doi">10.1684/ecn.2008.0114</pub-id>. <pub-id pub-id-type="pmid">18299268</pub-id></mixed-citation></ref><ref id="B86"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Michailowsky</surname><given-names>V.</given-names></name><name name-style="western"><surname>Silva</surname><given-names>N. M.</given-names></name><name name-style="western"><surname>Rocha</surname><given-names>C. D.</given-names></name><name name-style="western"><surname>Vieira</surname><given-names>L. Q.</given-names></name><name name-style="western"><surname>Lannes-Vieira</surname><given-names>J.</given-names></name><name name-style="western"><surname>Gazzinelli</surname><given-names>R. T.</given-names></name></person-group> (<year>2001</year>). <article-title>Pivotal role of interleukin-12 and interferon-gamma axis in controlling tissue parasitism and inflammation in the heart and central nervous system during <italic toggle="yes">Trypanosoma cruzi</italic> infection</article-title>. <source>Am. J. Pathol.</source><volume>159</volume>, <fpage>1723</fpage>&#8211;<lpage>1733</lpage>. <pub-id pub-id-type="doi">10.1016/S0002-9440(10)63019-2</pub-id><pub-id pub-id-type="pmid">11696433</pub-id><pub-id pub-id-type="pmcid">PMC3277321</pub-id></mixed-citation></ref><ref id="B87"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Milner</surname><given-names>T.</given-names></name><name name-style="western"><surname>Reilly</surname><given-names>L.</given-names></name><name name-style="western"><surname>Nausch</surname><given-names>N.</given-names></name><name name-style="western"><surname>Midzi</surname><given-names>N.</given-names></name><name name-style="western"><surname>Mduluza</surname><given-names>T.</given-names></name><name name-style="western"><surname>Maizels</surname><given-names>R.</given-names></name><etal/></person-group>. (<year>2010</year>). <article-title>Circulating cytokine levels and antibody responses to human Schistosoma haematobium: IL-5 and IL-10 levels depend upon age and infection status</article-title>. <source>Parasite Immunol</source>. <volume>32</volume>, <fpage>710</fpage>&#8211;<lpage>21</lpage>. <pub-id pub-id-type="doi">10.1111/j.1365-3024.2010.01235.x</pub-id><pub-id pub-id-type="pmid">21039611</pub-id><pub-id pub-id-type="pmcid">PMC3033519</pub-id></mixed-citation></ref><ref id="B88"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Miu</surname><given-names>J.</given-names></name><name name-style="western"><surname>Mitchell</surname><given-names>A. J.</given-names></name><name name-style="western"><surname>Muller</surname><given-names>M.</given-names></name><name name-style="western"><surname>Carter</surname><given-names>S. L.</given-names></name><name name-style="western"><surname>Manders</surname><given-names>P. M.</given-names></name><name name-style="western"><surname>McQuillan</surname><given-names>J. A.</given-names></name><etal/></person-group>. (<year>2008</year>). <article-title>Chemokine gene expression during fatal murine cerebral malaria and protection due to CXCR3 deficiency</article-title>. <source>J. Immunol.</source><volume>180</volume>, <fpage>1217</fpage>&#8211;<lpage>1230</lpage>. <pub-id pub-id-type="doi">10.4049/jimmunol.180.2.1217</pub-id><pub-id pub-id-type="pmid">18178862</pub-id></mixed-citation></ref><ref id="B89"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Miyazaki</surname><given-names>Y.</given-names></name><name name-style="western"><surname>Hamano</surname><given-names>S.</given-names></name><name name-style="western"><surname>Wang</surname><given-names>S.</given-names></name><name name-style="western"><surname>Shimanoe</surname><given-names>Y.</given-names></name><name name-style="western"><surname>Iwakura</surname><given-names>Y.</given-names></name><name name-style="western"><surname>Yoshida</surname><given-names>H.</given-names></name></person-group> (<year>2010</year>). <article-title>IL-17 is necessary for host protection against acute-phase Trypanosoma cruzi infection</article-title>. <source>J. Immunol.</source><volume>185</volume>, <fpage>1150</fpage>&#8211;<lpage>1157</lpage>. <pub-id pub-id-type="doi">10.4049/jimmunol.0900047</pub-id><pub-id pub-id-type="pmid">20562260</pub-id></mixed-citation></ref><ref id="B90"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Moncunill</surname><given-names>G.</given-names></name><name name-style="western"><surname>De Rosa</surname><given-names>S. C.</given-names></name><name name-style="western"><surname>Ayestaran</surname><given-names>A.</given-names></name><name name-style="western"><surname>Nhabomba</surname><given-names>A. J.</given-names></name><name name-style="western"><surname>Mpina</surname><given-names>M.</given-names></name><name name-style="western"><surname>Cohen</surname><given-names>K. W.</given-names></name><etal/></person-group>. (<year>2017</year>). <article-title>RTS,S/AS01E malaria vaccine induces memory and polyfunctional T cell responses in a pediatric african phase III trial</article-title>. <source>Front. Immunol.</source><volume>8</volume>:<fpage>1008</fpage>. <pub-id pub-id-type="doi">10.3389/fimmu.2017.01008</pub-id><pub-id pub-id-type="pmid">28878775</pub-id><pub-id pub-id-type="pmcid">PMC5572329</pub-id></mixed-citation></ref><ref id="B91"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Monteleone</surname><given-names>G.</given-names></name><name name-style="western"><surname>Monteleone</surname><given-names>I.</given-names></name><name name-style="western"><surname>Fina</surname><given-names>D.</given-names></name><name name-style="western"><surname>Vavassori</surname><given-names>P.</given-names></name><name name-style="western"><surname>Del Vecchio Blanco</surname><given-names>G.</given-names></name><name name-style="western"><surname>Caruso</surname><given-names>R.</given-names></name><etal/></person-group>. (<year>2005</year>). <article-title>Interleukin-21 enhances T-helper cell type I signaling and interferon-gamma production in Crohn's disease</article-title>. <source>Gastroenterology</source><volume>128</volume>, <fpage>687</fpage>&#8211;<lpage>694</lpage>. <pub-id pub-id-type="doi">10.1053/j.gastro.2004.12.042</pub-id><pub-id pub-id-type="pmid">15765404</pub-id></mixed-citation></ref><ref id="B92"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Moretto</surname><given-names>M. M.</given-names></name><name name-style="western"><surname>Hwang</surname><given-names>S.</given-names></name><name name-style="western"><surname>Khan</surname><given-names>I. A.</given-names></name></person-group> (<year>2017</year>). <article-title>Downregulated IL-21 response and T follicular helper cell exhaustion correlate with compromised CD8 T cell immunity during chronic toxoplasmosis</article-title>. <source>Front. Immunol.</source><volume>8</volume>:<fpage>1436</fpage>. <pub-id pub-id-type="doi">10.3389/fimmu.2017.01436</pub-id><pub-id pub-id-type="pmid">29163509</pub-id><pub-id pub-id-type="pmcid">PMC5671557</pub-id></mixed-citation></ref><ref id="B93"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Moretto</surname><given-names>M. M.</given-names></name><name name-style="western"><surname>Khan</surname><given-names>I. A.</given-names></name></person-group> (<year>2016</year>). <article-title>IL-21 Is Important for Induction of KLRG1+ effector CD8 T cells during acute intracellular infection</article-title>. <source>J. Immunol.</source><volume>196</volume>, <fpage>375</fpage>&#8211;<lpage>384</lpage>. <pub-id pub-id-type="doi">10.4049/jimmunol.1501258</pub-id><pub-id pub-id-type="pmid">26597007</pub-id><pub-id pub-id-type="pmcid">PMC4959448</pub-id></mixed-citation></ref><ref id="B94"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Nair</surname><given-names>S. S.</given-names></name><name name-style="western"><surname>Bommana</surname><given-names>A.</given-names></name><name name-style="western"><surname>Pakala</surname><given-names>S. B.</given-names></name><name name-style="western"><surname>Ohshiro</surname><given-names>K.</given-names></name><name name-style="western"><surname>Lyon</surname><given-names>A. J.</given-names></name><name name-style="western"><surname>Suttiprapa</surname><given-names>S.</given-names></name><etal/></person-group>. (<year>2011</year>). <article-title>Inflammatory response to liver fluke <italic toggle="yes">Opisthorchis viverrini</italic> in mice depends on host master coregulator MTA1, a marker for parasite-induced cholangiocarcinoma in humans</article-title>. <source>Hepatology</source><volume>54</volume>, <fpage>1388</fpage>&#8211;<lpage>1397</lpage>. <pub-id pub-id-type="doi">10.1002/hep.24518</pub-id><pub-id pub-id-type="pmid">21725997</pub-id><pub-id pub-id-type="pmcid">PMC3184196</pub-id></mixed-citation></ref><ref id="B95"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Naradikian</surname><given-names>M. S.</given-names></name><name name-style="western"><surname>Myles</surname><given-names>A.</given-names></name><name name-style="western"><surname>Beiting</surname><given-names>D. P.</given-names></name><name name-style="western"><surname>Roberts</surname><given-names>K. J.</given-names></name><name name-style="western"><surname>Dawson</surname><given-names>L.</given-names></name><name name-style="western"><surname>Herati</surname><given-names>R. S.</given-names></name><etal/></person-group>. (<year>2016</year>). <article-title>Cutting edge: IL-4, IL-21, and IFN-gamma interact to govern T-bet and CD11c expression in TLR-activated B cells</article-title>. <source>J. Immunol.</source><volume>197</volume>, <fpage>1023</fpage>&#8211;<lpage>1028</lpage>. <pub-id pub-id-type="doi">10.4049/jimmunol.1600522</pub-id><pub-id pub-id-type="pmid">27430719</pub-id><pub-id pub-id-type="pmcid">PMC4975960</pub-id></mixed-citation></ref><ref id="B96"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Natale</surname><given-names>M. A.</given-names></name><name name-style="western"><surname>Cesar</surname><given-names>G.</given-names></name><name name-style="western"><surname>Alvarez</surname><given-names>M. G.</given-names></name><name name-style="western"><surname>Castro Eiro</surname><given-names>M. D.</given-names></name><name name-style="western"><surname>Lococo</surname><given-names>B.</given-names></name><name name-style="western"><surname>Bertocchi</surname><given-names>G.</given-names></name><etal/></person-group>. (<year>2018</year>). <article-title>Trypanosoma cruzi-specific IFN-gamma-producing cells in chronic Chagas disease associate with a functional IL-7/IL-7R axis</article-title>. <source>PLoS Negl. Trop. Dis.</source><volume>12</volume>:<fpage>e0006998</fpage>. <pub-id pub-id-type="doi">10.1371/journal.pntd.0006998</pub-id><pub-id pub-id-type="pmid">30517089</pub-id><pub-id pub-id-type="pmcid">PMC6281225</pub-id></mixed-citation></ref><ref id="B97"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Nigg</surname><given-names>A. P.</given-names></name><name name-style="western"><surname>Zahn</surname><given-names>S.</given-names></name><name name-style="western"><surname>Ruckerl</surname><given-names>D.</given-names></name><name name-style="western"><surname>Holscher</surname><given-names>C.</given-names></name><name name-style="western"><surname>Yoshimoto</surname><given-names>T.</given-names></name><name name-style="western"><surname>Ehrchen</surname><given-names>J. M.</given-names></name><etal/></person-group>. (<year>2007</year>). <article-title>Dendritic cell-derived IL-12p40 homodimer contributes to susceptibility in cutaneous leishmaniasis in BALB/c mice</article-title>. <source>J. Immunol.</source><volume>178</volume>, <fpage>7251</fpage>&#8211;<lpage>7258</lpage>. <pub-id pub-id-type="doi">10.4049/jimmunol.178.11.7251</pub-id><pub-id pub-id-type="pmid">17513774</pub-id></mixed-citation></ref><ref id="B98"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Nurieva</surname><given-names>R. I.</given-names></name><name name-style="western"><surname>Chung</surname><given-names>Y.</given-names></name><name name-style="western"><surname>Martinez</surname><given-names>G. J.</given-names></name><name name-style="western"><surname>Yang</surname><given-names>X. O.</given-names></name><name name-style="western"><surname>Tanaka</surname><given-names>S.</given-names></name><name name-style="western"><surname>Matskevitch</surname><given-names>T. D.</given-names></name><etal/></person-group>. (<year>2009</year>). <article-title>Bcl6 mediates the development of T follicular helper cells</article-title>. <source>Science</source><volume>325</volume>, <fpage>1001</fpage>&#8211;<lpage>1005</lpage>. <pub-id pub-id-type="doi">10.1126/science.1176676</pub-id><pub-id pub-id-type="pmid">19628815</pub-id><pub-id pub-id-type="pmcid">PMC2857334</pub-id></mixed-citation></ref><ref id="B99"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Nurieva</surname><given-names>R. I.</given-names></name><name name-style="western"><surname>Treuting</surname><given-names>P.</given-names></name><name name-style="western"><surname>Duong</surname><given-names>J.</given-names></name><name name-style="western"><surname>Flavell</surname><given-names>R. A.</given-names></name><name name-style="western"><surname>Dong</surname><given-names>C.</given-names></name></person-group> (<year>2003</year>). <article-title>Inducible costimulator is essential for collagen-induced arthritis</article-title>. <source>J. Clin. Invest.</source><volume>111</volume>, <fpage>701</fpage>&#8211;<lpage>706</lpage>. <pub-id pub-id-type="doi">10.1172/JCI17321</pub-id><pub-id pub-id-type="pmid">12618524</pub-id><pub-id pub-id-type="pmcid">PMC151904</pub-id><related-article xmlns:xlink="http://www.w3.org/1999/xlink" related-article-type="retraction-forward" ext-link-type="pmc" xlink:href="PMC259142"/></mixed-citation></ref><ref id="B100"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Oeuvray</surname><given-names>C.</given-names></name><name name-style="western"><surname>Bouharoun-Tayoun</surname><given-names>H.</given-names></name><name name-style="western"><surname>Gras-Masse</surname><given-names>H.</given-names></name><name name-style="western"><surname>Bottius</surname><given-names>E.</given-names></name><name name-style="western"><surname>Kaidoh</surname><given-names>T.</given-names></name><name name-style="western"><surname>Aikawa</surname><given-names>M.</given-names></name><etal/></person-group>. (<year>1994b</year>). <article-title>Merozoite surface protein-3: a malaria protein inducing antibodies that promote <italic toggle="yes">Plasmodium falciparum</italic> killing by cooperation with blood monocytes</article-title>. <source>Blood</source><volume>84</volume>, <fpage>1594</fpage>&#8211;<lpage>1602</lpage>. <pub-id pub-id-type="doi">10.1182/blood.V84.5.1594.1594</pub-id><pub-id pub-id-type="pmid">8068948</pub-id></mixed-citation></ref><ref id="B101"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Oeuvray</surname><given-names>C.</given-names></name><name name-style="western"><surname>Bouharoun-Tayoun</surname><given-names>H.</given-names></name><name name-style="western"><surname>Grass-Masse</surname><given-names>H.</given-names></name><name name-style="western"><surname>Lepers</surname><given-names>J. P.</given-names></name><name name-style="western"><surname>Ralamboranto</surname><given-names>L.</given-names></name><name name-style="western"><surname>Tartar</surname><given-names>A.</given-names></name><etal/></person-group>. (<year>1994a</year>). <article-title>A novel merozoite surface antigen of <italic toggle="yes">Plasmodium falciparum</italic> (MSP-3) identified by cellular-antibody cooperative mechanism antigenicity and biological activity of antibodies</article-title>. <source>Mem. Inst. Oswaldo Cruz</source>. <volume>89</volume> (<issue>Suppl. 2</issue>), <fpage>77</fpage>&#8211;<lpage>80</lpage>. <pub-id pub-id-type="doi">10.1590/S0074-02761994000600018</pub-id><pub-id pub-id-type="pmid">7565137</pub-id></mixed-citation></ref><ref id="B102"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Okhuysen</surname><given-names>P. C.</given-names></name></person-group> (<year>2001</year>). <article-title>Traveler's diarrhea due to intestinal protozoa</article-title>. <source>Clin. Infect. Dis.</source><volume>33</volume>, <fpage>110</fpage>&#8211;<lpage>114</lpage>. <pub-id pub-id-type="doi">10.1086/320894</pub-id><pub-id pub-id-type="pmid">11389503</pub-id></mixed-citation></ref><ref id="B103"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Oyegue-Liabagui</surname><given-names>S. L.</given-names></name><name name-style="western"><surname>Bouopda-Tuedom</surname><given-names>A. G.</given-names></name><name name-style="western"><surname>Kouna</surname><given-names>L. C.</given-names></name><name name-style="western"><surname>Maghendji-Nzondo</surname><given-names>S.</given-names></name><name name-style="western"><surname>Nzoughe</surname><given-names>H.</given-names></name><name name-style="western"><surname>Tchitoula-Makaya</surname><given-names>N.</given-names></name><etal/></person-group>. (<year>2017</year>). <article-title>Pro- and anti-inflammatory cytokines in children with malaria in Franceville, Gabon</article-title>. <source>Am. J. Clin. Exp. Immunol.</source><volume>6</volume>, <fpage>9</fpage>&#8211;<lpage>20</lpage>. <pub-id pub-id-type="pmid">28337387</pub-id><pub-id pub-id-type="pmcid">PMC5344990</pub-id></mixed-citation></ref><ref id="B104"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Ozaki</surname><given-names>K.</given-names></name><name name-style="western"><surname>Kikly</surname><given-names>K.</given-names></name><name name-style="western"><surname>Michalovich</surname><given-names>D.</given-names></name><name name-style="western"><surname>Young</surname><given-names>P. R.</given-names></name><name name-style="western"><surname>Leonard</surname><given-names>W. J.</given-names></name></person-group> (<year>2000</year>). <article-title>Cloning of a type I cytokine receptor most related to the IL-2 receptor beta chain</article-title>. <source>Proc. Natl. Acad. Sci. U.S.A.</source><volume>97</volume>, <fpage>11439</fpage>&#8211;<lpage>11444</lpage>. <pub-id pub-id-type="doi">10.1073/pnas.200360997</pub-id><pub-id pub-id-type="pmid">11016959</pub-id><pub-id pub-id-type="pmcid">PMC17218</pub-id></mixed-citation></ref><ref id="B105"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Ozaki</surname><given-names>K.</given-names></name><name name-style="western"><surname>Spolski</surname><given-names>R.</given-names></name><name name-style="western"><surname>Feng</surname><given-names>C. G.</given-names></name><name name-style="western"><surname>Qi</surname><given-names>C. F.</given-names></name><name name-style="western"><surname>Cheng</surname><given-names>J.</given-names></name><name name-style="western"><surname>Sher</surname><given-names>A.</given-names></name><etal/></person-group>. (<year>2002</year>). <article-title>A critical role for IL-21 in regulating immunoglobulin production</article-title>. <source>Science</source><volume>298</volume>, <fpage>1630</fpage>&#8211;<lpage>1634</lpage>. <pub-id pub-id-type="doi">10.1126/science.1077002</pub-id><pub-id pub-id-type="pmid">12446913</pub-id></mixed-citation></ref><ref id="B106"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Pene</surname><given-names>J.</given-names></name><name name-style="western"><surname>Gauchat</surname><given-names>J. F.</given-names></name><name name-style="western"><surname>Lecart</surname><given-names>S.</given-names></name><name name-style="western"><surname>Drouet</surname><given-names>E.</given-names></name><name name-style="western"><surname>Guglielmi</surname><given-names>P.</given-names></name><name name-style="western"><surname>Boulay</surname><given-names>V.</given-names></name><etal/></person-group>. (<year>2004</year>). <article-title>Cutting edge: IL-21 is a switch factor for the production of IgG1 and IgG3 by human B cells</article-title>. <source>J. Immunol.</source><volume>172</volume>, <fpage>5154</fpage>&#8211;<lpage>5157</lpage>. <pub-id pub-id-type="doi">10.4049/jimmunol.172.9.5154</pub-id><pub-id pub-id-type="pmid">15100251</pub-id></mixed-citation></ref><ref id="B107"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Perera</surname><given-names>M. K.</given-names></name><name name-style="western"><surname>Herath</surname><given-names>N. P.</given-names></name><name name-style="western"><surname>Pathirana</surname><given-names>S. L.</given-names></name><name name-style="western"><surname>Phone-Kyaw</surname><given-names>M.</given-names></name><name name-style="western"><surname>Alles</surname><given-names>H. K.</given-names></name><name name-style="western"><surname>Mendis</surname><given-names>K. N.</given-names></name><etal/></person-group>. (<year>2013</year>). <article-title>Association of high plasma TNF-alpha levels and TNF-alpha/IL-10 ratios with TNF2 allele in severe <italic toggle="yes">P. falciparum</italic> malaria patients in Sri Lanka</article-title>. <source>Pathog. Glob. Health</source><volume>107</volume>, <fpage>21</fpage>&#8211;<lpage>29</lpage>. <pub-id pub-id-type="doi">10.1179/2047773212Y.0000000069</pub-id><pub-id pub-id-type="pmid">23432860</pub-id><pub-id pub-id-type="pmcid">PMC4001599</pub-id></mixed-citation></ref><ref id="B108"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Perez-Mazliah</surname><given-names>D.</given-names></name><name name-style="western"><surname>Ng</surname><given-names>D. H.</given-names></name><name name-style="western"><surname>Freitas do Rosario</surname><given-names>A. P.</given-names></name><name name-style="western"><surname>McLaughlin</surname><given-names>S.</given-names></name><name name-style="western"><surname>Mastelic-Gavillet</surname><given-names>B.</given-names></name><name name-style="western"><surname>Sodenkamp</surname><given-names>J.</given-names></name><etal/></person-group>. (<year>2015</year>). <article-title>Disruption of IL-21 signaling affects T cell-B cell interactions and abrogates protective humoral immunity to malaria</article-title>. <source>PLoS Pathog.</source><volume>11</volume>:<fpage>e1004715</fpage>. <pub-id pub-id-type="doi">10.1371/journal.ppat.1004715</pub-id><pub-id pub-id-type="pmid">25763578</pub-id><pub-id pub-id-type="pmcid">PMC4370355</pub-id></mixed-citation></ref><ref id="B109"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Pesce</surname><given-names>J.</given-names></name><name name-style="western"><surname>Kaviratne</surname><given-names>M.</given-names></name><name name-style="western"><surname>Ramalingam</surname><given-names>T. R.</given-names></name><name name-style="western"><surname>Thompson</surname><given-names>R. W.</given-names></name><name name-style="western"><surname>Urban</surname><given-names>J. F.</given-names><suffix>Jr.</suffix></name><name name-style="western"><surname>Cheever</surname><given-names>A. W.</given-names></name><etal/></person-group>. (<year>2006</year>). <article-title>The IL-21 receptor augments Th2 effector function and alternative macrophage activation</article-title>. <source>J. Clin. Invest.</source><volume>116</volume>, <fpage>2044</fpage>&#8211;<lpage>2055</lpage>. <pub-id pub-id-type="doi">10.1172/JCI27727</pub-id><pub-id pub-id-type="pmid">16778988</pub-id><pub-id pub-id-type="pmcid">PMC1479424</pub-id></mixed-citation></ref><ref id="B110"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Phillips</surname><given-names>S. M.</given-names></name><name name-style="western"><surname>Fox</surname><given-names>E. G.</given-names></name></person-group> (<year>1984</year>). <article-title>Immunopathology of parasitic diseases: a conceptual approach</article-title>. <source>Contemp. Top. Immunobiol.</source><volume>12</volume>, <fpage>421</fpage>&#8211;<lpage>461</lpage>. <pub-id pub-id-type="doi">10.1007/978-1-4684-4571-8_11</pub-id><pub-id pub-id-type="pmid">6365444</pub-id></mixed-citation></ref><ref id="B111"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Pitzalis</surname><given-names>C.</given-names></name><name name-style="western"><surname>Jones</surname><given-names>G. W.</given-names></name><name name-style="western"><surname>Bombardieri</surname><given-names>M.</given-names></name><name name-style="western"><surname>Jones</surname><given-names>S. A.</given-names></name></person-group> (<year>2014</year>). <article-title>Ectopic lymphoid-like structures in infection, cancer and autoimmunity</article-title>. <source>Nat. Rev. Immunol.</source><volume>14</volume>, <fpage>447</fpage>&#8211;<lpage>462</lpage>. <pub-id pub-id-type="doi">10.1038/nri3700</pub-id><pub-id pub-id-type="pmid">24948366</pub-id></mixed-citation></ref><ref id="B112"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Pober</surname><given-names>J. S.</given-names></name><name name-style="western"><surname>Sessa</surname><given-names>W. C.</given-names></name></person-group> (<year>2007</year>). <article-title>Evolving functions of endothelial cells in inflammation</article-title>. <source>Nat. Rev. Immunol.</source><volume>7</volume>, <fpage>803</fpage>&#8211;<lpage>815</lpage>. <pub-id pub-id-type="doi">10.1038/nri2171</pub-id><pub-id pub-id-type="pmid">17893694</pub-id></mixed-citation></ref><ref id="B113"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Poovassery</surname><given-names>J. S.</given-names></name><name name-style="western"><surname>Sarr</surname><given-names>D.</given-names></name><name name-style="western"><surname>Smith</surname><given-names>G.</given-names></name><name name-style="western"><surname>Nagy</surname><given-names>T.</given-names></name><name name-style="western"><surname>Moore</surname><given-names>J. M.</given-names></name></person-group> (<year>2009</year>). <article-title>Malaria-induced murine pregnancy failure: distinct roles for IFN-gamma and TNF</article-title>. <source>J. Immunol.</source><volume>183</volume>, <fpage>5342</fpage>&#8211;<lpage>5349</lpage>. <pub-id pub-id-type="doi">10.4049/jimmunol.0901669</pub-id><pub-id pub-id-type="pmid">19783682</pub-id><pub-id pub-id-type="pmcid">PMC2772180</pub-id></mixed-citation></ref><ref id="B114"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Pot</surname><given-names>C.</given-names></name><name name-style="western"><surname>Jin</surname><given-names>H.</given-names></name><name name-style="western"><surname>Awasthi</surname><given-names>A.</given-names></name><name name-style="western"><surname>Liu</surname><given-names>S. M.</given-names></name><name name-style="western"><surname>Lai</surname><given-names>C. Y.</given-names></name><name name-style="western"><surname>Madan</surname><given-names>R.</given-names></name><etal/></person-group>. (<year>2009</year>). <article-title>Cutting edge: IL-27 induces the transcription factor c-Maf, cytokine IL-21, and the costimulatory receptor ICOS that coordinately act together to promote differentiation of IL-10-producing Tr1 cells</article-title>. <source>J. Immunol.</source><volume>183</volume>, <fpage>797</fpage>&#8211;<lpage>801</lpage>. <pub-id pub-id-type="doi">10.4049/jimmunol.0901233</pub-id><pub-id pub-id-type="pmid">19570826</pub-id><pub-id pub-id-type="pmcid">PMC2768608</pub-id></mixed-citation></ref><ref id="B115"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Rankin</surname><given-names>A. L.</given-names></name><name name-style="western"><surname>MacLeod</surname><given-names>H.</given-names></name><name name-style="western"><surname>Keegan</surname><given-names>S.</given-names></name><name name-style="western"><surname>Andreyeva</surname><given-names>T.</given-names></name><name name-style="western"><surname>Lowe</surname><given-names>L.</given-names></name><name name-style="western"><surname>Bloom</surname><given-names>L.</given-names></name><etal/></person-group>. (<year>2011</year>). <article-title>IL-21 receptor is critical for the development of memory B cell responses</article-title>. <source>J. Immunol.</source><volume>186</volume>, <fpage>667</fpage>&#8211;<lpage>674</lpage>. <pub-id pub-id-type="doi">10.4049/jimmunol.0903207</pub-id><pub-id pub-id-type="pmid">21169545</pub-id></mixed-citation></ref><ref id="B116"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Riley</surname><given-names>E. M.</given-names></name><name name-style="western"><surname>Couper</surname><given-names>K. N.</given-names></name><name name-style="western"><surname>Helmby</surname><given-names>H.</given-names></name><name name-style="western"><surname>Hafalla</surname><given-names>J. C.</given-names></name><name name-style="western"><surname>de Souza</surname><given-names>J. B.</given-names></name><name name-style="western"><surname>Langhorne</surname><given-names>J.</given-names></name><etal/></person-group>. (<year>2010</year>). <article-title>Neuropathogenesis of human and murine malaria</article-title>. <source>Trends Parasitol.</source><volume>26</volume>, <fpage>277</fpage>&#8211;<lpage>278</lpage>. <pub-id pub-id-type="doi">10.1016/j.pt.2010.03.002</pub-id><pub-id pub-id-type="pmid">20338809</pub-id></mixed-citation></ref><ref id="B117"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Ritter</surname><given-names>M.</given-names></name><name name-style="western"><surname>Krupp</surname><given-names>V.</given-names></name><name name-style="western"><surname>Wiszniewsky</surname><given-names>K.</given-names></name><name name-style="western"><surname>Wiszniewsky</surname><given-names>A.</given-names></name><name name-style="western"><surname>Katawa</surname><given-names>G.</given-names></name><name name-style="western"><surname>Tamadaho</surname><given-names>R. S. E.</given-names></name><etal/></person-group>. (<year>2018</year>). <article-title>Absence of IL-17A in Litomosoides sigmodontis-infected mice influences worm development and drives elevated filarial-specific IFN-gamma</article-title>. <source>Parasitol. Res.</source><volume>117</volume>, <fpage>2665</fpage>&#8211;<lpage>2675</lpage>. <pub-id pub-id-type="doi">10.1007/s00436-018-5959-7</pub-id><pub-id pub-id-type="pmid">29931394</pub-id><pub-id pub-id-type="pmcid">PMC6061040</pub-id></mixed-citation></ref><ref id="B118"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Rosas</surname><given-names>L. E.</given-names></name><name name-style="western"><surname>Barbi</surname><given-names>J.</given-names></name><name name-style="western"><surname>Lu</surname><given-names>B.</given-names></name><name name-style="western"><surname>Fujiwara</surname><given-names>Y.</given-names></name><name name-style="western"><surname>Gerard</surname><given-names>C.</given-names></name><name name-style="western"><surname>Sanders</surname><given-names>V. M.</given-names></name><etal/></person-group>. (<year>2005</year>). <article-title>CXCR3-/- mice mount an efficient Th1 response but fail to control Leishmania major infection</article-title>. <source>Eur. J. Immunol.</source><volume>35</volume>, <fpage>515</fpage>&#8211;<lpage>523</lpage>. <pub-id pub-id-type="doi">10.1002/eji.200425422</pub-id><pub-id pub-id-type="pmid">15668916</pub-id></mixed-citation></ref><ref id="B119"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Roussilhon</surname><given-names>C.</given-names></name><name name-style="western"><surname>Oeuvray</surname><given-names>C.</given-names></name><name name-style="western"><surname>Muller-Graf</surname><given-names>C.</given-names></name><name name-style="western"><surname>Tall</surname><given-names>A.</given-names></name><name name-style="western"><surname>Rogier</surname><given-names>C.</given-names></name><name name-style="western"><surname>Trape</surname><given-names>J. F.</given-names></name><etal/></person-group>. (<year>2007</year>). <article-title>Long-term clinical protection from falciparum malaria is strongly associated with IgG3 antibodies to merozoite surface protein 3</article-title>. <source>PLoS Med.</source><volume>4</volume>:<fpage>e320</fpage>. <pub-id pub-id-type="doi">10.1371/journal.pmed.0040320</pub-id><pub-id pub-id-type="pmid">18001147</pub-id><pub-id pub-id-type="pmcid">PMC2071934</pub-id></mixed-citation></ref><ref id="B120"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Rudin</surname><given-names>W.</given-names></name><name name-style="western"><surname>Eugster</surname><given-names>H. P.</given-names></name><name name-style="western"><surname>Bordmann</surname><given-names>G.</given-names></name><name name-style="western"><surname>Bonato</surname><given-names>J.</given-names></name><name name-style="western"><surname>Muller</surname><given-names>M.</given-names></name><name name-style="western"><surname>Yamage</surname><given-names>M.</given-names></name><etal/></person-group>. (<year>1997</year>). <article-title>Resistance to cerebral malaria in tumor necrosis factor-alpha/beta-deficient mice is associated with a reduction of intercellular adhesion molecule-1 up-regulation and T helper type 1 response</article-title>. <source>Am. J. Pathol.</source><volume>150</volume>, <fpage>257</fpage>&#8211;<lpage>266</lpage>. <pub-id pub-id-type="pmid">9006341</pub-id><pub-id pub-id-type="pmcid">PMC1858518</pub-id></mixed-citation></ref><ref id="B121"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Ruebush</surname><given-names>M. J.</given-names></name><name name-style="western"><surname>Hanson</surname><given-names>W. L.</given-names></name></person-group> (<year>1979</year>). <article-title>Susceptibility of five strains of mice to Babesia microti of human origin</article-title>. <source>J. Parasitol.</source><volume>65</volume>, <fpage>430</fpage>&#8211;<lpage>433</lpage>. <pub-id pub-id-type="doi">10.2307/3280290</pub-id><pub-id pub-id-type="pmid">480073</pub-id></mixed-citation></ref><ref id="B122"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Ryg-Cornejo</surname><given-names>V.</given-names></name><name name-style="western"><surname>Ioannidis</surname><given-names>L. J.</given-names></name><name name-style="western"><surname>Ly</surname><given-names>A.</given-names></name><name name-style="western"><surname>Chiu</surname><given-names>C. Y.</given-names></name><name name-style="western"><surname>Tellier</surname><given-names>J.</given-names></name><name name-style="western"><surname>Hill</surname><given-names>D. L.</given-names></name><etal/></person-group>. (<year>2016</year>). <article-title>Severe malaria infections impair germinal center responses by inhibiting T follicular helper cell differentiation</article-title>. <source>Cell Rep.</source><volume>14</volume>, <fpage>68</fpage>&#8211;<lpage>81</lpage>. <pub-id pub-id-type="doi">10.1016/j.celrep.2015.12.006</pub-id><pub-id pub-id-type="pmid">26725120</pub-id></mixed-citation></ref><ref id="B123"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Saporito</surname><given-names>L.</given-names></name><name name-style="western"><surname>Giammanco</surname><given-names>G. M.</given-names></name><name name-style="western"><surname>De Grazia</surname><given-names>S.</given-names></name><name name-style="western"><surname>Colomba</surname><given-names>C.</given-names></name></person-group> (<year>2013</year>). <article-title>Visceral leishmaniasis: host-parasite interactions and clinical presentation in the immunocompetent and in the immunocompromised host</article-title>. <source>Int. J. Infect. Dis.</source><volume>17</volume>, <fpage>e572</fpage>&#8211;<lpage>e576</lpage>. <pub-id pub-id-type="doi">10.1016/j.ijid.2012.12.024</pub-id><pub-id pub-id-type="pmid">23380419</pub-id></mixed-citation></ref><ref id="B124"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Sarra</surname><given-names>M.</given-names></name><name name-style="western"><surname>Monteleone</surname><given-names>I.</given-names></name><name name-style="western"><surname>Stolfi</surname><given-names>C.</given-names></name><name name-style="western"><surname>Fantini</surname><given-names>M. C.</given-names></name><name name-style="western"><surname>Sileri</surname><given-names>P.</given-names></name><name name-style="western"><surname>Sica</surname><given-names>G.</given-names></name><etal/></person-group>. (<year>2010</year>). <article-title>Interferon-gamma-expressing cells are a major source of interleukin-21 in inflammatory bowel diseases</article-title>. <source>Inflamm. Bowel Dis.</source><volume>16</volume>, <fpage>1332</fpage>&#8211;<lpage>1339</lpage>. <pub-id pub-id-type="doi">10.1002/ibd.21238</pub-id><pub-id pub-id-type="pmid">20186935</pub-id></mixed-citation></ref><ref id="B125"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Sassi</surname><given-names>A.</given-names></name><name name-style="western"><surname>Kaak</surname><given-names>O.</given-names></name><name name-style="western"><surname>Ben Ammar Elgaied</surname><given-names>A.</given-names></name></person-group> (<year>2015</year>). <article-title>Identification of immunodominant Leishmania major antigenic markers of the early C57BL/6 and BALB/c mice infection stages</article-title>. <source>Parasite Immunol.</source><volume>37</volume>, <fpage>544</fpage>&#8211;<lpage>552</lpage>. <pub-id pub-id-type="doi">10.1111/pim.12223</pub-id><pub-id pub-id-type="pmid">26299940</pub-id></mixed-citation></ref><ref id="B126"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Scott</surname><given-names>P.</given-names></name></person-group> (<year>1991</year>). <article-title>IFN-gamma modulates the early development of Th1 and Th2 responses in a murine model of cutaneous leishmaniasis</article-title>. <source>J. Immunol.</source><volume>147</volume>, <fpage>3149</fpage>&#8211;<lpage>3155</lpage>. <pub-id pub-id-type="pmid">1833466</pub-id></mixed-citation></ref><ref id="B127"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Sebina</surname><given-names>I.</given-names></name><name name-style="western"><surname>Fogg</surname><given-names>L. G.</given-names></name><name name-style="western"><surname>James</surname><given-names>K. R.</given-names></name><name name-style="western"><surname>Soon</surname><given-names>M. S. F.</given-names></name><name name-style="western"><surname>Akter</surname><given-names>J.</given-names></name><name name-style="western"><surname>Thomas</surname><given-names>B. S.</given-names></name><etal/></person-group>. (<year>2017</year>). <article-title>IL-6 promotes CD4(+) T-cell and B-cell activation during Plasmodium infection</article-title>. <source>Parasite Immunol.</source><volume>39</volume>:<fpage>e12455</fpage>. <pub-id pub-id-type="doi">10.1111/pim.12455</pub-id><pub-id pub-id-type="pmid">28748530</pub-id></mixed-citation></ref><ref id="B128"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Sellge</surname><given-names>G.</given-names></name><name name-style="western"><surname>Magalhaes</surname><given-names>J. G.</given-names></name><name name-style="western"><surname>Konradt</surname><given-names>C.</given-names></name><name name-style="western"><surname>Fritz</surname><given-names>J. H.</given-names></name><name name-style="western"><surname>Salgado-Pabon</surname><given-names>W.</given-names></name><name name-style="western"><surname>Eberl</surname><given-names>G.</given-names></name><etal/></person-group>. (<year>2010</year>). <article-title>Th17 cells are the dominant T cell subtype primed by Shigella flexneri mediating protective immunity</article-title>. <source>J. Immunol.</source><volume>184</volume>, <fpage>2076</fpage>&#8211;<lpage>2085</lpage>. <pub-id pub-id-type="doi">10.4049/jimmunol.0900978</pub-id><pub-id pub-id-type="pmid">20089698</pub-id></mixed-citation></ref><ref id="B129"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Shainheit</surname><given-names>M. G.</given-names></name><name name-style="western"><surname>Smith</surname><given-names>P. M.</given-names></name><name name-style="western"><surname>Bazzone</surname><given-names>L. E.</given-names></name><name name-style="western"><surname>Wang</surname><given-names>A. C.</given-names></name><name name-style="western"><surname>Rutitzky</surname><given-names>L. I.</given-names></name><name name-style="western"><surname>Stadecker</surname><given-names>M. J.</given-names></name></person-group> (<year>2008</year>). <article-title>Dendritic cell IL-23 and IL-1 production in response to schistosome eggs induces Th17 cells in a mouse strain prone to severe immunopathology</article-title>. <source>J. Immunol.</source><volume>181</volume>, <fpage>8559</fpage>&#8211;<lpage>8567</lpage>. <pub-id pub-id-type="doi">10.4049/jimmunol.181.12.8559</pub-id><pub-id pub-id-type="pmid">19050275</pub-id><pub-id pub-id-type="pmcid">PMC2663362</pub-id></mixed-citation></ref><ref id="B130"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Silva</surname><given-names>J. S.</given-names></name><name name-style="western"><surname>Vespa</surname><given-names>G. N.</given-names></name><name name-style="western"><surname>Cardoso</surname><given-names>M. A.</given-names></name><name name-style="western"><surname>Aliberti</surname><given-names>J. C.</given-names></name><name name-style="western"><surname>Cunha</surname><given-names>F. Q.</given-names></name></person-group> (<year>1995</year>). <article-title>Tumor necrosis factor alpha mediates resistance to <italic toggle="yes">Trypanosoma cruzi</italic> infection in mice by inducing nitric oxide production in infected gamma interferon-activated macrophages</article-title>. <source>Infect. Immun.</source><volume>63</volume>, <fpage>4862</fpage>&#8211;<lpage>4867</lpage>. <pub-id pub-id-type="pmid">7591147</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1128/iai.63.12.4862-4867.1995</pub-id><pub-id pub-id-type="pmcid">PMC173696</pub-id></mixed-citation></ref><ref id="B131"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Sim</surname><given-names>B. K.</given-names></name></person-group> (<year>1990</year>). <article-title>Sequence conservation of a functional domain of erythrocyte binding antigen 175 in <italic toggle="yes">Plasmodium falciparum</italic></article-title>. <source>Mol. Biochem. Parasitol.</source><volume>41</volume>, <fpage>293</fpage>&#8211;<lpage>295</lpage>. <pub-id pub-id-type="doi">10.1016/0166-6851(90)90193-P</pub-id><pub-id pub-id-type="pmid">2204835</pub-id></mixed-citation></ref><ref id="B132"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Sim</surname><given-names>B. K.</given-names></name><name name-style="western"><surname>Orlandi</surname><given-names>P. A.</given-names></name><name name-style="western"><surname>Haynes</surname><given-names>J. D.</given-names></name><name name-style="western"><surname>Klotz</surname><given-names>F. W.</given-names></name><name name-style="western"><surname>Carter</surname><given-names>J. M.</given-names></name><name name-style="western"><surname>Camus</surname><given-names>D.</given-names></name><etal/></person-group>. (<year>1990</year>). <article-title>Primary structure of the 175K <italic toggle="yes">Plasmodium falciparum</italic> erythrocyte binding antigen and identification of a peptide which elicits antibodies that inhibit malaria merozoite invasion</article-title>. <source>J. Cell Biol.</source><volume>111</volume>(<issue>5 Pt 1</issue>), <fpage>1877</fpage>&#8211;<lpage>1884</lpage>. <pub-id pub-id-type="doi">10.1083/jcb.111.5.1877</pub-id><pub-id pub-id-type="pmid">2229177</pub-id><pub-id pub-id-type="pmcid">PMC2116314</pub-id></mixed-citation></ref><ref id="B133"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Solaymani-Mohammadi</surname><given-names>S.</given-names></name><name name-style="western"><surname>Berzofsky</surname><given-names>J. A.</given-names></name></person-group> (<year>2019</year>). <article-title>Interleukin 21 collaborates with interferon-gamma for the optimal expression of interferon-stimulated genes and enhances protection against enteric microbial infection</article-title>. <source>PLoS Pathog.</source><volume>15</volume>:<fpage>e1007614</fpage>. <pub-id pub-id-type="doi">10.1371/journal.ppat.1007614</pub-id><pub-id pub-id-type="pmid">30818341</pub-id><pub-id pub-id-type="pmcid">PMC6413951</pub-id></mixed-citation></ref><ref id="B134"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Solaymani-Mohammadi</surname><given-names>S.</given-names></name><name name-style="western"><surname>Singer</surname><given-names>S. M.</given-names></name></person-group> (<year>2010</year>). <article-title>Giardia duodenalis: the double-edged sword of immune responses in giardiasis</article-title>. <source>Exp. Parasitol.</source><volume>126</volume>, <fpage>292</fpage>&#8211;<lpage>297</lpage>. <pub-id pub-id-type="doi">10.1016/j.exppara.2010.06.014</pub-id><pub-id pub-id-type="pmid">20599999</pub-id><pub-id pub-id-type="pmcid">PMC2933943</pub-id></mixed-citation></ref><ref id="B135"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Solaymani-Mohammadi</surname><given-names>S.</given-names></name><name name-style="western"><surname>Singer</surname><given-names>S. M.</given-names></name></person-group> (<year>2013</year>). <article-title>Regulation of intestinal epithelial cell cytoskeletal remodeling by cellular immunity following gut infection</article-title>. <source>Mucosal Immunol.</source><volume>6</volume>, <fpage>369</fpage>&#8211;<lpage>378</lpage>. <pub-id pub-id-type="doi">10.1038/mi.2012.80</pub-id><pub-id pub-id-type="pmid">22910215</pub-id><pub-id pub-id-type="pmcid">PMC4094376</pub-id></mixed-citation></ref><ref id="B136"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Sommer</surname><given-names>F.</given-names></name><name name-style="western"><surname>Meixner</surname><given-names>M.</given-names></name><name name-style="western"><surname>Mannherz</surname><given-names>M.</given-names></name><name name-style="western"><surname>Ogilvie</surname><given-names>A. L.</given-names></name><name name-style="western"><surname>Rollinghoff</surname><given-names>M.</given-names></name><name name-style="western"><surname>Lohoff</surname><given-names>M.</given-names></name></person-group> (<year>1998</year>). <article-title>Analysis of cytokine patterns produced by individual CD4+ lymph node cells during experimental murine leishmaniasis in resistant and susceptible mice</article-title>. <source>Int. Immunol.</source><volume>10</volume>, <fpage>1853</fpage>&#8211;<lpage>1861</lpage>. <pub-id pub-id-type="doi">10.1093/intimm/10.12.1853</pub-id><pub-id pub-id-type="pmid">9885906</pub-id></mixed-citation></ref><ref id="B137"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Spolski</surname><given-names>R.</given-names></name><name name-style="western"><surname>Leonard</surname><given-names>W. J.</given-names></name></person-group> (<year>2008</year>). <article-title>Interleukin-21: basic biology and implications for cancer and autoimmunity</article-title>. <source>Annu. Rev. Immunol.</source><volume>26</volume>, <fpage>57</fpage>&#8211;<lpage>79</lpage>. <pub-id pub-id-type="doi">10.1146/annurev.immunol.26.021607.090316</pub-id><pub-id pub-id-type="pmid">17953510</pub-id></mixed-citation></ref><ref id="B138"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Spolski</surname><given-names>R.</given-names></name><name name-style="western"><surname>Leonard</surname><given-names>W. J.</given-names></name></person-group> (<year>2010a</year>). <article-title>IL-21 is an immune activator that also mediates suppression via IL-10</article-title>. <source>Crit. Rev. Immunol.</source><volume>30</volume>, <fpage>559</fpage>&#8211;<lpage>570</lpage>. <pub-id pub-id-type="doi">10.1615/CritRevImmunol.v30.i6.50</pub-id><pub-id pub-id-type="pmid">21175418</pub-id></mixed-citation></ref><ref id="B139"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Spolski</surname><given-names>R.</given-names></name><name name-style="western"><surname>Leonard</surname><given-names>W. J.</given-names></name></person-group> (<year>2010b</year>). <article-title>IL-21 and T follicular helper cells</article-title>. <source>Int. Immunol.</source><volume>22</volume>, <fpage>7</fpage>&#8211;<lpage>12</lpage>. <pub-id pub-id-type="doi">10.1093/intimm/dxp112</pub-id><pub-id pub-id-type="pmid">19933709</pub-id><pub-id pub-id-type="pmcid">PMC2795365</pub-id></mixed-citation></ref><ref id="B140"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Spolski</surname><given-names>R.</given-names></name><name name-style="western"><surname>Leonard</surname><given-names>W. J.</given-names></name></person-group> (<year>2014</year>). <article-title>Interleukin-21: a double-edged sword with therapeutic potential</article-title>. <source>Nat. Rev. Drug Discov.</source><volume>13</volume>, <fpage>379</fpage>&#8211;<lpage>395</lpage>. <pub-id pub-id-type="doi">10.1038/nrd4296</pub-id><pub-id pub-id-type="pmid">24751819</pub-id></mixed-citation></ref><ref id="B141"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Spolski</surname><given-names>R.</given-names></name><name name-style="western"><surname>West</surname><given-names>E. E.</given-names></name><name name-style="western"><surname>Li</surname><given-names>P.</given-names></name><name name-style="western"><surname>Veenbergen</surname><given-names>S.</given-names></name><name name-style="western"><surname>Yung</surname><given-names>S.</given-names></name><name name-style="western"><surname>Kazemian</surname><given-names>M.</given-names></name><etal/></person-group>. (<year>2019</year>). <article-title>IL-21/type I interferon interplay regulates neutrophil-dependent innate immune responses to Staphylococcus aureus</article-title>. <source>Elife</source><volume>8</volume>:<fpage>e45501</fpage>. <pub-id pub-id-type="doi">10.7554/eLife.45501</pub-id><pub-id pub-id-type="pmid">30969166</pub-id><pub-id pub-id-type="pmcid">PMC6504231</pub-id></mixed-citation></ref><ref id="B142"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Sripa</surname><given-names>B.</given-names></name><name name-style="western"><surname>Jumnainsong</surname><given-names>A.</given-names></name><name name-style="western"><surname>Tangkawattana</surname><given-names>S.</given-names></name><name name-style="western"><surname>Haswell</surname><given-names>M. R.</given-names></name></person-group> (<year>2018</year>). <article-title>Immune response to <italic toggle="yes">Opisthorchis viverrini</italic> infection and its role in pathology</article-title>. <source>Adv. Parasitol.</source><volume>102</volume>, <fpage>73</fpage>&#8211;<lpage>95</lpage>. <pub-id pub-id-type="doi">10.1016/bs.apar.2018.08.003</pub-id><pub-id pub-id-type="pmid">30442311</pub-id></mixed-citation></ref><ref id="B143"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Stevenson</surname><given-names>M. M.</given-names></name><name name-style="western"><surname>Gros</surname><given-names>P.</given-names></name><name name-style="western"><surname>Olivier</surname><given-names>M.</given-names></name><name name-style="western"><surname>Fortin</surname><given-names>A.</given-names></name><name name-style="western"><surname>Serghides</surname><given-names>L.</given-names></name></person-group> (<year>2010</year>). <article-title>Cerebral malaria: human versus mouse studies</article-title>. <source>Trends Parasitol.</source><volume>26</volume>, <fpage>274</fpage>&#8211;<lpage>275</lpage>. <pub-id pub-id-type="doi">10.1016/j.pt.2010.03.008</pub-id><pub-id pub-id-type="pmid">20382077</pub-id></mixed-citation></ref><ref id="B144"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Stolfi</surname><given-names>C.</given-names></name><name name-style="western"><surname>Rizzo</surname><given-names>A.</given-names></name><name name-style="western"><surname>Franze</surname><given-names>E.</given-names></name><name name-style="western"><surname>Rotondi</surname><given-names>A.</given-names></name><name name-style="western"><surname>Fantini</surname><given-names>M. C.</given-names></name><name name-style="western"><surname>Sarra</surname><given-names>M.</given-names></name><etal/></person-group>. (<year>2011</year>). <article-title>Involvement of interleukin-21 in the regulation of colitis-associated colon cancer</article-title>. <source>J. Exp. Med.</source><volume>208</volume>, <fpage>2279</fpage>&#8211;<lpage>2290</lpage>. <pub-id pub-id-type="doi">10.1084/jem.20111106</pub-id><pub-id pub-id-type="pmid">21987656</pub-id><pub-id pub-id-type="pmcid">PMC3201207</pub-id></mixed-citation></ref><ref id="B145"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Strengell</surname><given-names>M.</given-names></name><name name-style="western"><surname>Matikainen</surname><given-names>S.</given-names></name><name name-style="western"><surname>Siren</surname><given-names>J.</given-names></name><name name-style="western"><surname>Lehtonen</surname><given-names>A.</given-names></name><name name-style="western"><surname>Foster</surname><given-names>D.</given-names></name><name name-style="western"><surname>Julkunen</surname><given-names>I.</given-names></name><etal/></person-group>. (<year>2003</year>). <article-title>IL-21 in synergy with IL-15 or IL-18 enhances IFN-gamma production in human NK and T cells</article-title>. <source>J. Immunol.</source><volume>170</volume>, <fpage>5464</fpage>&#8211;<lpage>5469</lpage>. <pub-id pub-id-type="doi">10.4049/jimmunol.170.11.5464</pub-id><pub-id pub-id-type="pmid">12759422</pub-id></mixed-citation></ref><ref id="B146"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Strengell</surname><given-names>M.</given-names></name><name name-style="western"><surname>Sareneva</surname><given-names>T.</given-names></name><name name-style="western"><surname>Foster</surname><given-names>D.</given-names></name><name name-style="western"><surname>Julkunen</surname><given-names>I.</given-names></name><name name-style="western"><surname>Matikainen</surname><given-names>S.</given-names></name></person-group> (<year>2002</year>). <article-title>IL-21 up-regulates the expression of genes associated with innate immunity and Th1 response</article-title>. <source>J. Immunol.</source><volume>169</volume>, <fpage>3600</fpage>&#8211;<lpage>3605</lpage>. <pub-id pub-id-type="doi">10.4049/jimmunol.169.7.3600</pub-id><pub-id pub-id-type="pmid">12244150</pub-id></mixed-citation></ref><ref id="B147"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Stumhofer</surname><given-names>J. S.</given-names></name><name name-style="western"><surname>Silver</surname><given-names>J. S.</given-names></name><name name-style="western"><surname>Hunter</surname><given-names>C. A.</given-names></name></person-group> (<year>2013</year>). <article-title>IL-21 is required for optimal antibody production and T cell responses during chronic <italic toggle="yes">Toxoplasma gondii</italic> infection</article-title>. <source>PLoS ONE</source><volume>8</volume>:<fpage>e62889</fpage>. <pub-id pub-id-type="doi">10.1371/journal.pone.0062889</pub-id><pub-id pub-id-type="pmid">23667536</pub-id><pub-id pub-id-type="pmcid">PMC3647013</pub-id></mixed-citation></ref><ref id="B148"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Taniguchi</surname><given-names>T.</given-names></name><name name-style="western"><surname>Miyauchi</surname><given-names>E.</given-names></name><name name-style="western"><surname>Nakamura</surname><given-names>S.</given-names></name><name name-style="western"><surname>Hirai</surname><given-names>M.</given-names></name><name name-style="western"><surname>Suzue</surname><given-names>K.</given-names></name><name name-style="western"><surname>Imai</surname><given-names>T.</given-names></name><etal/></person-group>. (<year>2015</year>). <article-title>Plasmodium berghei ANKA causes intestinal malaria associated with dysbiosis</article-title>. <source>Sci. Rep.</source><volume>5</volume>:<fpage>15699</fpage>. <pub-id pub-id-type="doi">10.1038/srep15699</pub-id><pub-id pub-id-type="pmid">26503461</pub-id><pub-id pub-id-type="pmcid">PMC4621605</pub-id></mixed-citation></ref><ref id="B149"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Torben</surname><given-names>W.</given-names></name><name name-style="western"><surname>Molehin</surname><given-names>A. J.</given-names></name><name name-style="western"><surname>Blair</surname><given-names>R. V.</given-names></name><name name-style="western"><surname>Kenway</surname><given-names>C.</given-names></name><name name-style="western"><surname>Shiro</surname><given-names>F.</given-names></name><name name-style="western"><surname>Roslyn</surname><given-names>D.</given-names></name><etal/></person-group>. (<year>2017</year>). <article-title>The self-curing phenomenon of schistosome infection in rhesus macaques: insight from <italic toggle="yes">in vitro</italic> studies</article-title>. <source>Ann. N. Y. Acad. Sci.</source><volume>1408</volume>, <fpage>79</fpage>&#8211;<lpage>89</lpage>. <pub-id pub-id-type="doi">10.1111/nyas.13565</pub-id><pub-id pub-id-type="pmid">29239481</pub-id></mixed-citation></ref><ref id="B150"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Torgerson</surname><given-names>P. R.</given-names></name><name name-style="western"><surname>de Silva</surname><given-names>N. R.</given-names></name><name name-style="western"><surname>Fevre</surname><given-names>E. M.</given-names></name><name name-style="western"><surname>Kasuga</surname><given-names>F.</given-names></name><name name-style="western"><surname>Rokni</surname><given-names>M. B.</given-names></name><name name-style="western"><surname>Zhou</surname><given-names>X. N.</given-names></name><etal/></person-group>. (<year>2014</year>). <article-title>The global burden of foodborne parasitic diseases: an update</article-title>. <source>Trends Parasitol.</source><volume>30</volume>, <fpage>20</fpage>&#8211;<lpage>26</lpage>. <pub-id pub-id-type="doi">10.1016/j.pt.2013.11.002</pub-id><pub-id pub-id-type="pmid">24314578</pub-id></mixed-citation></ref><ref id="B151"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Torgerson</surname><given-names>P. R.</given-names></name><name name-style="western"><surname>Devleesschauwer</surname><given-names>B.</given-names></name><name name-style="western"><surname>Praet</surname><given-names>N.</given-names></name><name name-style="western"><surname>Speybroeck</surname><given-names>N.</given-names></name><name name-style="western"><surname>Willingham</surname><given-names>A. L.</given-names></name><name name-style="western"><surname>Kasuga</surname><given-names>F.</given-names></name><etal/></person-group>. (<year>2015</year>). <article-title>World Health Organization estimates of the global and regional disease burden of 11 foodborne parasitic diseases, 2010: a data synthesis</article-title>. <source>PLoS Med.</source><volume>12</volume>:<fpage>e1001920</fpage>. <pub-id pub-id-type="doi">10.1371/journal.pmed.1001920</pub-id><pub-id pub-id-type="pmid">26633705</pub-id><pub-id pub-id-type="pmcid">PMC4668834</pub-id></mixed-citation></ref><ref id="B152"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Tortola</surname><given-names>L.</given-names></name><name name-style="western"><surname>Pawelski</surname><given-names>H.</given-names></name><name name-style="western"><surname>Sonar</surname><given-names>S. S.</given-names></name><name name-style="western"><surname>Ampenberger</surname><given-names>F.</given-names></name><name name-style="western"><surname>Kurrer</surname><given-names>M.</given-names></name><name name-style="western"><surname>Kopf</surname><given-names>M.</given-names></name></person-group> (<year>2019</year>). <article-title>IL-21 promotes allergic airway inflammation by driving apoptosis of FoxP3(+) regulatory T cells</article-title>. <source>J. Allergy Clin. Immunol</source>. <volume>143</volume>, <fpage>2178</fpage>&#8211;<lpage>2189</lpage>.e5. <pub-id pub-id-type="doi">10.1016/j.jaci.2018.11.047</pub-id><pub-id pub-id-type="pmid">30654048</pub-id></mixed-citation></ref><ref id="B153"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Vinuesa</surname><given-names>C. G.</given-names></name><name name-style="western"><surname>Linterman</surname><given-names>M. A.</given-names></name><name name-style="western"><surname>Yu</surname><given-names>D.</given-names></name><name name-style="western"><surname>MacLennan</surname><given-names>I. C.</given-names></name></person-group> (<year>2016</year>). <article-title>Follicular helper T cells</article-title>. <source>Annu. Rev. Immunol.</source><volume>34</volume>, <fpage>335</fpage>&#8211;<lpage>368</lpage>. <pub-id pub-id-type="doi">10.1146/annurev-immunol-041015-055605</pub-id><pub-id pub-id-type="pmid">26907215</pub-id></mixed-citation></ref><ref id="B154"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>von Stebut</surname><given-names>E.</given-names></name><name name-style="western"><surname>Belkaid</surname><given-names>Y.</given-names></name><name name-style="western"><surname>Jakob</surname><given-names>T.</given-names></name><name name-style="western"><surname>Sacks</surname><given-names>D. L.</given-names></name><name name-style="western"><surname>Udey</surname><given-names>M. C.</given-names></name></person-group> (<year>1998</year>). <article-title>Uptake of Leishmania major amastigotes results in activation and interleukin 12 release from murine skin-derived dendritic cells: implications for the initiation of anti-Leishmania immunity</article-title>. <source>J. Exp. Med.</source><volume>188</volume>, <fpage>1547</fpage>&#8211;<lpage>1552</lpage>. <pub-id pub-id-type="doi">10.1084/jem.188.8.1547</pub-id><pub-id pub-id-type="pmid">9782133</pub-id><pub-id pub-id-type="pmcid">PMC2213412</pub-id></mixed-citation></ref><ref id="B155"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>von Stebut</surname><given-names>E.</given-names></name><name name-style="western"><surname>Belkaid</surname><given-names>Y.</given-names></name><name name-style="western"><surname>Nguyen</surname><given-names>B. V.</given-names></name><name name-style="western"><surname>Cushing</surname><given-names>M.</given-names></name><name name-style="western"><surname>Sacks</surname><given-names>D. L.</given-names></name><name name-style="western"><surname>Udey</surname><given-names>M. C.</given-names></name></person-group> (<year>2000</year>). <article-title>Leishmania major-infected murine langerhans cell-like dendritic cells from susceptible mice release IL-12 after infection and vaccinate against experimental cutaneous Leishmaniasis</article-title>. <source>Eur. J. Immunol.</source><volume>30</volume>, <fpage>3498</fpage>&#8211;<lpage>3506</lpage>. <pub-id pub-id-type="doi" assigning-authority="pmc">10.1002/1521-4141(2000012)30:12&amp;#x0003c;3498::AID-IMMU3498&amp;#x0003e;3.0.CO;2-6</pub-id><pub-id pub-id-type="pmid">11093169</pub-id></mixed-citation></ref><ref id="B156"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Von Stebut</surname><given-names>E.</given-names></name><name name-style="western"><surname>Ehrchen</surname><given-names>J. M.</given-names></name><name name-style="western"><surname>Belkaid</surname><given-names>Y.</given-names></name><name name-style="western"><surname>Kostka</surname><given-names>S. L.</given-names></name><name name-style="western"><surname>Molle</surname><given-names>K.</given-names></name><name name-style="western"><surname>Knop</surname><given-names>J.</given-names></name><etal/></person-group>. (<year>2003</year>). <article-title>Interleukin 1alpha promotes Th1 differentiation and inhibits disease progression in Leishmania major-susceptible BALB/c mice</article-title>. <source>J. Exp. Med.</source><volume>198</volume>, <fpage>191</fpage>&#8211;<lpage>199</lpage>. <pub-id pub-id-type="doi">10.1084/jem.20030159</pub-id><pub-id pub-id-type="pmid">12860932</pub-id><pub-id pub-id-type="pmcid">PMC2194079</pub-id></mixed-citation></ref><ref id="B157"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Wan</surname><given-names>C. K.</given-names></name><name name-style="western"><surname>Andraski</surname><given-names>A. B.</given-names></name><name name-style="western"><surname>Spolski</surname><given-names>R.</given-names></name><name name-style="western"><surname>Li</surname><given-names>P.</given-names></name><name name-style="western"><surname>Kazemian</surname><given-names>M.</given-names></name><name name-style="western"><surname>Oh</surname><given-names>J.</given-names></name><etal/></person-group>. (<year>2015</year>). <article-title>Opposing roles of STAT1 and STAT3 in IL-21 function in CD4+ T cells</article-title>. <source>Proc. Natl. Acad. Sci. U.S.A.</source><volume>112</volume>, <fpage>9394</fpage>&#8211;<lpage>9399</lpage>. <pub-id pub-id-type="doi">10.1073/pnas.1511711112</pub-id><pub-id pub-id-type="pmid">26170288</pub-id><pub-id pub-id-type="pmcid">PMC4522759</pub-id></mixed-citation></ref><ref id="B158"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Wan</surname><given-names>C. K.</given-names></name><name name-style="western"><surname>Oh</surname><given-names>J.</given-names></name><name name-style="western"><surname>Li</surname><given-names>P.</given-names></name><name name-style="western"><surname>West</surname><given-names>E. E.</given-names></name><name name-style="western"><surname>Wong</surname><given-names>E. A.</given-names></name><name name-style="western"><surname>Andraski</surname><given-names>A. B.</given-names></name><etal/></person-group>. (<year>2013</year>). <article-title>The cytokines IL-21 and GM-CSF have opposing regulatory roles in the apoptosis of conventional dendritic cells</article-title>. <source>Immunity</source><volume>38</volume>, <fpage>514</fpage>&#8211;<lpage>527</lpage>. <pub-id pub-id-type="doi">10.1016/j.immuni.2013.02.011</pub-id><pub-id pub-id-type="pmid">23453633</pub-id><pub-id pub-id-type="pmcid">PMC3705920</pub-id></mixed-citation></ref><ref id="B159"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Wang</surname><given-names>B.</given-names></name><name name-style="western"><surname>Liang</surname><given-names>S.</given-names></name><name name-style="western"><surname>Wang</surname><given-names>Y.</given-names></name><name name-style="western"><surname>Zhu</surname><given-names>X. Q.</given-names></name><name name-style="western"><surname>Gong</surname><given-names>W.</given-names></name><name name-style="western"><surname>Zhang</surname><given-names>H. Q.</given-names></name><etal/></person-group>. (<year>2015</year>). <article-title>Th17 down-regulation is involved in reduced progression of schistosomiasis fibrosis in ICOSL KO mice</article-title>. <source>PLoS Negl. Trop. Dis.</source><volume>9</volume>:<fpage>e0003434</fpage>. <pub-id pub-id-type="doi">10.1371/journal.pntd.0003434</pub-id><pub-id pub-id-type="pmid">25590646</pub-id><pub-id pub-id-type="pmcid">PMC4295877</pub-id></mixed-citation></ref><ref id="B160"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Wang</surname><given-names>S.</given-names></name><name name-style="western"><surname>Wang</surname><given-names>J.</given-names></name><name name-style="western"><surname>Kumar</surname><given-names>V.</given-names></name><name name-style="western"><surname>Karnell</surname><given-names>J. L.</given-names></name><name name-style="western"><surname>Naiman</surname><given-names>B.</given-names></name><name name-style="western"><surname>Gross</surname><given-names>P. S.</given-names></name><etal/></person-group> (<year>2018</year>). <article-title>IL-21 drives expansion and plasma cell differentiation of autoreactive CD11c(hi)T-bet(+) B cells in SLE</article-title>. <source>Nat. Commun.</source><volume>9</volume>, <fpage>1758</fpage><pub-id pub-id-type="doi">10.1038/s41467-018-03750-7</pub-id><pub-id pub-id-type="pmid">29717110</pub-id><pub-id pub-id-type="pmcid">PMC5931508</pub-id></mixed-citation></ref><ref id="B161"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Wang</surname><given-names>Y.</given-names></name><name name-style="western"><surname>Jiang</surname><given-names>X.</given-names></name><name name-style="western"><surname>Zhu</surname><given-names>J.</given-names></name><name name-style="western"><surname>Dan</surname><given-names>Y.</given-names></name><name name-style="western"><surname>Zhang</surname><given-names>X.</given-names></name><name name-style="western"><surname>Wang</surname><given-names>X.</given-names></name><etal/></person-group>. (<year>2016</year>). <article-title>IL-21/IL-21R signaling suppresses intestinal inflammation induced by DSS through regulation of Th responses in lamina propria in mice</article-title>. <source>Sci. Rep.</source><volume>6</volume>:<fpage>31881</fpage>. <pub-id pub-id-type="doi">10.1038/srep31881</pub-id><pub-id pub-id-type="pmid">27545302</pub-id><pub-id pub-id-type="pmcid">PMC4992961</pub-id></mixed-citation></ref><ref id="B162"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Weaver</surname><given-names>J. D.</given-names></name><name name-style="western"><surname>Hoffman</surname><given-names>V. J.</given-names></name><name name-style="western"><surname>Roffe</surname><given-names>E.</given-names></name><name name-style="western"><surname>Murphy</surname><given-names>P. M.</given-names></name></person-group> (<year>2019</year>). <article-title>Low-level parasite Persistence drives vasculitis and myositis in skeletal muscle of mice chronically infected with <italic toggle="yes">Trypanosoma cruzi</italic></article-title>. <source>Infect. Immun.</source><volume>87</volume>:<fpage>e00081-19</fpage>. <pub-id pub-id-type="doi">10.1128/IAI.00081-19</pub-id><pub-id pub-id-type="pmid">30936158</pub-id><pub-id pub-id-type="pmcid">PMC6529661</pub-id></mixed-citation></ref><ref id="B163"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Wikenheiser</surname><given-names>D. J.</given-names></name><name name-style="western"><surname>Brown</surname><given-names>S. L.</given-names></name><name name-style="western"><surname>Lee</surname><given-names>J.</given-names></name><name name-style="western"><surname>Stumhofer</surname><given-names>J. S.</given-names></name></person-group> (<year>2018</year>). <article-title>NK1.1 expression defines a population of CD4(+) effector T cells displaying Th1 and Tfh Cell properties that support early antibody production during <italic toggle="yes">Plasmodium yoelii</italic> infection</article-title>. <source>Front. Immunol.</source><volume>9</volume>:<fpage>2277</fpage>. <pub-id pub-id-type="doi">10.3389/fimmu.2018.02277</pub-id><pub-id pub-id-type="pmid">30374346</pub-id><pub-id pub-id-type="pmcid">PMC6196288</pub-id></mixed-citation></ref><ref id="B164"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Wynn</surname><given-names>T. A.</given-names></name></person-group> (<year>2004</year>). <article-title>Fibrotic disease and the T(H)1/T(H)2 paradigm</article-title>. <source>Nat. Rev. Immunol.</source><volume>4</volume>, <fpage>583</fpage>&#8211;<lpage>594</lpage>. <pub-id pub-id-type="doi">10.1038/nri1412</pub-id><pub-id pub-id-type="pmid">15286725</pub-id><pub-id pub-id-type="pmcid">PMC2702150</pub-id></mixed-citation></ref><ref id="B165"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Wynn</surname><given-names>T. A.</given-names></name><name name-style="western"><surname>Thompson</surname><given-names>R. W.</given-names></name><name name-style="western"><surname>Cheever</surname><given-names>A. W.</given-names></name><name name-style="western"><surname>Mentink-Kane</surname><given-names>M. M.</given-names></name></person-group> (<year>2004</year>). <article-title>Immunopathogenesis of schistosomiasis</article-title>. <source>Immunol. Rev.</source><volume>201</volume>, <fpage>156</fpage>&#8211;<lpage>167</lpage>. <pub-id pub-id-type="doi">10.1111/j.0105-2896.2004.00176.x</pub-id><pub-id pub-id-type="pmid">15361239</pub-id></mixed-citation></ref><ref id="B166"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Yi</surname><given-names>W.</given-names></name><name name-style="western"><surname>Bao</surname><given-names>W.</given-names></name><name name-style="western"><surname>Rodriguez</surname><given-names>M.</given-names></name><name name-style="western"><surname>Liu</surname><given-names>Y.</given-names></name><name name-style="western"><surname>Singh</surname><given-names>M.</given-names></name><name name-style="western"><surname>Ramlall</surname><given-names>V.</given-names></name><etal/></person-group>. (<year>2018</year>). <article-title>Robust adaptive immune response against <italic toggle="yes">Babesia microti</italic> infection marked by low parasitemia in a murine model of sickle cell disease</article-title>. <source>Blood Adv</source>. <volume>2</volume>, <fpage>3462</fpage>&#8211;<lpage>3478</lpage>. <pub-id pub-id-type="doi">10.1182/bloodadvances.2018026468</pub-id><pub-id pub-id-type="pmid">30518538</pub-id><pub-id pub-id-type="pmcid">PMC6290097</pub-id></mixed-citation></ref><ref id="B167"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Yong</surname><given-names>L.</given-names></name><name name-style="western"><surname>Tang</surname><given-names>Y.</given-names></name><name name-style="western"><surname>Ren</surname><given-names>C.</given-names></name><name name-style="western"><surname>Liu</surname><given-names>M.</given-names></name><name name-style="western"><surname>Shen</surname><given-names>J.</given-names></name><name name-style="western"><surname>Hou</surname><given-names>X.</given-names></name></person-group> (<year>2019</year>). <article-title>B1 cells protect against <italic toggle="yes">Schistosoma japonicum</italic>-induced liver inflammation and fibrosis by controlling monocyte infiltration</article-title>. <source>PLoS Negl. Trop. Dis.</source><volume>13</volume>:<fpage>e0007474</fpage>. <pub-id pub-id-type="doi">10.1371/journal.pntd.0007474</pub-id><pub-id pub-id-type="pmid">31194740</pub-id><pub-id pub-id-type="pmcid">PMC6592576</pub-id></mixed-citation></ref><ref id="B168"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Zelante</surname><given-names>T.</given-names></name><name name-style="western"><surname>De Luca</surname><given-names>A.</given-names></name><name name-style="western"><surname>D'Angelo</surname><given-names>C.</given-names></name><name name-style="western"><surname>Moretti</surname><given-names>S.</given-names></name><name name-style="western"><surname>Romani</surname><given-names>L.</given-names></name></person-group> (<year>2009</year>). <article-title>IL-17/Th17 in anti-fungal immunity: what's new?</article-title><source>Eur. J. Immunol.</source><volume>39</volume>, <fpage>645</fpage>&#8211;<lpage>648</lpage>. <pub-id pub-id-type="doi">10.1002/eji.200839102</pub-id><pub-id pub-id-type="pmid">19283705</pub-id></mixed-citation></ref><ref id="B169"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Zeng</surname><given-names>R.</given-names></name><name name-style="western"><surname>Spolski</surname><given-names>R.</given-names></name><name name-style="western"><surname>Finkelstein</surname><given-names>S. E.</given-names></name><name name-style="western"><surname>Oh</surname><given-names>S.</given-names></name><name name-style="western"><surname>Kovanen</surname><given-names>P. E.</given-names></name><name name-style="western"><surname>Hinrichs</surname><given-names>C. S.</given-names></name><etal/></person-group>. (<year>2005</year>). <article-title>Synergy of IL-21 and IL-15 in regulating CD8+ T cell expansion and function</article-title>. <source>J. Exp. Med.</source><volume>201</volume>, <fpage>139</fpage>&#8211;<lpage>148</lpage>. <pub-id pub-id-type="doi">10.1084/jem.20041057</pub-id><pub-id pub-id-type="pmid">15630141</pub-id><pub-id pub-id-type="pmcid">PMC2212766</pub-id></mixed-citation></ref><ref id="B170"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Zhang</surname><given-names>C.</given-names></name><name name-style="western"><surname>Wang</surname><given-names>L.</given-names></name><name name-style="western"><surname>Ali</surname><given-names>T.</given-names></name><name name-style="western"><surname>Li</surname><given-names>L.</given-names></name><name name-style="western"><surname>Bi</surname><given-names>X.</given-names></name><name name-style="western"><surname>Wang</surname><given-names>J.</given-names></name><etal/></person-group>. (<year>2016</year>). <article-title>Hydatid cyst fluid promotes peri-cystic fibrosis in cystic echinococcosis by suppressing miR-19 expression</article-title>. <source>Parasit. Vectors</source><volume>9</volume>:<fpage>278</fpage>. <pub-id pub-id-type="doi">10.1186/s13071-016-1562-x</pub-id><pub-id pub-id-type="pmid">27177776</pub-id><pub-id pub-id-type="pmcid">PMC4866024</pub-id></mixed-citation></ref><ref id="B171"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Zhang</surname><given-names>F.</given-names></name><name name-style="western"><surname>Pang</surname><given-names>N.</given-names></name><name name-style="western"><surname>Zhu</surname><given-names>Y.</given-names></name><name name-style="western"><surname>Zhou</surname><given-names>D.</given-names></name><name name-style="western"><surname>Zhao</surname><given-names>H.</given-names></name><name name-style="western"><surname>Hu</surname><given-names>J.</given-names></name><etal/></person-group>. (<year>2015</year>). <article-title>CCR7(lo)PD-1(hi) CXCR5(+) CD4(+) T cells are positively correlated with levels of IL-21 in active and transitional cystic echinococcosis patients</article-title>. <source>BMC Infect. Dis.</source><volume>15</volume>:<fpage>457</fpage>. <pub-id pub-id-type="doi">10.1186/s12879-015-1156-9</pub-id><pub-id pub-id-type="pmid">26503442</pub-id><pub-id pub-id-type="pmcid">PMC4624577</pub-id></mixed-citation></ref><ref id="B172"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Zhang</surname><given-names>J.</given-names></name><name name-style="western"><surname>Gao</surname><given-names>W.</given-names></name><name name-style="western"><surname>Guo</surname><given-names>Q.</given-names></name><name name-style="western"><surname>Huang</surname><given-names>B.</given-names></name><name name-style="western"><surname>Wang</surname><given-names>B.</given-names></name><name name-style="western"><surname>Xia</surname><given-names>G.</given-names></name><etal/></person-group>. (<year>2013</year>). <article-title>Helminth protein vaccine induced follicular T helper cell for enhancement of humoral immunity against <italic toggle="yes">Schistosoma japonicum</italic></article-title>. <source>Biomed. Res. Int.</source><volume>2013</volume>:<fpage>798164</fpage>. <pub-id pub-id-type="doi">10.1155/2013/798164</pub-id><pub-id pub-id-type="pmid">24308005</pub-id><pub-id pub-id-type="pmcid">PMC3838807</pub-id></mixed-citation></ref><ref id="B173"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Zhang</surname><given-names>W.</given-names></name><name name-style="western"><surname>Ahmad</surname><given-names>G.</given-names></name><name name-style="western"><surname>Molehin</surname><given-names>A. J.</given-names></name><name name-style="western"><surname>Torben</surname><given-names>W.</given-names></name><name name-style="western"><surname>Le</surname><given-names>L.</given-names></name><name name-style="western"><surname>Kim</surname><given-names>E.</given-names></name><etal/></person-group>. (<year>2018</year>). <article-title><italic toggle="yes">Schistosoma mansoni</italic> antigen Sm-p80: prophylactic efficacy using TLR4 agonist vaccine adjuvant glucopyranosyl lipid A-Alum in murine and non-human primate models</article-title>. <source>J. Investig. Med.</source><volume>66</volume>, <fpage>1124</fpage>&#8211;<lpage>1132</lpage>. <pub-id pub-id-type="doi">10.1136/jim-2018-000786</pub-id><pub-id pub-id-type="pmid">29997146</pub-id><pub-id pub-id-type="pmcid">PMC6288690</pub-id></mixed-citation></ref><ref id="B174"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Zhang</surname><given-names>Y.</given-names></name><name name-style="western"><surname>Wang</surname><given-names>Y.</given-names></name><name name-style="western"><surname>Jiang</surname><given-names>Y.</given-names></name><name name-style="western"><surname>Pan</surname><given-names>W.</given-names></name><name name-style="western"><surname>Liu</surname><given-names>H.</given-names></name><name name-style="western"><surname>Yin</surname><given-names>J.</given-names></name><etal/></person-group>. (<year>2016</year>). <article-title>T follicular helper cells in patients with acute schistosomiasis</article-title>. <source>Parasit. Vectors</source><volume>9</volume>:<fpage>321</fpage>. <pub-id pub-id-type="doi">10.1186/s13071-016-1602-6</pub-id><pub-id pub-id-type="pmid">27266984</pub-id><pub-id pub-id-type="pmcid">PMC4895967</pub-id></mixed-citation></ref><ref id="B175"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Zotos</surname><given-names>D.</given-names></name><name name-style="western"><surname>Coquet</surname><given-names>J. M.</given-names></name><name name-style="western"><surname>Zhang</surname><given-names>Y.</given-names></name><name name-style="western"><surname>Light</surname><given-names>A.</given-names></name><name name-style="western"><surname>D'Costa</surname><given-names>K.</given-names></name><name name-style="western"><surname>Kallies</surname><given-names>A.</given-names></name><etal/></person-group>. (<year>2010</year>). <article-title>IL-21 regulates germinal center B cell differentiation and proliferation through a B cell-intrinsic mechanism</article-title>. <source>J. Exp. Med.</source><volume>207</volume>, <fpage>365</fpage>&#8211;<lpage>378</lpage>. <pub-id pub-id-type="doi">10.1084/jem.20091777</pub-id><pub-id pub-id-type="pmid">20142430</pub-id><pub-id pub-id-type="pmcid">PMC2822601</pub-id></mixed-citation></ref></ref-list></back></article></pmc-articleset>